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1 Summary 
The cell membrane is crucial for living cells; it encloses the intracellular 
matrix, maintains the concentration of cytosolic components, and controls 
the in-/outward signalling and interaction pathways. The cell membrane 
consists mainly of lipids and proteins. Membrane proteins are involved in 
essential physiological functions of the cell; in addition, they have the 
ability to organize, interact and assemble laterally to form clusters or 
platforms that are biologically important for cell function. The mechanisms 
underlying membrane protein organization and assembly in clusters are 
still not completely understood. 
Tetraspanins are a family of membrane proteins exhibiting a particularly 
high propensity to interact with each other or with partner proteins to form 
so-called tetraspanin enriched microdomains (TEM) or tetraspanin webs. 
TEMs are involved in pathogen infections, creating entry and exit 
platforms, and promote different stages of cancer. Until now, the 
mechanism of TEM assembly is poorly understood. All tetraspanin family 
members share a similar molecular structure that comprises four 
transmembrane domains, intracellular N- and C-termini, a very short 
intracellular loop, a small extracellular loop (SEL), and a large 
extracellular loop (LEL), which is further subdivided in five helical 
domains, the -, -, -, - and -domain. 
CD81 is an ubiquitously expressed tetraspanin; it is the best studied 
tetraspanin and one of the most important family members. CD81 plays a 
crucial role in TEM building and can form with its partner proteins large 
tetraspanin webs that play physiological roles in different cellular functions 
and regulate diverse cellular processes. Here, I examined which part of 
the CD81 molecule is required for protein clustering and protein 
organization leading to formation of tetraspanin microdomains in the 
plasma membrane of T cells and hepatocytes. Astonishingly, I find that 
the organization and assembly of large CD81 platforms are driven by the 
short extracellular -domain of CD81-LEL, independent from the strong 
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primary interactions with partner proteins as well as the secondary weak 
stabilizing interactions mediated by palmitoylation. Moreover, the -
domain is not only necessary for protein clustering but it is also essential 
for platform function and viral entry. Here, a new model of tetraspanin web 
formation was presented, in which the -domain plays the key role for 
protein clustering, tetraspanin web organization and function. This model 
is based on specific interactions via the -domain, possibly including a 
protein dimerization step, to control the organization of tetraspanins into 
large webs and to regulate their function, instead of stable binary 
interactions as described by the classical view of TEM organization. 
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2 Zusammenfassung 
Die Zellmembran ist unabdingbar für lebendige Zellen; sie umschließt die 
intrazelluläre Matrix, reguliert die Konzentration zytosolischer 
Komponenten, und kontrolliert die in-/auswärtigen Signale und 
Interaktionswege. Die Zellmembran besteht hauptsächlich aus Lipiden 
und Proteinen. Die Membranproteine sind in essenzielle physiologische 
Funktionen der Zelle involviert; zudem haben sie die Fähigkeit sich zu 
organisieren, miteinander zu interagieren und zu assemblieren, um 
Cluster oder Plattformen zu bilden, welche für die biologischen 
Funktionen der Zelle wichtig sind. Die Mechanismen, die die 
Proteinorganisation und die Assemblierung zu Clustern steuern, sind noch 
nicht vollständig verstanden. 
Tetraspanine sind eine Familie der Membranproteine, die eine hohe 
Tendenz haben mit sich selbst und mit anderen Proteinpartnern zu 
interagieren, um sogenannte Tetraspanin angereicherte Microdomänen 
(TEM) oder Tetraspaninnetzwerke zu bilden. TEMs spielen eine Rolle bei 
Infektionen, u.a. indem sie bei der Bildung von Zugangs- und 
Ausgangsplattformen mitwirken, sowie bei der Steuerung verschiedener 
Krebsphasen. Aktuell ist der TEM-Bildungsmechanismus nur 
unzureichend aufgeklärt. Alle Tetraspaninfamilienmitglieder haben eine 
ähnliche molekulare Struktur gemein, die vier Transmembrandomänen, 
intrazelluläre N- und C-Termini, eine sehr kleine intrazelluläre Schleife, 
eine kleine extrazelluläre Schleife (SEL), und eine große extrazelluläre 
Schleife (LEL) beinhaltet. Die große extrazelluläre Schleife ist weiter in 
fünf helikale Domänen, die -, -, -, - and -Domäne, unterteilt. 
CD81 ist ein ubiquitär exprimiertes Tetraspanin; es ist das am intensivsten 
untersuchte Tetraspanin und eines der wichtigsten Familienmitglieder. 
CD81 spielt eine wichtige Rolle bei der TEM-Bildung und kann mit 
anderen Proteinpartnern große Tetraspaninnetzwerke ausbilden, die 
physiologische Rollen in verschiedenen zellulären Funktionen spielen und 
diverse zelluläre Prozessen regulieren. Hier habe ich untersucht, welcher 
Zusammenfassung 
 
4 
 
 
Teil des CD81 Moleküls für die Bildung von Proteinclustern notwendig ist, 
die die Vorrausetzung für Tetraspanin-Mikrodomänen in der 
Plasmamembran von T-Zellen und Hepatozyten darstellt. 
Erstaunlicherweise zeigte sich, dass die Organisation der großen CD81-
Plattformen von der kleinen extrazellulären -Domäne des CD81-LEL 
Moleküls gesteuert wird. Zudem ist dieser Effekt der -Domäne 
unabhängig von starken primären Interaktionen mit Proteinpartnern sowie 
von den schwächeren sekundären stabilisierenden Interaktionen die 
durch Palmitoylierung ermittelt werden. Außerdem ist die -Domäne nicht 
nur für die Bildung von Proteinclustern notwendig, sondern auch für die 
Funktionsfähigkeit der Plattformen und für Vireninfektionen erforderlich. In 
dieser Arbeit wird ein neues Modell für die Bildung von 
Tetraspaninnetzwerken vorgestellt, in dem die -Domäne eine 
Schlüsselrolle bei der Bildung von Proteinclustern und bei der 
Organisation und Funktionsfähigkeit der Tetraspaninnetzwerke spielt. 
Dieses Modell basiert auf spezifischen Interaktionen der -Domäne und 
einem potenziellen CD81 Dimerisierungsschritt, welche die Organisierung 
von Tetraspaninen innerhalb großer Netzwerke kontrollieren und deren 
Funktionen regulieren im Gegensatz zum klassischen Modell in dem 
stabile binäre Interaktionen die Organisation von TEMs dominieren. 
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3 Preamble 
Studying molecular processes in cells has provided explanations and 
more accurate characterisation for many different cellular functions. 
Molecular biology has made major contributions to science as it describes 
how molecular processes control most cell activities and their growth. 
Cellular activities can be seen as a result of a network of molecular 
processes facilitated by different biological components which initiate and 
regulate chemical, biochemical and biological pathways in the cell. The 
improved understanding of molecular mechanisms controlling cellular 
behaviours and functions in living cells enabled researchers to unravel the 
mechanisms of many cellular disorders and infectious diseases providing 
the basis for clinical treatments. The here described work deals with a 
family of proteins, called tetraspanins, that are involved in different cellular 
processes as well as in diseases with the goal to unravel their relevance 
of function. 
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4 Introduction 
4.1 The theory of the cell 
The term cell in its biological meaning was introduced by Robert Hooke in 
1664 after the examination of a cork sample (figure 1) using a very simple 
light microscope. He was able to observe small grid-like structures which 
he called “chambers”, or in Latin cellula (cell, small chamber) (Hooke, 
1667). 
 
 
 
Figure 1. Cells in a cork preparation 
Microscopic structure of a cork sample 
showing the first scientific description of 
the cell (adapted from Hooke, 1667). 
The development of more elaborate microscopy setups enabled the 
visualization of cells and cell organelles in different biological 
preparations. In 1838, Matthias Schleiden and Theodor Schwann 
recognized similarities between samples from plants and animals, and 
established a general cell theory. The main point of their theory is that “all 
living things are composed of cells that have analogue structures and 
cells are the basic unit of the life” (Schleiden, 1838; Schwann, 1838). A 
few years later, Rudolf Virchow further developed this theory and 
described that every single cell is derived from a pre-existing cell 
(Virchow, 1871). Despite the very basic microscopy and laboratory 
techniques available at that time, the main principles postulated in this 
theory i.e. the cell is the smallest unit of an organism and the starting point 
for new cells, are valid until today. 
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4.2 The cell membrane 
The cell membrane constitutes only 1 % of the total cell volume. 
Nevertheless, it is crucial for the viability of the cell because it encloses, 
defines and maintains the essential components of the intracellular matrix 
separating them from the extracellular surrounding. Besides constituting 
barriers separating the inside of the cell from the external world, the cell 
membrane also selectively controls the flux of certain ions and organic 
molecules in and out of the cell. This property is known as semi-
permeability of the membrane. Moreover, cell membranes contain sensor 
proteins which allow forwarding and controlling of signal transduction into 
and out of the cell. Finally, many biochemical processes that are essential 
for the cell occur at the cell membranes (Goñi, 2014). 
4.2.1 Composition of the cell membrane 
Cell membranes are composed of a defined proportion of lipids and 
proteins (Phillips, Ursell et al., 2009). The Lipids are amphipathic 
molecules that form a bilayer via hydrophobic interactions, van-der-Waals 
forces and other secondary weak interactions, so that the lipophilic 
residues are oriented towards the inside and the hydrophilic residues are 
oriented towards the outside of the bilayer. Proteins bind to or are 
anchored to both leaflets of the bilayer. At the extracellular side of the 
membrane, some proteins and lipids additionally are linked to 
carbohydrates to form glycoproteins or glycolipids (Ohtsubo & Marth, 
2006). The exact composition of these membrane components varies 
depending on cell type and function (Dupuy & Engelman, 2008). 
4.2.2 Lipids of the cell membrane 
The common feature of all lipids is their amphipathic character. The 
chemical structure typically shows a hydrophilic head combined with two 
hydrophobic acyl chains of different lengths (figure 2A). In aqueous 
surroundings, the polar head groups of the lipids and the nonpolar acyl 
chains tend to associate with each other in order to form the energetically 
Introduction 
 
8 
 
 
most stable structure of lipid bilayer: The polar head groups interact with 
each other and are oriented towards the aqueous milieu, while the 
nonpolar tails assemble at the inside of the bilayer. This simple principle 
enables cells to form a boundary for their internal contents from the 
external environment and in addition to form intracellular compartments. 
Furthermore, lipids provide the cell membrane with the ability of budding, 
tubulation, fission and fusion, which is essential for cell division, biological 
reproduction and intracellular trafficking (van Meer et al., 2008). The 
majority of the plasma membrane lipids constitute phospholipids followed 
by sphingolipids and sterols (figure 2). 
 
Figure 2. The major lipid classes of the plasma membrane. 
Structures of different lipids of eukaryotic cells. (A) Pictogram showing the amphipathic 
nature of lipid molecules that have a hydrophilic headgroup (polar) and hydrophobic tails 
(nopolar), (B) cholesterol, (C) phospholipids based on diacylglycerol carrying two acyl 
chains, one of which contains a cis double bound. The rest R of the head group can be 
either serine, inositol, ethanolamine or choline. (D) Sphingolipids are based on ceramide 
and typically have saturated acyl chains. The rest R of the head group is generally 
choline (sphingomyelin) (modified from Munro, 2003). 
The distribution of these lipid classes in the membrane bilayer is 
asymmetric; certain lipids are found predominantly in the extracellular 
leaflet while others are mainly located in the intracellular leaflet (van Meer 
et al., 2008). Likewise, glycolipids i.e. lipids bound to an oligosaccharide 
chain are located only in the outer lipid leaflet. 
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4.2.3 Membrane proteins 
Membrane proteins are proteins that can integrate into or associate to the 
membrane. Those that can span the membrane bilayer are called 
transmembrane proteins. They are embedded in the lipid bilayer via their 
transmembrane domains and have intra- and extracellular parts 
protruding into the cytosol and the extracellular environment, respectively. 
Other proteins are attached to the inner or outer leaflet of the lipid bilayer 
by different anchors or linkers (figure 3). Additionally, membrane proteins 
can also bind to different oligosaccharide chains to from glycoproteins that 
are exclusively restricted to the extracellular leaflet. 
 
Figure 3. Different association possibilities of membrane proteins to the lipid 
bilayer. 
Proteins associate with the lipid bilayer in various ways: some span the bilayer with a 
single -helix (1), or multiple -helices (2) as a rolled-up -sheet (3) as in the case of 
channels. Other membrane proteins are integrated only into one side of the lipid bilayer 
by an amphipathic -helix (4), by a covalently attached lipid chain or prenyl group (5) or 
via an oligosaccharide linker (6). Proteins can also bind to the membrane by noncovalent 
interactions with other membrane proteins (7,8) (derived from Alberts et al., 2008). 
Membrane proteins play an important role in cell physiology: they function 
as transporters, pumps, receptors, enzymes or anchors and promote 
fundamental cellular processes. They convey the membrane’s semi-
permeability which enables the cell to maintain charge and concentration 
gradients in an active and highly selective way. Membrane proteins assist 
the transduction of signals through the cell membrane or initiate signalling 
cascades. Moreover, they organize the structure of the membrane and the 
shape of the cell, since they serve as anchors for cytoskeleton proteins 
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and make connections with other cells or the extracellular matrix. Finally, 
membrane proteins are also involved in enzymatic catalyses. 
4.3 Models of the plasma membrane organization 
4.3.1 The fluid mosaic model 
The foundation of the current understanding of the structure and dynamics 
of biological membranes has been laid by the fluid mosaic model 
postulated by Singer and Nicolson in 1972 (Singer & Nicolson, 1972). This 
model was developed on the basis of a previous model of Danielli and 
Davson in 1935 (Danielli & Davson, 1935), who already correctly 
described a bilayer of amphipathic phospholipids as the basic structural 
element of membranes, however did not account for proteins able to 
incorporate into the bilayer (figure 4A). 
 
Figure 4. Models of biomembrane structures. 
(A) Danielli-Davson model (1935). (B) Fluid mosaic model proposed by Singer and 
Nicolson in 1972. Lipids are arranged in a way that the lipophilic tails are oriented 
towards the middle of the lipid bilayer and the hydrophilic heads are exposed to the 
aqueous surrounding. The embedded proteins diffuse or rotate freely (modified from 
Goñi, 2014). 
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In 1972, Singer and Nicolson postulated a new model describing 
membranes as a fluid of phospholipids that contains a mosaic of dissolved 
proteins. Lipids and proteins are assumed to constantly diffuse laterally 
through the planar shape of the membrane, or rotate around an axis 
perpendicular to the membrane’s orientation. The fluid mosaic model 
(figure 4B) was a revolution and a great success in the field and had 
incorporated a wide range of experimental observation and ideas about 
the proteins’ and lipids’ association with the membrane. This model is 
accepted as a general starting point in membrane biology research, and 
new concepts and findings have been constantly complementing and 
expanding the model. 
4.3.2 The Picket-Fence-Model 
Though the Singer and Nicolson model provided explanations for a range 
of questions; it was not able to explain experimental observations showed 
that proteins in the plasma membrane are restricted in mobility and both 
lipids and proteins have a 5 to 50 times smaller diffusion coefficient in the 
plasma membrane than in artificially reconstituted membranes or 
liposomes (Chang et al., 1981; Kusumi et al., 2005; Sheetz et al., 1980; 
Sheetz, 1983). Moreover, much evidence showed the existence of factors 
in the cells that confine the mobility of membrane proteins. These new 
findings contradicted the free diffusion theory of the fluid mosaic model. In 
1980, Sheetz studied protein diffusion coefficients in erythrocyte 
membranes and showed that the cytoskeleton influences the lateral 
diffusion of membrane proteins (Sheetz et al., 1980). Hence, the picket 
fence model was proposed, which states that the lateral diffusion of lipids 
and proteins is restricted by intracellular factors such as the cytoskeleton. 
Complementary experiments showed that the degradation of the 
cytoskeleton by treatment with e.g. trypsin or latrunculin B increases the 
diffusion of proteins in the plasma membrane (Tsuji & Ohnishi, 1986). The 
picket fence model describes the cytoskeleton as a fence limiting the 
lateral diffusion of plasma membrane anchored proteins to the enclosed 
pickets (figure 5) (Kusumi et al., 2005).  
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Figure 5. The picket-fence model 
Cartoons depicting the picket-fence model. (Left) the membrane skeleton fence model: 
transmembrane proteins are confined within membrane skeleton network via physical 
unspecific collision of their cytoplasmic tail with the membrane skeleton. Trajectory of 
single transmembrane protein crossing different areas formed by membrane skeleton 
fence network is shown in different colours. (Right) the membrane skeleton anchored 
transmembrane proteins picket model: transmembrane proteins anchor to and line up 
along the membrane skeleton fence and act as pickets creating barriers that affect the 
free diffusion of phospholipids of the plasma membrane. Tracks of phospholipid within 
confined areas created by cytoskeleton (fence) and anchored proteins (pickets) are 
shown in different colours (modified from Kusumi et al., 2005). 
4.3.3 The membrane raft model 
The picket fence model assumes that the formation of protein domains is 
organized by membrane protein/cytoskeleton interactions. Parallel studies 
observed an asymmetrical lipid compartmentalization in the plasma 
membrane of polarized cells in form of lipid microdomains. In the apical 
membrane, lipid rafts composed of sphingomyelin and cholesterol that 
clustered into platforms were observed. These lipid rafts appeared to be 
resistant to detergent treatment, and were enriched with specific raft 
proteins (Simons & Ikonen, 1997). The mechanism of the membrane raft 
model is based on the physico-chemical properties of lipids which tend to 
form ordered phases or platforms - so-called lipid rafts. These rafts allow 
the recruitment of specific proteins (figure 6). Later, it was shown that the 
chemical composition of the outer monolayer of the cell membrane differs 
from those of the cytoplasmic monolayer inducing the propensity of phase 
separation (Simons & Gerl, 2010). 
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Figure 6. Membrane raft platform 
Membrane rafts comprise cholesterols and sphingolipids such as glycosphigolipids as 
well as membrane proteins. The rafts are fluctuating platforms that assemble via lipid-
lipid, lipid-protein and protein-protein interactions and may play a role in signaling and 
membrane trafficking (modified from Simons & Gerl, 2010). 
The detection of lipid rafts became a major point of debate because the 
biochemical methods used for preparing detergent resistant membranes 
(DRM) are prone to artefacts (Munro, 2003). Later, lipid rafts were defined 
as highly dynamic heterogeneous microdomains of 10 – 200 nm in size, 
which are rich in sphingomyelin and sterols and serve to 
compartmentalize cellular processes (Simons & Gerl, 2010). Currently, 
the transient nature of rafts is highlighted by platforms stabilized through 
protein-protein and protein-lipid interactions (Pike, 2006). 
4.3.4 The protein cluster model 
The picket fence model suggests that proteins of similar structure and 
comparable steric hindrance also show a comparable diffusion and similar 
domain localization. In contrast, the membrane raft model assumes the 
hydrophobic lipid-lipid and lipid-protein interactions to be responsible for 
membrane protein organization in lipid domains. Therefore, proteins which 
have similar lipid anchors or transmembrane domains and tertiary 
structures should be confined to the same domains of the plasma 
membrane. Surprisingly, experimental observations show contradictory 
results.  
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Sieber et al. showed that protein isoforms with identical transmembrane 
domains and similar structures are localized in different membrane protein 
clusters (Sieber et al., 2006). This observation cannot be reconciled with 
one of the models described so far. Moreover, several membrane proteins 
isoforms sharing highly similar features were not found in the same 
membrane region (Kai et al., 2006; Low et al., 2006; Uhles et al., 2003; 
Zacharias et al., 2002). In addition, the modification of a single small 
protein motif can lead to distinct segregation of the protein into different 
protein clusters (Sieber et al., 2006). This difference in clustering upon 
such subtle changes can be explained by the presence of highly specific 
protein-protein interactions. The protein cluster model is based on these 
specific protein-protein interactions and how they influence protein 
clustering. Syntaxin 1A is a model protein for clustering driven by protein-
protein interactions (Sieber et al., 2007). In this case, cluster size and 
stability are determined by an equilibrium between attractive forces 
(between protein monomers) and accumulation repulsion (upon cluster 
growth) (figure 7) (Sieber et al., 2007). 
 
Figure 7. Protein cluster model of syntaxin 1A 
Protein clustering driven by specific protein-protein interactions is reached after 
balancing attractive and repulsive forces. Charge and/or steric crowding may play an 
important role in the determination of cluster size and stability (derived from Sieber et al., 
2007). 
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The protein cluster model contradicts neither the picket fence model nor 
the membrane raft model, but it offers new ways to explain observations 
and answer questions that could not be addressed with the previous 
models. 
4.4 Tetraspanin protein family 
Tetraspanins constitute a large family of small surface membrane proteins 
(~20 – 30 kDa) (Hemler, 2008) which comprise four transmembrane 
domains and are present in a high copy number in all cell and tissue 
types. Generally, tetraspanins are expressed in nearly all organisms 
including plants, fungi and humans, in which 33 tetraspanin members 
have been identified (Charrin et al., 2009; Huang et al., 2005). 
Tetraspanins were first cloned and studied in the early 1990ies. The most 
important feature of this protein family is the high tendency to interact 
laterally with one another or with multiple molecular partners in a dynamic 
assembly process forming tetraspanin webs or so-called tetraspanin-
enriched microdomains (TEMs) (Berditchevski & Odintsova, 2007; 
Berditchevski & Rubinstein, 2013; Charrin et al., 2009; Hemler, 2005, 
2008; Homsi et al., 2014; Levy & Shoham, 2005a; Rubinstein et al., 1996; 
Yáñez-Mó et al., 2009). Therefore, TEMs result from the tetraspanins’ 
ability to associate in high stoichiometry with integrins, members of the 
immunoglobuline (Ig) superfamily and membrane receptors (Berditchevski 
& Rubinstein, 2013; Hemler, 2005; Homsi et al., 2014; Rubinstein et al., 
1996). 
TEMs play an important role in a diverse range of cellular processes and 
activities, including cell adhesion, morphology, motility, proliferation, 
signal-transduction, intercellular communication, cell-cell fusion, 
intracellular signalling, endocytic trafficking as well as in immune system, 
malignancy and host-pathogen interactions (Berditchevski & Rubinstein, 
2013; Homsi et al., 2014; Wright et al., 2004; Yáñez-Mó et al., 2009; 
Zhang & Huang, 2012). Because of their involvement in infectious and 
non-infectious diseases, the immune system and malignancy, TEMs have 
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been gaining in prominence and become more and are becoming more 
and more important targets in therapeutic strategies (Hemler, 2008, 2013; 
Homsi et al., 2014). 
4.4.1 Tetraspanins involvement in infectious diseases 
Apart from their role in a wide range of biological and cellular processes 
as well as in promoting different stages of cancer, tetraspanins are also 
known to have a prominent roles in the pathology of infectious diseases 
such as diphtheria and malaria (Martin et al., 2005; van Spriel, Annemiek 
B & Figdor, 2010). Recent reports indicate that tetraspanins are not only 
involved in infections by various microbes but also that tetraspanins play 
an important role in viral infections and parasites (table 1). Tetraspanins 
associate selectively with specific viruses and affect multiple stages of 
infectivity, from the initial cellular attachment to final viral particles release 
(Martin et al., 2005). 
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Tetraspanin Alternative names Tissue distribution Involved in infectious 
disease 
CD9  Tspan 29, BA2, p24, 
GIG2, MIC3, MRP-1, 
BTCC-1, DRAP-27 
Broad Linked with HIV-1, FIV, 
CDV. Modulates 
Diphtheria toxin 
binding 
CD37 Tspan 26, Gp40e52 Immune system (B and 
T cells, monocytes, 
macrophages, 
granulocytes, immature 
DC) 
Regulates immune 
response to C. 
albicans 
CD53  Tspan 25, MOX44 Immune system (B,T 
and NK cells, 
monocytes, 
macrophages, 
granulocytes, DC) 
Human CD53 
deficiency linked to 
recurrent infections. 
Role in HIV-1 egress 
CD63  Tspan 30, MEL1, 
ME491, 
granulophysin, 
LAMP3, OMA81H, 
MLA1, NGA, LIMP 
Broad  Roles in HIV-1 entry 
and egress, HTLV 
mediated syncytium 
formation, endocytosis 
of HPV16. 
CD81  Tspan 28, TAPA-1, 
S5.7 
Broad Receptor for HCV. 
Role in HIV-1, HTLV. 
Binds to P. falciparum 
and P. yoelii. 
CD82 Tspan 27, Kangai1, 
R2, 4F9, C33, IA4, 
ST6, GR15, KAI1, 
SAR2 
Broad Role in HIV-1 and 
HTLV assembly. 
CD151  Tspan 24, PETA3, 
SFA1, gp27 
Broad Involved in 
endocytosis of HPV16, 
role in porcine RRSV. 
Uroplakin 
Ia 
Tspan 21, UP1A, 
UPIA, UPKA, 
MGC14388 
Bladder epithelium  Binds FimH protein in 
E. coli during urinary 
tract infection. 
Uroplakin 
Ib  
 
Tspan 20, UPIB, 
UPK1 
Bladder epithelium Binds FimH protein in 
E. coli during urinary 
tract infection. 
Table 1. Different tetraspanin expression profiles with their suggested involvement 
in the pathogenesis of infectious diseases. 
Viruses’ abbreviations: Human immunodeficiency virus (HIV), feline immunodeficiency 
virus (FIV), canine distemper virus (CDV), human T cell leukemia virus (HTLV), human 
papillomavirus type 16 (HPV16), Hepatitis C virus (HCV), porcine reproductive and 
respiratory syndrome virus (porcine RRSV) (adapted from van Spriel, Annemiek B & 
Figdor, 2010). 
4.4.2 TEM formation and classification of the underlying 
tetraspanin interactions 
As mentioned above, the most important feature of tetraspanin proteins is 
their ability to associate laterally with each other and with other partner 
proteins with high stoichiometry to form tetraspanin webs or TEMs 
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(Charrin et al., 2001; Hemler, 2003; Stipp, Kolesnikova et al., 2001; Stipp, 
Orlicky et al., 2001). More than 100 different tetraspanin interaction 
partners have been identified to associate with one or more tetraspanins 
(Hemler, 2008). The most important tetraspanin-associated proteins 
include membrane-bound ligands, integrins, cadherins, different 
immunoglobulin superfamily members (e.g. EWI-2, EWI-F, CD4, CD8, 
MHC class I and II, etc.), proteoglycans, complement-regulatory proteins, 
signalling receptors, growth factors (e.g. EGFR) and others (table 2) 
(Berditchevski & Rubinstein, 2013; Hemler, 2003, 2008; Yáñez-Mó et al., 
2009). These interactions form the basis for the involvement of TEMs in 
so many different cellular functions and their major role in diverse cellular 
processes including cell signaling, adhesion, proliferation, morphology, 
motility, biosynthesis, in the immune system, pathogen infection, 
malignancy, infectious and non-infectious diseases. Therefore, 
tetraspanins are considered as master organizers of the plasma 
membrane (Cambi & Lidke; Hemler, 2005). This wide implication of TEMs 
in both physiological and pathological processes makes them an 
important topic in research. 
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Partner Associated 
tetraspanins 
Partner Associated 
tetraspanins 
31, integrin CD151, CD9 Dectin-1 CD63, CD37 
71 integrin  CD151, CD9 UroplakinII  UPIa 
61 integrin  CD151, CD9 UroplakinIII  UPIb 
64 integrin  CD151 CD2  CD9,CD53 
41 integrin  CD81 CD3  CD9, CD81, CD82 
L2 integrin  CD82, CD63 CD4  CD81,CD82 
M2 integrin  CD63 CD5 CD9 
11 integrin  CD9 CD8 CD81,CD82 
21 integrin  CD9, CD151 CD19 CD81 
51 integrin  CD9,CD151 CD20 CD53,CD81, CD82 
v5 integrin  CD81 CD21 CD81 
gpIIb-IIIa  CD9 CD36 CD9 
CD41/gpIIb CD9 CD38 CD9 
CD42/gpIb CD9 CD46 CD9 
CD44 CD9, D6.1A/CO-
029/Tspan8 
CD47 CD9 
GPVI  Tspan9, CD151 Leu 13  CD81 
Syndecan  CD9 BCR/IgM  CD9 
EWI-2/ 
PGRL/CD316 
CD9/CD81 MHC-I  CD82,CD81, CD53 
EWI-F/CD9P-
1/FPRP/CD315 
CD9/CD81 MHC-II CD53,CD81, CD82, 
CD37 
ICAM-1/CD54 CD9 EGFR CD82 
VCAM-1/CD106  CD151 GPCR56 CD9, CD81 
EP-CAM/GA733-2  CD9, D6.1A/CO-
029/Tspan8 
BAI2  CD9 
Lu/B-CAM/CD239  CD9 cKit/CD117  CD9, CD63, CD81 
GA733-1/TACSTD2  CD9 Pro-TGF CD9 
Claudin-7  D6.1A/CO-
029/Tspan8 
Pro-HB-EGF  CD9 
E-cadherin CD151 ADAM10/CD156c CD9 
L6  CD151 MT1-MMP CD151, CD63, 
CD9,CD81, Tspan12 
Table 2. Overview of tetraspanin-associated transmembrane partner proteins 
(adapted from Yáñez-Mó et al., 2009). 
TEMs were characterized by immunoelectron microscopy as individual 
microdomains of ~0.2 µm2 in size which are separated from each other by 
0.6 – 0.7 µm (Nydegger et al., 2006). To date, TEM formation and 
organization have been studied using mostly classical biochemical 
methods such as immunoprecipitation and isopycnic centrifugation. 
Immuoprecipitated tetraspanin complexes collected after lysing cells with 
detergents of different strength have revealed diverse interaction classes 
of varying strength that are involved in tetraspanin web formation (figure 
8) (Hemler, 2005, 2008; Homsi et al., 2014). 
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Figure 8. Multistep interactions of tetraspanins. 
(a) Level 1 or primary interaction: this interaction is direct and in most cases resistant to 
stringent detergent treatment. This kind of interaction includes homodimerizations and 
hetero-associations with other tetraspanin partner proteins such as integrins, EWI 
proteins, CD19 and others. (b) Level 2 or secondary interaction: is the result of a network 
of secondary interactions that can be stabilized by palmitoylation of both tetraspanins 
tetraspanin-associated partner proteins and other weak interactions. These interactions 
are generally maintained after treatment with mild detergents e.g. CHAPS (derived from 
Hemler, 2005). 
Primary interactions or level 1 interactions are the result of direct binding 
with high stoichiometry between tetraspanins and non-tetraspanin partner 
proteins. In addition, tetraspanin homo-dimerization or homo-
oligomerization interactions are assumed to be included in this interaction 
level. These primary protein complexes are resistant to harsh detergents 
such as Triton X-100 or digitonin (Boucheix & Rubinstein, 2001; Hemler, 
2003, 2008). TEMs are further stabilized and assembled through a 
network of secondary interactions. These secondary interactions define 
the level 2 interactions that allow different tetraspanins to associate with 
each other and recruit different tetraspanin partners together into 
complexes to form large tetraspanin webs. This level of interaction is not 
resistant to harsh detergents, but can be maintained using mild detergents 
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such as Brij97 or CHAPS (Charrin et al., 2009; Hemler, 2008; Homsi et 
al., 2014; Yáñez-Mó et al., 2009). The stability of tetraspanin complexes is 
further enhanced by protein palmitoylation (Charrin et al., 2002; Hemler, 
2008; Yang et al., 2002). Palmitoylation was described to stabilize 
tetraspanin-tetraspanin interactions and palmitoylation deficient mutants 
showed impaired binding of CD81 to the tetraspanin CD9 and one of its 
binding partners EWI-2 (Delandre et al., 2009; Stipp, Kolesnikova et al., 
2001), as well as impaired binding of CD151 to other tetraspanins (CD9, 
CD81, CD63) (Berditchevski et al., 2002). In contrast, the association of 
CD151 and 31 integrin was not affected in non-palmitoylated mutants 
(Yang et al., 2002). Similarly, inhibition of palmitoylation through treatment 
with specific drugs does not disrupt pre-existing interactions 
(Berditchevski et al., 2002; Stipp et al., 2003). Therefore, role of 
palmitoylation in the TEM formation is not completely understood, but it 
appears to be mainly important for complex stabilization. Additionally, 
treatment with mild detergents has led to formation of incomplete 
solubilized tetraspanin complexes which separate into the low-density 
fractions of sucrose gradients. TEM complexes have shown interactions 
with lipids like gangliosides and cholesterols (Claas et al., 2001). Such 
associations with lipids may be explained by the lipid raft model (see 
4.3.3). However, TEMs were shown to have a protein composition 
different from those of lipid rafts, which indicates a distinct nature (Barreiro 
et al., 2008; Charrin et al., 2009; Claas et al., 2001; Espenel et al., 2008; 
Hemler, 2005; Le Naour et al., 2006; Min et al., 2006). Hence, the role of 
lipids in the TEM assembly is still under debate, but they may be 
important for stabilization of tetraspanin interactions during tetraspanin 
web building (Charrin et al., 2009). 
4.4.3 Dynamic model of tetraspanin web assembly 
The classical research strategies in the tetraspanin field were based 
exclusively on biochemical approaches that deliver a primarily static 
image of the TEM formation process and do not address the behaviour in 
a natural environment. Recently, the development of microscopy 
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techniques has allowed studying TEMs in the intact membrane of living 
cells, revealing biophysical characteristics of microdomains including size, 
diffusion, molecular compositions and interactions. Using modern 
microscopy methods such as total internal reflection fluorescence (TIRF) 
microscopy, fluorescence recovery after photobleaching (FRAP) and 
fluorescence correlation spectroscopy (FCS), it was possible to track 
single tetraspanin molecules and to study molecular interactions between 
TEM components over time in a dynamic and more realistic approach. 
Single molecule tracking has revealed two ways of molecular interaction 
which differ in their dynamics. Molecular diffusion is transiently slowed 
down when the molecule enters tetraspanin enriched platforms. The 
platforms are in permanent exchange with the rest of the membrane and 
have a constant shape and location. These new observations have 
demonstrated the dynamic interactions of tetraspanins within the 
tetraspanin webs (Barreiro et al., 2008; Espenel et al., 2008; Rocha-
Perugini et al., 2013). In contrast to the classical view of tetraspanin 
interactions, another model of TEM building was proposed which takes 
into account the dynamic behaviour of tetraspanins to describe the 
molecular assembly of TEMs (figure 9) (Charrin et al., 2009). 
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Figure 9. Model of tetraspanin web assembly in a dynamic view 
This model is based on the multistep tetraspanin interactions revealed by the 
biochemical analysis of tetraspanin webs and supplemented with the results of recent 
analyses of tetraspanin dynamics. The figure shows two tetraspanin – partner pairs and 
their corresponding movement traces which are labelled in red and blue. The left part of 
the figure shows a basal level of tetraspanin interactions in the plasma membrane, where 
small clusters of specifically associated tetraspanin – partner molecules (T1 – P1, T2 – P2, 
etc.) diffuse, frequently interact and exchange some of their constituents with other 
clusters. The right part illustrates cluster behaviours upon particular stimulations. 
Tetraspanins show a confined movement within a particular area in the plasma 
membrane (referring to TEMs), in which more stable interactions take place. This model 
describes a dynamic view based on single molecule tracking data, but other models are 
possible (derived from Charrin et al., 2009).  
Thus, while studies of tetraspanin multilevel interactions and tetraspanin 
dynamics have explained the basis of TEM formation, the underlying 
mechanism that drives the association of the wide variety of different 
proteins and proteins complexes into large tetraspanin webs has 
remained unclear. 
4.5 The tetraspanin CD81 
Tetraspanins protrude only 4 – 5 nm out of the plasma membrane 
(Hemler, 2005, 2008; Kitadokoro et al., 2001; Min et al., 2006). Therefore, 
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they are hardly accessible for biochemical and immunological methods 
(Hemler, 2005), making it difficult to unravel their structural features. One 
of the best studied tetraspanins is CD81 (cluster of differentiation 81), 
from which a 3D structure has been thoroughly studied and predicted 
using both computational and crystallographic methods (Seigneuret, 
2006). 
4.5.1 CD81 topology and structure specificities  
CD81 or tetraspanin 28 (26 kDa) contains like all other tetraspanin family 
members, four transmembrane domains (1 – 4) and two extracellular 
loops. The small extracellular loop (SEL) and the large extracellular loop 
(LEL) are flanked by the transmembrane regions 1/2 and 
3/respectively (figure 10). The LEL contains a cysteine-cysteine-
glycine (CCG) motif which is common to all tetraspanin proteins and 
ensures the formation of disulfide bridges with other cysteine residues of 
the LEL. The formation of disulfide bridges is important for the correct 
conformation and maintenance of the secondary structure of the LEL 
(Kitadokoro et al., 2001; Seigneuret, 2006). The intracellular 
compartments comprise a very short intracellular loop between 2/3 as 
well as small N-terminal and C-terminal cytoplasmic tails that harbour two 
palmitoylation sites each. This palmitoylation may be involved in protein 
cluster stabilization (see below). 
The large extracellular loop is further subdivided into five (, , ,  and ) 
helical domains, of which the,  and domains constitute the constant 
region that appears to play a crucial role in tetraspanin dimerization 
(Kitadokoro et al., 2001; Seigneuret, 2006). The  and  domains form the 
variable region which shows marked conformational fluctuations and may 
play a role in protein-protein interactions (Hemler, 2003; Kitadokoro et al., 
2002; Seigneuret, 2006; Stipp et al., 2003). The crystallographic structure 
of the water soluble CD81 LEL was solved by Kitadokoro in 2001; the five 
helical domains form a mushroom-like structure that is stabilized by two 
disulfide bridges (figure 11) (Kitadokoro et al., 2001).  
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Figure 10. Pictogram of the tetraspanin protein CD81 and its intramolecular 
domains 
CD81 is membrane embedded via its four transmembrane domains (1 – 4); SEL is the 
small extracellular loop; LEL is the large extracellular loop subdivided in five helical 
domains (, , ,  and ), where the blue colored (,  and ) domains constitute the 
constant region and the orange colored and domains constitute the variable region; 
the two disulfide bridges are shown as thin black dashes within the LEL; the red dots with 
acyl chains show the palmitoylation sites in the intracellular segments of the protein 
(modified from Homsi et al., 2014). 
Based on Kitadokoro’s crystallographic data, Seigneuret employed 
molecular modeling to predict the complete 3D structure of CD81 
(Seigneuret, 2006; for more detailed domain structures see figure 23). 
The four transmembrane domains are closely packed and appear as a 
twisted left-handed coiled coil bundle. The transmembrane regions 3 and 
4 span the membrane bilayer and extend towards the extracellular part in 
continuity with the anti-parallel  and  helices that form the stalk of the 
LEL. The   and  helices form the head subdomain, which is inserted 
within the stalk subdomain sequence and located on its top giving the 
whole CD81 molecule a compact rod shape structure. Within the head 
subdomain, the -domain is particularly exposed to the extracellular space 
(figure 11) (Homsi et al., 2014; Kitadokoro et al., 2001; Kitadokoro et al., 
2002). 
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Figure 11. Crystal structure of the human CD81-LEL 
The view shows at a realistic scale the orientation of the head (constituted by ,  and  
domains) and the stalk (constituted by  and domains) of the mushroom like structure 
of the LEL. The structure of the molecule highlights the exposed orientation of the  
domain (red) to outside of the molecule (modified from a figure kindly provided by Dr. 
Thomas Schmidt and based on Kitadokoro et al., 2001). 
Most of the known antibodies raised against CD81 target epitopes within 
the LEL variable domain i.e. the - and -helices of the LEL. Both in 
solution and in hexagonal and monoclinic crystals the LEL shows a high 
degree of structural flexibility. It is assumed that the structural hyper-
flexibility of this region reflects its importance for TEM building and 
function (Kitadokoro et al., 2002; Seigneuret et al., 2001; Seigneuret, 
2006). In addition, the variable domain contains nearly all known 
tetraspanin protein-protein interaction sites and defines their classes and 
functions (DeSalle et al., 2010; Homsi et al., 2014; Seigneuret et al., 2001; 
Seigneuret, 2006; Stipp et al., 2003). The transmembrane domains are 
highly similar among members of the tetraspanin family, and are involved 
in inter- and intra-molecular interactions (Charrin et al., 2003; Kovalenko 
et al., 2005; Montpellier et al., 2011). Interestingly, the tetraspanin 
transmembrane domains 1, 3 and 4 also contain polar residues that 
might play a role in transmembrane domain packing (Stipp et al., 2003). 
Little is known about the small extracellular loop. It may assist in 
maintaining the correct conformation of the LEL, and it is required for the 
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optimal surface expression of CD81, but not for protein-protein binding 
and interactions (Masciopinto et al., 2001). The SEL has a β-strand 
secondary structure and it may interact with residues in the constant 
domain of the LEL (Seigneuret et al., 2001; Seigneuret, 2006). The 
intracellular N- and C-terminal regions are unstructured and have a 
disordered conformation (Seigneuret, 2006). In addition, the intracellular 
segments of CD81 provide palmitoylation sites that may be important for 
TEM stabilization (Hemler, 2005). Moreover, the C-terminus ensures 
binding to ezrin-radixin-moesin (ERM) proteins, the cytoskeleton (Coffey 
et al., 2009; Sala-Valdés et al., 2006; Stipp et al., 2003) and signalling 
proteins (Stipp et al., 2003) and also regulates molecule dynamics and 
pathogen receptor activity (Harris et al., 2013). 
4.5.2 Role of CD81 and CD81 enriched TEMs in pathogen 
infection 
CD81 was initially discovered on activated B- and T-cells as a target of an 
antiproliferative antibody (Oren et al., 1990). In the last 20 years, CD81 
has been shown to be essential for different biological and physiological 
processes, including immune responses (Levy & Shoham, 2005b), protein 
biosynthesis (Shoham et al., 2003), brain development (Geisert et al., 
2002), retinal pigment epithelium development (Pan et al., 2011), fertility 
(Rubinstein et al., 2006) and others. 
In addition to its physiological functions, CD81 plays a clinically significant 
role as a receptor for pathogen entry, e.g. for the hepatitis C virus (HCV) 
(Pileri et al., 1998), the malaria Plasmodium parasite (see also table 1) 
(Silvie et al., 2003) and Listeria monocytogenes (Tham et al., 2010). 
Moreover, CD81 enriched TEMs are crucial for entry of the human 
papilloma virus (HPV) (Homsi et al., 2014). Therefore, they provide entry 
and/or exit platforms for HPV (Spoden et al., 2008), and human 
immunodeficiency virus (HIV) (Krementsov et al., 2010; Nydegger et al., 
2006) and other pathogens (Monk & Partridge, 2012; van Spriel, 
Annemiek B & Figdor, 2010). 
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Recently, two pathways of internalization with pathogens have been 
described. Pathogens can directly associate with CD81. One of the first 
observations of CD81/pathogen association was shown for HCV (Pileri et 
al., 1998), where CD81 and at least three receptors as human scavenger 
receptor SR-BI/Clas1 (Scarselli et al., 2002), tight junction molecules 
Claudin-1 (CLDN-1) (Evans et al., 2007) and occludin (Liu et al., 2009) 
are the essential receptors that mediate HCV entry (Burlone & 
Budkowska, 2009). The interaction between CD81 and HCV is based on 
CD81 LEL binding to HCV E2 glycoprotein (Pileri et al., 1998). Moreover, 
this interaction is specific for CD81; other tetraspanin proteins such as 
CD9, CD63 and CD151 do not show any interaction with HCV E2 
glycoprotein (Flint et al., 1999). The functional role of the CD81 interaction 
with HCV in HCV entry was further experimentally confirmed. It was 
shown that non-permissive human cell lines such HepG2 and HH29, 
which do not express endogenous CD81, become susceptible to HCV 
infection upon ectopical expression of CD81 (Bartosch et al., 2003; 
Cormier et al., 2004; Lavillette et al., 2007; Zhang et al., 2004). Conversly, 
CD81 monoclonal antibodies and a soluble form of CD81 LEL inhibited 
HCVpp (HCV pseudoparticles) and HCVcc (HCV in cell culture) infectivity 
in vitro (Bartosch et al., 2003, 2003; Cormier et al., 2004) and HCV 
infection in vivo (Meuleman & Leroux-Roels, 2008). The current 
description of the HCV entry mechanism suggests that HCV cell entry is a 
multi-step process which requires direct binding of HCV to a couple of 
membrane receptors including CD81. These successive interactions, 
which do not require the formation of TEM, facilitate virus uptake via 
clathrin-mediated endocytosis into pH-sensitive early endosomes. In 
conclusion, the incorporation of CD81 into TEM is not essential for HCV 
entry (Rocha-Perugini et al., 2009).  
A second pathogen entry mechanism has been proposed that requires the 
association of tetraspanin proteins (including CD81) into TEMs for 
successful pathogen uptake. It has been shown that CD81 is required for 
infection with Plasmodium sporozoites, but here no evidence proves that 
a direct interaction with the pathogen takes place. This data suggests that 
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CD81 does not act as a receptor, but rather associates into TEMs that 
constitute a novel type of membrane microdomain which can be used for 
pathogen entry (Silvie et al., 2006). A similar pathogen entry mechanism 
was proposed for HIV infection, where the virus particles accumulate at 
surface TEMs containing CD81 that can function as gateways for the 
pathogen (Nydegger et al., 2006). The actual entry of HIV is clathrin-
independent. Therefore, CD81 may directly associate with CD4, integrins 
and EWI-2 which could influence the surface organization of HIV receptor 
and virus-cell adhesion. Then, both CD81 and EWI-2 bind to F-actin by 
ERMs and other factors. In this way the TEMs facilitate pathogen entry 
through actin cytoskeleton activity (Rocha-Perugini et al., 2014). A similar 
mechanism, in which TEMs act as pathogen entry gateway, has been 
observed for HPV. The experimental data suggest that HPV entry does 
not occur in a clathrin- and caveolin-dependent manner, but rather via 
specific TEM-organizations containing CD151, CD81 and other 
tetraspanins (Scheffer et al., 2013; Spoden et al., 2008). Therefore, TEMs 
are essential for mediating HPV uptake and constitute a novel route for 
pathogen entry (Spoden et al., 2008). In conclusion, CD81 and CD81 
assembled into TEMs play a fundamental role in pathogen entry as well 
as in other biological processes which makes the characterization of 
CD81 functional domains a very important issue since they are essential 
for the relevant CD81 interactions and drive integration of CD81 into 
TEMs. 
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5 Aims of the work 
Tetraspanins have fascinated researchers due to their ability to associate 
with each other and with different membrane protein partners to form 
supra-molecular assemblies, so-called TEMs or webs. The exact 
mechanism of TEM building and tetraspanin assembly is still not 
completely understood. Since the identification of this protein family, 
tetraspanins were studied and isolated using mainly static biochemical 
approaches such as immunoprecipitation and density gradient 
centrifugation. However, these methods are limited to a specific 
observation timepoint and cannot deliver information about the dynamics 
of TEM formation or behavior; moreover, they yield no information on 
TEM size, shape or number. 
Applying modern microscopy techniques to living cells and plasma 
membrane sheet preparations, this work focused on clustering of the 
tetraspanins. In particular, CD81 was studied since the CD81 molecule is 
the most extensively examined tetraspanin and its 3D structure has been 
solved, providing a basis for structural deletions. Since all tetraspanins 
share a common structure, I believed that studying the clustering of CD81 
would be a paradigm to reveal the fundamental principles of TEM building 
mechanism. 
The major aim of this work was the characterization of the protein 
domains important for CD81 clustering and enrichment into TEM to be 
studied in both static (STED microscopy and immunoprecipitation) and 
dynamic approaches (TIRF and FRAP microscopy). 
Further, I aimed to identify the functional role of the clustering behavior 
mediated by the related domains of the CD81 molecule. In this context, 
the effect of TEMs assembly on infection with different pathogens was 
also to be tested. 
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The insights in the clustering mechanism and functional roles of CD81 
should help us to introduce a new general model for tetraspanin assembly 
and TEM building.  
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6 Materials and Methods 
6.1 Materials 
If not stated otherwise, the chemicals and reagents used for this work are 
products of the following companies: Carl Roth (Karlsruhe, Germany), 
Merck (Darmstadt, Germany), Sigma-Aldrich (Hamburg, Germany), 
Biochrom (Berlin, Germany), Promega (Madison, WI, USA), Fermentas 
(St. Leon-Rot, Germany), NEB (UK), Bio-Rad (Germany), Machery-Nagel 
(Düren, Germany). All media, buffers and solutions were prepared using 
autoclaved deionized water if necessary. 
6.1.1 Small instruments 
6.1.1.1 UV-Vis spectrophotometer 
NanoDrop2000 (Thermo Fisher Scientific, Waltham, MA, USA) was used 
for DNA concentration measurements 
6.1.1.2 Microplate reader 
Infinite® 200 PRO multimode microplate reader (Tecan, Maennedorf, 
Switzerland) 
6.1.1.3 Sonifier 
Sonopuls HD 2070, 70 W (Bandelin, Berlin, Germany) 
6.1.1.4 SDS-PAGE and agarose gel electrophoresis 
equipments  
Mini-PROTEAN Tetra Cell, Mini Trans-Blot® module, PowerPac HC 
Power Supply and Trans-Blot® SD Semi-Dry Electrophoretic Transfer Cell 
(Bio-Rad, Hercules, CA, USA), electrophoresis chambers and accessories 
for agarose gel electrophoresis (biostep, Jahnsdorf, Germany). 
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6.1.1.5 Membrane scanner  
Odyssey® CLx Imaging System (LI-COR Inc., Lincoln, USA) was used for 
western blot detection and kindly provided by the Kolanus’ laboratory 
(LIMES-Institute, University of Bonn). 
6.1.1.6 Thermocyclers 
TPersonal (#050-551, Biometra, Goettingen, Germany) 
TProfessional basic gradient (#070-601, Biometra, Germany) 
6.1.1.7 Centrifuges 
Eppendorf centrifuges (5415 R, 5430 R and 5810, Eppendorf, Hamburg, 
Germany) 
Allegra® X-15R (Beckman Coulter, Brea, CA, USA) 
6.1.2 Microscope 
Several microscope set-ups were used as indicated in the respective 
sections, where also details about adjusted pixel size and setting are 
stated. 
6.1.2.1 Bright-field microscope 
Inverted microscope ECLIPSE TS100, CFI60 Infinity Optical System 
(Nikon, Tokyo, Japan) was used for cell culture 
6.1.2.2 Epifluorescence/TIRF microscope 
Olympus IX81 microscope equipped with an oil immersion objective 60x 
1.49 NA Apochromat and a 1.6 x magnifying lens (Olympus, Japan). The 
microscope is coupled with a 16-bit EMCCD camera (16 x 16 µm2 pixel 
size, ImagEM C9100-13, Hamamatsu Photonics, Japan) with diverse 
magnification lenses (1x, 2x, 4x). For Epifluorescence illumination, the 
system is equipped with a 150 W Xenon lamp integrated into a MT20E 
fluorescence illumination system (Olympus, Japan) in combination with 
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F36-500 DAPI HC, F36-525 EGFP HC and F36-503 Tritc HC filter sets 
(AHF Analysentechnik, Tuebingen Germany). The TIRF modus was 
realized by an integrated 488 laser LAS/488/20 (Olympus, Japan) in 
combination with CMR-U-MTIR-488-HC filter set (Olympus, Japan). The 
CellR software (Olympus, Japan) was used for recording.  
6.1.2.3 Confocal laser scanning microscope 
Olympus FluoView™ FV1000 (Olympus, Japan) confocal laser scanning 
microscope with an integrated oil immersion objective UPlanSApo 60x NA 
1.35 (Olympus, Japan) and equipped with 405, 488 and 543 Lasers 
(located at the Kolanus’ laboratory, LIMES Institute, university of Bonn). 
The system was controlled with the Olympus Fluoview 3.0 software 
(Olympus, Japan). 
6.1.2.4 Gated Stimulated Emission Depletion (g-STED) 
microscope 
All STED microscopy was performed on a TCS SP8 gated-STED 
microscope (Leica, Mannheim, Germany) from the German Centre for 
Neurodegenerative Diseases (DZNE) in Bonn and located at the center of 
advanced European studies and research (caesar) in Bonn, at the Light 
Microscopy Facility (LMF). The microscope used a 100x 1.4 NA oil 
immersion objective and was equipped with a pulsed Laser (White Light 
Laser) for fluorescence excitation and a continuous 592 nm laser for 
stimulated emission depletion. Fluorescence detection and time gating 
was controlled via hybrid detectors (HyD). 
6.1.3 Flow cytometer 
A LSR II (BD Biosciences) flow cytometer was used for FACS 
experiments. The cytometer was kindly provided by the Schultze’ 
laboratory (LIMES Institute, University of Bonn). 
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6.1.4 Antibodies 
6.1.4.1 Primary antibodies 
Anti-Human CD81: Functional Grade Purified: mouse monoclonal IgG1 
clone 1D6 (#16-0819, eBioscience, San Diego, CA, USA) 
Anti-CD81 (5A6): mouse monoclonal IgG1 clone 5A6 (#sc-23962, Santa 
Cruz, USA) 
Anti-CD81 (1.3.3.22): mouse monoclonal IgG1 (#sc-7637, Santa Cruz, 
USA) 
Anti-CD9: mouse monoclonal IgG1 (#SM3039P, Acris, USA) 
Anti-CD9: mouse monoclonal IgG2b Kappa clone MM2/57 (#CBL 162, Merck 
Millipore, USA) 
Anti-GFP (JL-8): Living Colors® A.v. Monoclonal Antibody mouse IgG2a, 
(#632381, Clontech, Mountain View, CA, USA) 
Anti-GFP (B-2): mouse monoclonal IgG2a (#sc-9996, Santa Cruz, USA) 
Anti GFP: rabbit polyclonal IgG (#A11122, Invitrogen, Carlsbad, CA, USA) 
Anti-GFP (clone 3E6): mouse monoclonal IgG2a (#A11120, Invitrogen)  
Anti-HPV-L1 (K75): rabbit polyclonal (kindly provided by Dr. Luise Florin, 
university of Mainz) 
6.1.4.2 Secondary antibodies 
Goat anti-rabbit IgG-HRP (#sc-2030, Santa Cruz, USA) 
Goat anti-mouse IgG-HRP (#sc-2031, Santa Cruz, USA) 
Goat anti-Mouse IgG (H+L) IRDye800CW (#926-32210, LI-COR, 
Germany) 
Alexa Fluor® 488 donkey anti-mouse IgG (H+L) (#A21202, Invitrogen) 
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Alexa Fluor® 546 donkey anti-rabbit IgG (H+L) (#A10040, Invitrogen) 
Alexa Fluor® 594 donkey anti-mouse IgG (H+L) (#A21203, Invitrogen) 
Alexa Fluor® 594 donkey anti-rabbit IgG (H+L) (#A21207, Invitrogen) 
Alexa Fluor® 647 goat anti-mouse IgG (H+L) (#A21235, Invitrogen) 
Alexa Fluor® 647 chicken anti-rabbit IgG (H+L) (#A21443, Invitrogen) 
6.1.5 DNA-purification kits 
NucleoSpin ExtractII (#740609, Machery-Nagel, Dueren, Germany) 
NucleoSpin Plasmid (#740588, Machery-Nagel) 
NucleoBond PC500 (#740574, Machery-Nagel) 
6.1.6 Protein purification and analysis 
Pierce® BCA protein assay kit (#23225, Thermo Scientific, USA) 
GFP-Trap®_A (#gta-20, Chromotek, Martinsried, Germany) 
Protein G Mag Sepharose (#28-9440-08, GE Healthcare, USA) 
Odyssey® Blocking Buffer (#402-467-0700, LI-COR, Bad Homburg, 
Deutschland) 
Western Blotting Luminol Reagent (#sc-2048, Santa Cruz, USA) 
6.1.7 Plasmids 
pGEM®-T-Easy Vector System I (#A1360, Promega, Madison, WI, USA) 
pEGFP-C1 (#6084-1, Clontech, USA) 
pCD3Zeta-mEGFP (kindly provided by Dr. Jan van Üüm) used to amplify 
monomeric EGFP-sequence via PCR 
Materials and Methods 
    
    37 
 
pCD3Delta-mRFP (kindly provided by Dr. Jan van Üüm) used to amplify 
monomeric RFP-sequence via PCR 
6.1.8 Human papilloma type 16 pseudovirions (PsVs)  
PsVs were kindly provided by Dr. Luise Florin (University of Mainz, 
Germany) 
6.1.9 Fluorescent beads for imaging 
TetraSpek™ Microspheres, 0.1 µm, fluorescent blue/green/orange/dark 
red (#T-7279, Invitrogen) 
TetraSpek™ Microspheres, 0.2 µm, fluorescent blue/green/orange/dark 
red (#T-7280, Invitrogen) 
TetraSpek™ Microspheres, 0.5 µm, fluorescent blue/green/orange/dark 
red (#T-7281, Invitrogen) 
6.1.10 Buffers and solutions 
6.1.10.1 20x Poly-L-Lysin (PLL) stock solution 
PLL (#P1524, Sigma-Aldrich) was dissolved in ddH2O at a concentration 
of 2 mg/ml and stored at -20 °C in single-use aliquots of 1.5 ml volume.  
6.1.10.2 Cytomix solution 
120 mM KCl, 10 mM KH2PO4, 10 mM K2HPO4, 0.15 mM CaCl2, 2 mM 
EGTA, 5 mM MgCl2, 25 mM HEPES-KOH, pH 7.6. The solution was 
sterile-filtered using a Ø 0.2 µm filter, aliquoted and stored at -20 °C. 
6.1.10.3 Ringer Solution 
130 mM NaCl, 4 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 48 mM D(+)Glucose, 
10 mM HEPES-NaOH, pH 7.4. The solution was sterile filtered using a Ø 
0.2 µm filter, aliquoted and stored at -20 °C. 
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6.1.10.4 Sonication buffer 
120 mM potassium glutamate, 20 mM potassium acetate, 10 mM EGTA, 
20 mM HEPES, pH 7.2 
6.1.10.5 10x Phosphate buffered saline (PBS) 
1.37 M NaCl, 27 mM KCl, 81 mM Na2HPO4, pH 7.2 
6.1.10.6 Tris buffered saline (TBS) 
50 mM Tris, 150 mM NaCl, pH 7.4 
6.1.10.7 TBST 
TBS with 0.1 % (v/v) Tween 20 
6.1.10.8 SDS runnig buffer 
25 mM Tris, 192 mM Glycin, 0.1 % SDS, pH 8.3 
6.1.10.9 Western blot transfer buffer 
25 mM Tris, 192 mM Glycin, 20 % (v/v) Methanol, pH 8.3 
6.1.10.10 Western blot blocking buffer 
5 % (w/v) milk powder in TBST  
6.1.10.11 50x Tris-Acetate-EDTA (TAE) buffer 
2 M Tris, 50 mM Na2EDTA, 5.71 % (v/v) Acetic acid, pH 8.0 
6.1.10.12 16 % paraformaldehyde (PFA) stock solution 
16 % (w/v) paraformaldehyde was dissolved in ddH2O under continuous 
agitation at 65 °C in the fume hood. After cooling to RT, the pH was 
adjusted to 7.2 by dropwise addition of NaOH. The prepared solution was 
aliquoted into single-use aliquots of 12.5 ml and stored at -20 °C. 
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6.1.10.13 4 % PFA fixation solution 
The solution was prepared under the hood by mixing 12.5 ml 16 % PFA 
aliquot with 5 ml 10x PBS in 50 ml Falcon tube. The mixture was adjusted 
to 50 ml with ddH2O to reach a final concentration of 4 % PFA/1 x PBS pH 
7.2. 
6.1.10.14 TMA-DPH solution 
Saturated 1-(4-Trimethylammoniumphenyl)-6-Phenyl-1,3,5-Hexatriene p-
Toluenesulfonate (TMA-DPH; #T204, Invitrogen) solution was centrifuged 
in 1.5 ml eppendorf tubes for 5 min at 16,000 x g. The supernatant was 
pipetted into a fresh tube and used directly (1:3 v/v) in the microscopy 
chamber solution (PBS for membrane sheets or Ringer solution for intact 
living cells) to visualize cellular membranes. 
6.1.10.15 50 mM sulforhodamine 101 stock solution 
30.3 mg sulforhodamine 101 (#S7635, Sigma) was dissolved in 1 ml 
autoclaved ddH2O and stored in dark at RT.  
6.1.10.16 100 µM phenylmethylsulfonyl fluoride (PMSF) 
stock solution 
1.74 mg PMSF was dissolved in 10 ml pure isopropanol, aliquoted and 
stored at -20 °C. 
6.1.10.17 4x Laemmli sample buffer 
 250 mM Tris pH 6.8, 30 % (v/v) Glycerol, 6 % (w/v) SDS, 0.04 % (w/v) 
bromphenolblue. The buffer was stored at -20 °C and supplemented 1:5 
with β-mercaptoethanol when necessary.  
6.1.10.18 Protease inhibitor cocktail stock solution 
One tablet of Complete® EDTA free (Roche, Mannheim, Germany) was 
dissolved in 1 ml autoclaved ddH2O and stored at -20 °C. The solution 
was added freshly at a concentration of 1:50 
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6.1.10.19 Radio immunoprecipitation assay (RIPA) 
buffer 
10 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 % (v/v) Triton X-100, 0.5 % 
(w/v) DOC, 0.1 % (w/v) SDS, pH 7.4 in autoclaved ddH2O. The buffer was 
stored at 4 °C. 1 mM PMSF and protease inhibitor cocktail were added 
freshly prior to use. 
6.1.10.20 HEPES wash buffer 
150 mM NaCl, 5 mM MgCl2, 25 mM HEPES, pH 7.2 
6.1.10.21 HEPES lysis buffer 
150 mM NaCl, 5 mM MgCl2, 25 mM HEPES, 1 % (w/v) CHAPS (C5070, 
Sigma-Aldrich), pH 7.2 in autoclaved ddH2O. The buffer was stored at 4 
°C and was supplemented with 10 µM PMSF and protease inhibitor 
cocktail before use. 
6.1.10.22 100x FACS buffer 
10 % BSA, 0.5 % NaN3 dissolved in 1x PBS and stored at 4 °C 
6.1.10.23 1x FACS buffer 
100x FACS buffer diluted (1:100) in pre-cooled 1x PBS and stored at 4 °C  
6.1.11 Bacteria culture 
All media prepared for bacteria cultures were autoclaved and stored at 
RT. In case of antibiotic selection mediums, antibiotics were added after 
autoclaving at a concentration of 100 µg/ml and 50 µg/ml for ampicillin 
and kanamycin, respectively. For long time storage, bacteria cultures 
were mixed with 30 % (v/v) glycerol and stored at – 80 °C. 
6.1.11.1 E. coli bacteria 
E. coli XL-10 Gold® Ultracompetent Cells (#200315, Stratagene, La Jolla, 
CA, USA)  
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6.1.11.2 LB-medium 
2 % (w/v) LB-medium powder according to Lennox (#A6666, AppliChem, 
Darmstadt, Germany) in ddH2O. 
6.1.11.3 LB-agar plates 
2 % (w/v) LB-medium powder according to Lennox, 2 % (w/v) agar in 
ddH2O. The mixture was autoclaved and cooled at RT to ~55 °C; 
antibiotics were added at this step for antibiotic selection plates. 
Afterwards, the mixture was poured into petri dishes (~25ml/10 mm plate), 
cured at RT and stored at 4 °C. 
6.1.12 Cell culture 
All cell culture procedures with the human cell lines Jurkat E6.1 and 
HepG2 were performed under sterile conditions.  
6.1.12.1 Cell lines 
6.1.12.1.1 Jurkat E6.1 cells 
Jurkat E6.1 cells are human leukemic T cell lymphoblast derived from 
peripheral blood of a fourteen year old male with T cell leukemia (Jurkat 
clone E6.1, homo sapiens, ATCC® TIB-152™)(Purchased from Sigma-
Aldrich, #88042803).  
6.1.12.1.2 HepG2 cells 
HepG2 cells are a human liver hepatocellular carcinoma cell line derived 
from the liver tissue of fifteen years old male (HepG2, homo sapiens, 
ATCC® HB-8065™). HepG2 cells are adherent and grow as monolayers 
in small aggregates (Purchased from CLS, #300198). Preliminary 
experiments on HepG2 cells were performed on cells that were a gift from 
the Famulok’ laboratory (University of Bonn). Note that no differences 
between cell types were observed. 
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6.1.12.2 Medium for Jurkat E6.1 cells 
RPMI-1640 (#21875-091, gibco, UK), supplemented with 10 % (v/v) FBS 
superior (#S0615, Biochrom, Germany), 1 % (v/v), Penicillin-Streptomycin 
100x (10,000 U/ml potassium penicillin and 10 mg/ml streptomycin 
sulfate) (#DE17-602E, Lonza, Belgium). 
6.1.12.3 Medium for HepG2 cells 
EMEM (#12-662F, Lonza, Belgium), supplemented with 10 % (v/v) FBS 
superior (#S0615, Biochrom, Germany), 1 % (v/v), Penicillin-Streptomycin 
100x (10,000 U/ml potassium penicillin and 10 mg/ml streptomycin 
sulfate) (#DE17-602E, Lonza, Belgium). 
6.1.12.4 Trypsin 
Trypsin-EDTA (1x), Dextrose 1 g/l, KCl 400 mg/l, NaHCO3 580 mg/l, NaCl 
8 g/l, Trypsin 500 mg/l, EDTA 200 mg/l (#BE17-161E, Lonza, Belgium) 
6.1.12.5 PBS for cell culture 
Dulbecco’s Phosphate Buffered Saline (DPBS) without Ca2+ and Mg2+, 
KCl 200 mg/l, KH2PO4 200 mg/l, NaCl 8 g/l, Na2HPO4.7H2O 2.16 g/l 
(#BE17-512F, Lonza, Belgium) 
6.2 Methods 
6.2.1 Cloning 
The cloning steps of all constructs were performed following the standard 
methods of cloning described by Sambrook and Russell (Sambrook and 
Russell, 2006). Primers used for cloning were designed manually and 
ordered from MWG Operon (Obersberg, Germany). All cloned constructs 
were sequenced by GATC (Konstanz, Germany). If necessary, the 
sequencing procedures were done stepwise using different primer 
positions to cover the whole desired sequence. 
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Starting from a cDNA library, I amplified by polymerase chain reaction 
(PCR) the sequences for CD81 (NM_004356.3) EWI-2 (NM_052868.4) 
and CD9 (NM_001769.3) using primers which align perfectly to the 5’ 
ends of the sense and antisense strands of the cDNA to get blunt-ended 
PCR products. Using OneTaq® DNA-Polymerase (#M0480S, NEB, UK), I 
added an adenine at the 3’ ends of the PCR products. The amplified PCR 
products carrying 3’ adenines rests were subcloned into a pGEM-T easy 
vector (#A1360, Promega, Madison, WI, USA). 
The subcloned CD81 cDNA was fused directly, via fusion PCR (Heckman 
& Pease, 2007), to the N-terminus of monomeric enhanced GFP 
(Zacharias et al., 2002) (see 6.1.7), or to the N-terminus of monomeric 
RFP (Campbell et al., 2002) (see 6.1.7); carrying two silent mutations at 
the positions 4 and 5 to generate a XhoI restriction side) with a stop 
codon. The fused PCR products were inserted via NheI/KpnI restriction 
sites into the expression vector pEGFP-C1 (#6084-1, clontech, Mountain 
View, CA, USA) lacking EGFP to generate the two wild-type CD81 
constructs versions CD81-GFP (figure 12) and CD81-RFP (figure 13). 
 
Figure 12. CD81-GFP construct cloned in the expression vector pEGFP-C1 
CMV; human cytomegalovirus, MCS; multiple cloning site, f1 ori; f1 origin, KanR/NeoR; 
Kanamycin/Neomycin resistance, pUC ori; pUC origin. (Created using ApE software 
http://biologylabs.utah.edu/jorgensen/wayned/ape/) 
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Figure 13. CD81-RFP construct cloned in the expression vector pEGFP-C1 
For abbreviations see figure 12. (Created using ApE software 
http://biologylabs.utah.edu/jorgensen/wayned/ape/) 
CD81 constructs were derived from CD81-GFP after substitution or 
deletion using fusion PCR and then inserted between NheI and Kpn2I a 
C-terminal restriction site within the CD81 sequence. If the mutation was 
downstream of the Kpn2I site, the fusion PCR was performed for the 
whole CD81-GFP sequence and products were inserted via NheI/KpnI 
sites. Using this procedure I generated the following constructs: CD81-
C/A with all juxtamembrane cycteins at the positions 6, 9, 80, 89, 227 and 
228 substituted for alanine; CD81- lacking aa 115-155; CD81- 
lacking aa 156-174; CD81- lacking aa 156-190 and CD81- lacking 
aa 176-186.  
The same cloning procedures were performed using fusion PCR to fuse 
EWI-2 or CD9 C-terminally to the N-terminus of mRFP carrying a C-
terminal myc-tag (myc sequence; 
GAACAAAAACTTATTTCTGAAGAAGATCTG) followed by a stop codon. 
Finally, the pEGFP-C1 expression vector was used as a target for 
inserting EWI-2-RFP-myc via the AgeI/KpnI sites (figure 14) or CD9-RFP-
myc via NheI/KpnI sites (figure 15). 
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Figure 14. EWI-2-RFP construct cloned in the expression vector pEGFP-C1 
For abbreviations see figure 12. (Created using ApE software 
http://biologylabs.utah.edu/jorgensen/wayned/ape/) 
 
 
Figure 15. CD9-RFP construct cloned in the expression vector pEGFP-C1 
For abbreviations see figure 12. (Created using ApE software 
http://biologylabs.utah.edu/jorgensen/wayned/ape/) 
For the amplification of plasmid DNA, the bacterial strain E. coli XL-10 
Gold® Ultracompetent Cells (see 6.1.11.1) was used. DNA/PCR products 
were purified using plasmid/PCR purification kits (see 6.1.5).  
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6.2.2 Cell culture 
All cell lines were cultivated in standard cell culture vessels (Sarstedt, 
Nümbrecht, Germany and Labomedic Bonn, Germany). 
6.2.2.1 Cell culture and splitting  
HepG2 and Jurkat E6.1 cells were cultivated in 75 cm2 and 175 cm2 
flasks, respectively. Adherent HepG2 cells were split 1:4 every 3 days 
when they reached 80 % confluence. In brief, cells were washed once 
with DPBS and detached from the flask after 3 min incubation with 1 ml 
Trypsin/EDTA at 37 °C. The cells were washed with 9 ml full medium and 
pipetted up and down to collect all detached cells in the flask. 2.5 ml of 
cell suspension were pipetted into fresh flask containing 22.5 ml full 
medium. Cell culture was maintained further by 37 °C. Jurkat E6.1 cells 
were split every 3 – 4 days by simple dilution to yield a concentration of 2 
× 105 cells/ml. 
6.2.2.2 Cryo-stocks 
HepG2 cells were washed, detached and collected as described in 
6.2.2.1. At this step the cell concentration was determined using a 
Neubauer counting chamber. The cell suspension was transferred into a 
15 ml falcon tube and centrifuged for 3 min at 1000 rpm in an Eppendorf 
centrifuge 5810. The supernatant was aspirated and the cell pellet was 
resuspended in freezing medium (full medium supplemented with 10 % 
DMSO) at a concentration of 2.5 × 106 cells/ml. For the suspension Jurkat 
E6.1 cell line, cells were counted directly from the culture and then 
collected by centrifugation, washed with DPBS, centrifuged again and 
resuspended in freezing medium at a concentration of 5 × 106 following 
the same protocol as for HepG2 cells. 1 ml cell suspension aliquots were 
pipetted in cryovials and then frozen in a gradient freezing chamber 
(Nalgene Cryo containers, #C1562-1EA, Sigma-Aldrich, Hamburg, 
Germany) at -80 °C over night and transferred to a liquid nitrogen 
container on the next day. 
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For thawing cells, a cryovial aliquot was removed from the liquid nitrogen 
tank and allowed to thaw directly in a water bath at 37 °C for 2 min. The 
cell suspension was washed in 9 ml pre-warmed full medium, centrifuged 
and the cells were taken up in the appropriate volume of pre-warmed full 
medium. 
6.2.2.3 Cell transfection 
HepG2 and Jurkat E6.1 cells were transfected using the Gene pulser 
Xcell electroporation system (Bio-Rad, Hercules, CA, USA). 60 µg 
plasmid DNA were used for a single transfection, while 30 µg of each 
plasmid were used for a double transfection.  
3 × 106 HepG2 cells/transfection were resuspended with DNA in 400 µl 
Cytomix solution, transferred to a 2 mm electroporation cuvette and 
electroporated at the following settings: Exponential protocol, 200 V, 950 
µF, 200 Ω. For Jurkat E6.1 cells, 1 × 107 cells/transfection were used and 
electroporation was performed in a 4 mm electroporation cuvette after 
resuspending the cells with DNA in 800 µl Cytomix solution. The 
electroporation pulse was set to the following pulse program: Exponential 
protocol, 250 V, 1500 µF and infinite Ω. Accumulated cell debris on top of 
the cell suspension after electroporation was carefully aspirated and 
subsequently the cell suspension was pipetted directly into pre-warmed 
medium and cultured at 37 °C in an appropriate flask. Experiments with 
HepG2 and Jurkat E6.1 cells were performed 1 day and 2 days after 
transfection, respectively. 
6.2.2.4 Glass coverslips cleaning and coating with poly-L-
Lysine 
For all microscopy experiments, the glass coverslips used were first 
cleaned and, if required, coated with poly-L-Lysine. For cleaning, 
coverslips were first incubated for 2 h in 1 M HCl in a glass beaker under 
constant agitation followed by five wash steps with ddH2O. Next, 
coverslips were incubated for 2 h in 1 M NaOH under constant agitation. 
Subsequently, the coverslips were washed again five times with ddH2O 
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and once with absolute EtOH. Finally, the coverslips were incubated for 2 
h in absolute EtOH. Afterwards, the EtOH was discarded and the cleaned 
coverslips were baked, dried at 70 °C and kept at RT in a sterile 
surrounding. 
Coating was performed in a sterile hood. A 1x working solution of 100 
µg/ml poly-L-Lysine was prepared by diluting a 20x poly-L-Lysine stock 
solution in autoclaved ddH2O. The coverslips were transferred into 6-well 
plates and coated with 500 µl of 1x poly-L-Lysine solution for 30 min at 
RT. Finally, the poly-L-Lysine solution was aspirated and the coverslips 
were dried at RT under the sterile hood for 2 h. The prepared coverslips in 
6-well plates were then stored at 4 °C. 
6.2.3 Preparation of membrane sheets 
The preparation of unroofed cells or membrane sheets facilitates 
visualization and examination of membrane protein organization with high 
sensitivity. This detergent-free preparation uses a 100 ms ultrasound 
pulse to generate two dimensional, pure, native basal plasma membranes 
by applying mechanical shearing forces (Avery et al., 2000; Heuser, 
2000). The prepared membrane sheets allow biochemical access to the 
cytosolic side of the native cell membrane and allow exclusive imaging of 
the basal membrane and its tightly attached components with a high 
signal to noise ratio (figure 16). 
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Figure 16. Preparation of membrane sheets 
Intact living cells adhered on poly-L-Lysine coated glass coverslip are treated with a 100 
ms sonication pulse. The mechanical shearing force leads to washing off the upper part 
of the cell leaving only the native basal membrane and membrane associated vesicles 
attached to the coverslip. Membrane sheet preparations are devoid from out-of-focus 
signals and present a detergent free preparation to analyze membrane structures 
organizations.  
The preparation of membrane sheets from HepG2 cells was performed 
after transfecting and plating on poly-L-Lysine coated coverslips in 6-well 
plates at a concentration of ~5 × 105 cells/coverslip. After one day, HepG2 
cells were ready to use for sonication. In contrast, Jurkat E6.1 cells were 
collected 2 days after transfection (see 6.2.2.3) and resuspended in pre-
warmed Ringer solution. Then, the cell suspension was plated onto 6-well 
plates containing poly-L-Lysine coated coverslips at a concentration of 
~1.5 × 106 cells/coverslip. Cells were incubated in the cell incubator for 20 
min to allow for adhesion of cell to the coverslips before sonication. For 
membrane sheets generation, each coverslip was placed with the cells 
facing up in a glass dish containing ice-cold sonication buffer. The tip of 
an ultrasound sonicator Sonopuls HD 2070 (Bandelin, Berlin, Germany) 
was submerged into the sonication buffer above the coverslip at a 
distance of ~0.5 cm. Afterwards, a 100 ms sonication pulse was applied at 
a pulse power optimized for each cell line, which was 75 % and 25 % for 
HepG2 and Jurkat cells, respectively. The successful generation of 
membrane sheets was verified by visual inspection confirming the 
appearance of a star-shape transparency clearing in the center of the 
coverslip, indicating the presence of unroofed cells in this area. 
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Subsequently, the coverslip was transferred to a new 6-well plate and 
fixed directly for 30 min at RT with 4 % PFA in PBS. Finally, the fixative 
was quenched for 30 min at RT with 50 mM NH4Cl in PBS, followed by 3 
washes of 10 min with PBS. 
6.2.4 Immunostaining of membrane sheets from cells 
expressing CD81-GFP 
Membrane sheets were generated from transfected cells, fixed, quenched 
and washed (see 6.2.3). Subsequently, membrane sheets were incubated 
with the first antibody anti-CD81 (Anti-Human CD81 mouse monoclonal 
IgG1 clone 1D6, eBioscience) diluted (1:100) in 3 % BSA-PBS for 1 h at 
RT in a dark humid chamber followed by washing 3 times with PBS for 10 
min. The incubation with the secondary antibody (Alexa Fluor® 594 
donkey anti-mouse IgG (H+L), Invitrogen) diluted (1:200) in 3 % BSA-PBS 
was performed in the dark for 1 h at RT for HepG2 and overnight at 4 °C 
for Jurkat E6.1 cell membrane sheets. Then, the coverslips were washed 
3 times with PBS for 10 min and directly imaged in PBS supplemented 
with a lipid dye (TMA-PDH) for visualization of membranes. The sheets 
were observed using the Olympus IX81 microscope (see 6.1.2.2) in 
epifluorescence modus. The exposure times in the green channel for 
imaging of HepG2 and Jurkat membrane sheets were 1 s and 100 ms, 
respectively. In the red channel, the exposure times were 500 ms and 100 
ms for HepG2 and Jurkat samples, respectively. All images are shown 
applying a linear lookup table at arbitrary scaling. 
6.2.5 Determination of protein concentration 
The protein concentration was determined using the BCA Protein Assay 
Reagent (#23225, Thermo Scientific, Rockford, USA) following the 
manufacture’s protocol. The absorbance at 595 nm was measured in 96-
well-plates using the microplate reader Infinite® F200pro (TECAN, 
Maennedorf, Switzerland). The protein concentration was determined 
referring to a BSA standard curve. 
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6.2.6 Immunoprecipitation 
For immunoprecipitation, 1 × 107 Jurkat T cells were used two days after 
transfection (see 6.2.2.3). Cells were washed once with ice cold HEPES 
buffer and then lysed in 1 ml HEPES lysis buffer. The solution was 
incubated for 2 h at 4 °C on the tube rotator. Afterwards, the cell lysate 
was centrifuged for 5 min at 6000 rpm using an Eppendorf centrifuge 
(Eppendorf centrifuge 5430R) and the lysate supernatant was transferred 
into a new tube 50 µl of the lysate were removed and kept for input 
samples. During the lysis, GFP-Trap® A (#gta-20, Chromotek, 
Martinsried, Germany) beads, which are covalently coupled with anti-GFP 
recombinant antibody fragments, were equilibrated by washing once with 
ddH2O and twice with HEPES buffer. Between each washing step beads 
were collected by centrifugation for 2 min at 2500 x g and the supernatant 
was carefully aspirated. The cell lysate was incubated with 30 µl pre-
equilibrated GFP-Trap® A beads rotating for 2 h at 4 °C. Subsequently, 
beads were collected by centrifugation for 2 min at 2500 x g and then 
washed twice with 500 µl HEPES buffer. Finally, beads were loaded into 
the gel pockets under non-reducing conditions to avoid cleavage of the 
disulfide bridges in the LEL which precludes later detection of the epitope 
in western blot analysis. 
6.2.7 SDS-PAGE and western blot analysis 
The protein biochemistry experiments were performed following standard 
methods as described in (Kyhse-Andersen, 1984; Laemmli, 1970; Towbin 
et al., 1979) or (Rehm & Letzel, 2010). 
Immunoprecipitation samples were prepared for SDS-PAGE by mixing the 
samples (1:4) with 4x Laemmli sample buffer under non-reducing 
conditions and boiled for 10 min at 95 °C. For further analysis, samples 
were shipped to the laboratory of Dr. Luise Florin (University of Mainz). 
Florin’ laboratory is equipped with a more sensitive protein detection 
system. Further processing was performed by Dr. Konstanze Scheffer 
using the following protocol. In brief, proteins were separated on 10 % 
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polyacrylamide gels and then transferred to nitrocellulose membranes 
(#10485376, Whatman, Maidstone, UK). Afterwards, membranes were 
blocked for 1 h at RT with TBS-T 5 % milk and then incubated with the 
first antibody anti-GFP (Living Colors® A.v. Monoclonal Antibody (JL-8), 
#632381, Clontech, Mountain View, CA, USA) diluted 1:10,000 in TBS-T 5 
% milk followed by 3 washing steps with TBS-T for 10 min. Next, 
membranes were incubated with the HRP-coupled secondary antibody 
anti-mouse (goat anti-mouse IgG-HRP, #sc-2031, Santa Cruz, USA) 
diluted 1:5,000 in TBS-T 5 % milk for 1 h at RT and then washed 3 times 
for 10 min with TBS-T and once with TBS. Then the same protocol was 
performed using either anti-CD81 (mouse monoclonal (1.3.3.22),#sc-
7637, Santa Cruz, USA) diluted 1:200 or anti-CD9 (mouse monoclonal, 
#SM3039P, Acris, USA) diluted 1:10,000 in TBS-T 5 % milk after 
membrane stripping by washing with 1 M NaOH for 5 min. Finally, 
membranes were developed on autoradiography films. In other western 
blot analyses performed in Bonn, the same protocol was used following 
the immunoprecipitation lysis protocol, the GFP antibody used was anti-
GFP (rabbit polyclonal IgG, #A11122, Invitrogen, Carlsbad, CA, USA) 
diluted 1:1000 and the secondary antibody used was anti-rabbit (goat anti-
rabbit IgG-HRP, #sc-2030, Santa Cruz, USA) diluted 1:5000 in TBS-T 5 % 
milk. 
Alternatively, another western blot protocol was also optimized in this 
work, which was varied in some steps. Cells were lysed in 100 µl ice cold 
RIPA buffer and incubated under rotation for 30 min at 4 °C. Afterwards, 
cells were centrifuged for 5 min at 4 °C at 13000 rpm and the cell lysate 
samples were mixed (1:4) with 4x Laemmli buffer supplemented with β-
mercaptoethanol. After protein separation on 10 % polyacrylamide gels, 
the proteins were transferred onto a nitrocellulose membrane using a 
semi-dry blotting system (Bio-rad). In the following steps, Odyssey® 
Blocking Buffer (#402-467-0700, LI-COR, Bad Homburg, Deutschland) 
was used instead of TBS-T 5 % milk. The first antibody was an anti-GFP 
antibody (mouse monoclonal IgG2a (B-2), #sc-9996, Santa Cruz, USA) 
diluted (1:1000) in Odyssey® Blocking Buffer and the secondary antibody 
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was labeled with the fluorescent dye IRDye®800CW (Goat anti-Mouse 
IgG (H+L) IRDye800CW, #926-32210, LI-COR, Germany) diluted 
(1:5000). Finally the antibody staining was visualized using the Odyssey® 
CLx Imaging System (LI-COR Inc., Lincoln, USA). 
6.2.8 Flow cytometry, fluorescence activated cell sorting 
(FACS) analysis 
Transfected cells were washed once with ice cold DPBS and then 
harvested by cell scraping in the case of HepG2 cells or by centrifugation 
(for 3 min at 1000 rpm) in the case of Jurkat T cells. The cell pellet was 
resuspended in ice cold 1x FACS buffer at a concentration of 106 
cells/100 µl. For each FACS sample 100 µl cell suspension was pipetted 
into FACS tube (Polystyrene round-bottom 12 x 75 mm) (#2017257, 
Labomedic, Germany). Since low temperature inhibits endocytosis and 
surface internalization pathways, all staining and washing steps were 
performed on ice and all buffers and reagents were pre-cooled before 
use. 1 µg of the first antibody anti-CD81 (anti-human CD81 mouse 
monoclonal IgG1 clone 1D6, eBioscience) was directly added to the cell 
suspension in the FACS tubes, mixed by a quick vortex-pulse and 
incubated in the dark for 30 min at 4 °C. Next, cells were washed twice 
with 500 µl 1x FACS buffer centrifuging for 5 min at 300 x g and 4 °C. 
Afterwards, cells were incubated in the dark with 1 µg of the secondary 
antibody anti-mouse (Alexa Fluor® 647 goat anti-mouse IgG (H+L), 
#A21235, Invitrogen) for 30 min at 4 °C followed by two washing steps for 
5 min centrifuging at 300 x g and 4 °C. Control conditions included 
omission of the first antibody as well as unstained transfected and non-
transfected cells which were prepared and incubated in parallel with the 
treated samples. Finally, samples were analyzed on a LSR II (BD 
Biosciences) (see 6.1.3). The fluorescence intensity of all channels is 
shown at logarithmic scaling and the thresholds of the fluorescence 
channels were adjusted once for each cell line in order to set the control 
population at the origin of the axes. Samples were sorted at low flow 
speed to avoid the detection of multiple events, measuring no more than 
Materials and Methods 
 
54 
 
 
1000 events/sec. The data were analyzed and plotted using FlowJo 
software (TreeStar Inc., Ashland, OR, USA). 
6.3 Microscopy 
To visualize different proteins of interest on the cell membrane, they were 
coupled directly to fluorophores by generating fusion proteins with mGFP 
or mRFP proteins. Alternatively, immunostaining was performed using a 
first antibody raised against the protein of interest and a secondary 
antibody coupled to a fluorescent dye. As outlined in detail below, for 
studying static and dynamic aspects of tetraspanin domains several 
microscopy methods including epifluorescence, TIRF, FRAP and STED 
microscopy were applied. 
6.3.1 Epifluorescence microscopy 
Epifluorescence microscopes have a relatively simple setup consisting of 
a light source (usually a Xenon lamp) coupled to filter sets for specific 
excitation and detection of different dyes followed by an optical system 
and an EMCCD camera. In an epifluorescence microscope, the excitation 
light propagates through the whole sample and the light emitted by dyes 
located in a relatively large area along the z-axis is collected, which can 
increase the signal to noise ratio (figure 17). This microscopy modus was 
mostly used with 2-dimensional samples (membrane sheets) that in an 
ideal case generate no out-of-focus light. 
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Figure 17. Technical differences between epi- and TIRF-microscopy 
Epifluorescence microscopy setup is shown on the left and a TIRF microscopy setup on 
the right. The excitation beam is depicted in green and the emission beam in red. An 
EMCCD camera is used for low noise imaging of low light levels. In the case of 
epifluorescence microscopy (left), the dichroic mirror in the middle of the objective light 
trajectory reflects the excitation light into the objective from which it focused into the 
sample, while emission light collected by the objective passes through. In the case of 
TIRF microscopy (right), small mirrors at the edge of the objective serve for generation a 
total internal reflection at the interface between the sample and the objective. The 
excitation light propagates through the sample and excites all fluorophores within the 
light trajectory in the case of epifluorescence, whereas the propagated excitation laser 
light at the edge of the objective in the case of TIRF-microscopy will be reflected on the 
interface between the sample and the coverslip, yielding a standing evanescent light 
decays exponentially by distance and excites the fluorophores close to the interface 
(modified from Veigel & Schmidt, 2011). 
An Olympus IX81 microscope (see 6.1.2.2) was operated in 
epifluorescence modus. The fixed membrane sheet preparations were 
imaged in PBS supplemented with the lipid dye TMA-DPH to verify the 
integrity of the plasma membrane. The system was set to 192x 
magnification using optical lenses yielding a pixel size of to 83.3 nm. The 
microscope was controlled with the CellR Olympus software. Recorded 
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images were exported as TIFF files and analyzed with ImageJ software. 
Information about recording times are given in the respective sections.  
6.3.2 Total internal reflection fluorescence (TIRF) 
microscopy 
TIRF microscopy is a fluorescence microscopy technique that allows 
exclusive sample illumination up to 50 – 100 nm distance (in the z-axis) 
from the interface between glass and sample. This enables specific 
excitation of a thin optical layer in the close proximity of the glass. In case 
of adherent cells, this method allows the detailed visualization of 
fluorophores or fluorophore-coupled proteins in the basal plasma 
membrane and membrane docked vesicles at a high signal to noise ratio 
while using whole cells. The physical principle behind this method is total 
internal reflection occurring at the interface between two media with 
different refractive indices (nglass > nsample), when the angle of the incident 
light becomes greater than the critical angle (Mattheyses et al., 2010). 
Total reflection of the incident light creates an evanescent wave on the 
interface which enters the sample. The intensity of the evanescent 
illumination decays exponentially with the distance from the interface. 
Therefore, out of plane signals originating from inner compartments of the 
cell are strongly diminished (figure 17).  
TIRF imaging was performed with an Olympus IX81 microscope coupled 
to a 488 nm laser using the TIRF modus of the microscope (see 6.1.2.2). 
TIRF microscopy was used to study cluster immobilization and stability on 
living Jurkat cells. Cells were collected and then resuspended in pre-
warmed Ringer solution. Cell suspensions were plated on 6-well plates 
containing poly-L-Lysine coated coverslips at a concentration of ~1.5 × 
106 cells/well. Cells were adhered in the cell incubator for 20 min and 
imaged at RT within the next 20 min. Images series were recorded at 2 Hz 
for 15 s. Images series were analyzed by calculating the Pearson 
correlation coefficient (PCC) between two successive images. The PCC 
values obtained from each measurement were averaged and for each 
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independent experiment all calculated values were averaged using Excel 
(Microsoft Corporation, Redmon, USA). The pixel, the system 
magnification and the controlling software were the same as described in 
the previous section (see 6.3.2).  
6.3.3 Confocal laser scanning microscopy (CLSM) 
6.3.3.1 Static views 
An Olympus FluoView™ FV1000 confocal microscope (see 6.1.2.3) was 
used to visualize fluorescence signals with optical sectioning of the cell 
body. An overview image of intact living transfected Jurkat cells was 
acquired in Ringer solution at a pixel size of 103 nm while experiments 
performed with immunostaining after permeabilization with Triton X 100 
were imaged at a pixel size of 207 nm. The intensity of the utilized laser 
lines (405 nm, 488 nm and 543 nm) was set to 5 % and the dwell time 
was adjusted to 8 µs/pixel. In the case of living cells, samples were 
additionally recorded in the bright-field mode. 
6.3.3.2 Fluorescence recovery after photobleaching (FRAP) 
FRAP enables studying the dynamics of fluorophore-coupled proteins and 
the determination of their lateral diffusion coefficient. The FRAP 
experiments were done using an Olympus FluoView™ FV1000 confocal 
laser scanning microscope (see 6.1.2.3) on intact, living transfected Jurkat 
cells adhered on poly-L-Lysine pre-coated glass coverslips in Ringer 
solution. The measurement was done on the basal plasma membrane of 
the cells and the image sequences were recorded at 0.5 Hz for 160 s. The 
recording laser intensity of the utilized laser line (488 nm) was set to 0.2 
%, the pixel size was adjusted to 207 nm and the dwell time was set to 40 
µs/pixel. The recorded image size was defined by 100 x 100 pixels and 
bleaching was performed within a 10 x 10 pixel ROI (~2.1 µm x 2.1 µm 
area) using the 405 nm and 488 nm laser line simultaneously at full 
intensity. The recording series of each FRAP measurement was initiated 
with 3 pre-bleach frames, subsequently the sample was bleached for 500 
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ms at full laser intensity followed by 76 post-bleach recording frames. The 
overall bleaching effect and/or potential focus drift occurring during the 
measurement was assessed by recording the fluorescence intensity within 
a control ROI of the same size placed near the ROI used for bleaching. 
For background correction another ROI was placed outside of the cell. 
The recorded intensities of all ROIs were used to calculate the 
background-subtracted, relative fluorescence intensities within the bleach 
and control ROIs. The whole measurement was recorded for 160 s. 
During this time, the system occasionally showed instabilities toward the 
end of the measurement; therefore only the first 80 s were used for the 
analysis. The recorded data from the control, bleach and background 
ROIs were imported to Excel (Microsoft Corporation, Redmon, USA). The 
background intensities were subtracted from the intensity values of the 
control and bleach regions. All measurements showing an intensity 
deviation greater than 15 % in the control ROI after 80 s were excluded 
from the analysis. This deviation was calculated from the averaged 
background-corrected fluorescence intensities of the first three and last 
three (until 80 s) frames. Cells with very high and very low expression 
levels were also excluded. The background-corrected fluorescence 
intensities recorded in the bleach ROI were normalized to the average of 
the three pre-bleach values to calculate the percentage of the 
fluorescence recovery over the time. For each independent experiment 
the average of all measured cells was calculated. Finally, the averaged 
fluorescence recovery was plotted against time using Origin 8 Pro 
software (OriginLab Corporation, Northampton, USA) and FRAP curves 
were fitted to the hyperbola equation described in (Ficz et al., 2005). 
y(t) = y0 + RecMax × t / (T1/2 + t), 
where y0 is the offset, RecMax is the maximal recovery and T1/2 
corresponds to the half-maximum recovery time. The calculated half-
maximum recovery was used to calculate the diffusion coefficient using 
the following equation described by Axelrod (Axelrod et al., 1976). 
D = (w2 / 4 T1/2) γD, 
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where w is the radius of the bleached area (here: ~1 µm), T1/2 is the half-
maximum recovery and γD is shape correction factor of the bleached area 
(here: 1.1). 
6.3.4 Super resolution microscopy: gated stimulated 
emission depletion (g-STED) 
For a long time the resolution of the light microscopy was limited by the 
diffraction or spreading of light waves. This effect occurs when light waves 
of point light sources pass through a small aperture or are focused onto a 
small spot (Huang et al., 2010) and yields a blurred, widened image of this 
spot. Blurring is systematic and a feature of the microscope specific point 
spread function (PSF). For visible light, this results in a resolution limit of 
~250 nm in the x, y axis as described by Ernst Abbe about 150 years ago 
and widely known as the Abbe limit (Abbe, 1873). This means that 
subcellular structures at distances smaller than the diffraction limit are not 
resolvable by light microscopy (figure 18). Super resolution microscopy 
has broken this limit and has allowed the resolution to reach much higher 
ranges. 
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Figure 18. Barrier of the diffraction-limited resolution produced by light 
microscopes 
(A) Signal from a point emitter modulated by the point spread function from a typical 
objective with high numerical aperture pictured by the cyan ellipsoid, has a width of ~250 
nm in the x-axis (lateral direction) and ~550 nm in the z-axis (axial direction). These 
dimensions define the diffraction-limited resolution of the light microscope; therefore two 
objects separated by a distance greater than this resolution limit can be resolved and 
appear as two separate entities. At smaller distance objects appear as a single 
unresolved entity. These two cases are shown for two line scans on a microtubule image 
(middle) showing in the right panel two cyan curves A and B, where the scan in A is 
resolved and the scan in B is unresolved. (B) Various biological structures are shown in a 
size scale, where the left part to the red dashed line (the diffraction-limited barrier) can 
be resolved by light microscopy; whereas the right part remains unresolvable. From left 
to right; a mammalian cell, a bacterial cell, a mitochondrion, an influenza virus, a 
ribosome, the GFP protein and a small molecule (thymine) (derived from Huang et al., 
2010). 
The theoretical background of super resolution STED fluorescence 
microscopy was first described by Hell and Wichmann (Hell & Wichmann, 
1994). The STED microscope is a confocal laser scanning microscope 
with an excitation laser and an additional doughnut-shaped STED laser 
which overlaps with the excitation beam. The STED laser depletes the 
excited fluorophores so that only fluorophores in the doughnut center, 
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which defines the subdiffraction size, remain in an excited state (figure 19) 
(Willig et al., 2006). STED microscopy has been further developed in the 
Hell laboratory in order to improve the resolution of the system. The gated 
STED microscope is based on a conventional STED microscope applying 
pulsed excitation and continuous depletion together with time-gated 
detection (figure 19) (Vicidomini et al., 2011). The gated STED 
microscope can reach a resolution up to ~20 nm, which makes it an 
excellent tool for accurate measurements of cluster size and organization. 
Figure 19. Principle of 
STED and g-STED super 
resolution microscopy 
(A) Principle of STED 
microscopy. The excitation 
laser beam (blue, EXC) is 
focused to a diffraction-
limited excitation spot (blue 
spot in right panel), while 
the STED beam (orange), 
which is able to de-excite 
molecules, is focused to a 
doughnut-shaped spot 
(orange spot in right panel). 
Superimposition of these 
two spots reduces the 
excitation area to the 
doughnut center, yielding a 
subdiffraction excitation spot 
size shown in green in the 
lower panel, which shows in 
this example 11-fold 
reduction in size beyond the 
diffraction limit (modified 
from Willig et al., 2006). (B) 
Principle of gated STED 
microscopy. (a) As in 
continuous wave (CW) 
STED, the excitation (green) 
and STED (brown) focal 
spots are superimposed. 
Gated STED employs a 
single-photon-counting (SPC) detector, whose detection events of emitted fluorescence 
light (magenta), are time-gated with respect to the excitation pulses (Trigger) and 
registered by a computer. The time-gated detection is characterized by the time delay 
(Tg) of detection after excitation, and the detection period during recording. Therefore, 
this kind of detection increases the quality of the detected signal via preferential 
collection of fluorescence from the center of the excited spot (as shown in b). (b) Upper 
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panels, fluorescence image point sources (beads) for confocal (left) and CW-STED 
(right). Lower panels, fluorescence lifetime image for the CW-STED recording (left), 
fluorescence image for g-STED (right, Tg = 15 ns). Only the fluorescence signal from the 
center of the light sources is collected (g-STED). (e) Normalized intensity profiles through 
the center of the confocal, CW-STED and g-STED images (modified from Vicidomini et 
al., 2011). 
In this work STED imaging was performed using a TCS-SP8 gated-STED 
microscope (see 6.1.2.4). Membrane sheets were generated from HepG2 
cells expressing CD81-GFP, fixed, quenched and washed as described 
above (see 6.2.3). However, the signal of bio-synthetized GFP has a short 
life-time (bleached easily) and is not sufficient for high quality detection. 
Therefore, the GFP-signal was amplified by immunohistochemistry 
labelling of GFP with a commercial fluorescent dye (Alexa Fluor® 488). 
After membrane sheets generation, sheets were blocked for 1 h at RT in 3 
% BSA in PBS and then incubated overnight at 4 °C with anti-GFP 
antibody (clone 3E6) (mouse monoclonal, #A11120, Invitrogen) diluted 
(1:100) with 1 % BSA in PBS. Next, membrane sheets were washed 4 
times with PBS and directly incubated for 2 h at RT with the secondary 
antibody Alexa Fluor® 488 donkey anti-mouse (#A21202, Invitrogen) 
diluted (1:100) with 1 % BSA in PBS. Coverslips were mounted on 
microscopy slides in 15 µl mounting medium (Prolong® Gold Antifade 
Mountant; #P10144, Invitrogen) and cured for 24 h at RT. Finally, the 
edges of the coverslips were sealed with clear nail polish and stored at 4 
°C. Membrane sheets were also generated from cells co-expressing 
CD81-GFP and EWI-2-RFP proteins. Imaging was performed first by 
recording conventional confocal overview images in the red channel for 
EWI-2-RFP expression and in the green channel for CD81-GFP 
expression. 
The overview images in the red channel were recorded at 400 Hz scan 
speed with STED laser turned off. Excitation was realized using the 
pulsed white light laser at 558 nm and 28 % power detecting fluorescence 
between 570 – 700 nm using the hybrid detector at 200 gain and with a 0 
– 6.5 ns time gate and a pixel size close to 70 nm ± 0.5. For the green 
channel, overview images were acquired using similar settings with 1.4 % 
excitation laser power at 488 nm and detection between 495 – 571 nm at 
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200 gain gating from 0.1 – 6.5 ns. STED images were recorded at 200 Hz 
scan speed at 40 % STED laser power, excitation with the 488 nm line of 
the pulsed white light laser at 14 % power and detection between 495 – 
507 nm using the hybrid detector at 200 gain gating between 1 – 6.5 ns. 
The pixel size was close to 20 nm ± 0.5. STED images were assembled 
from six individually recorded scans and averaged using ImageJ. 
6.4 Pseudovirion induced endocytosis 
Pathogen endocytosis is mediated by cell surface components, which 
gate its entry. CD81-GFP/CD81--GFP expressing Jurkat cells were 
used to study pathogen entry during infection with pseudovirions (PsVs) 
prepared from the human papilloma virus 16 (Spoden et al., 2012) (see 
6.1.8). 106 cells were used for each sample. First, cells were collected by 
centrifugation, resuspended in 5 ml pre-warmed full medium and 
transferred into 25 cm2 flasks. The medium was supplemented with the 
fluid phase marker sulforhodamine101 (#s7635, Sigma-Aldrich, St. Louis, 
MO, USA) at a final concentration of 20 µM. Afterwards, the cell cultures 
were infected (except for controls) by carefully pipetting of 2 µl PsVs, 
which corresponds to 0.42 µg total protein or 0.2 µg of the capsid protein 
L1 of HPV16. The control and infected cell culture samples were 
incubated for 10 min in the cell incubator and were gently shaken from 
time to time to assure homogeneity of the culture and avoid cell 
sedimentation. This short incubation period was sufficient for the PsVs to 
bind to the membrane and to be taken up into early endosomes (data not 
shown). Subsequently, cells were collected by centrifugation for 3 min at 
800 rpm using an Allegra X-15R centrifuge (Beckman Coulter, Brea, CA, 
USA), the cell pellet was resuspended directly in 1 ml pre-warmed Ringer 
solution and plated onto two (0.5 ml aliquot each) poly-L-Lysine coated 
coverslips dispersed in 6-well plates. Afterwards, the cells were adhered 
for 20 min in the cell incubator and either fixed directly or after membrane 
sheet preparation. Cells or membrane sheets were then imaged in PBS 
supplemented with TMA-DPH and 100 nm Tetraspeck beads, which 
served to correct lateral shifts that may occur during filter changes. 
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Microscopy was performed using the Olympus IX81 microscope (see 
6.1.2.2) in the epifluorescence modus. Samples were imaged in the 
green, red and blue channels to analyze protein distribution (GFP), 
endosomes (fluid phase marker) and plasma membrane (TMA-DPH), 
respectively. The recorded images were aligned using the Align Slice 
plugin of ImageJ, and imported into the program CorelDRAW (Ottawa, 
Canada). The data were analyzed manually by counting endosomes 
(visualized in the red channel) per cell base colocalizing pixelwise with 
protein clusters in the green channel. 
Infection with PsVs for 10 min, as described above, was performed to 
study the early step of pathogen endocytosis at the cell membrane. In a 
second set of experiments, a longer incubation time was chosen to allow 
the PsVs to enter the cell body. In addition, sulforhodamine was omitted 
and instead PsVs were stained in the red channel. 5 × 105 transfected 
Jurkat cells were incubated under constant agitation with 5 µl of PsVs for 
1 h at 37 °C. Afterwards, cells were adhered and fixed as previously 
described. Cells were permeabilized for 2 min in 0.2 % Triton X-100 in 
PBS, washed twice with PBS for 10 min and blocked for 30 min with 1 % 
BSA in PBS. The pseudovirions were then immunostained using the 
rabbit antibody anti HPV-L1 (K75) raised against L1 protein of HPV16. 
The incubation with the first antibody diluted (1:1,000) with 1 % BSA in 
PBS was performed for 1 h at 37 °C followed by two washing steps (first 
with PBS and then with 1 % BSA in PBS for 10 min). Cells were incubated 
with the secondary antibody anti-rabbit (Alexa Fluor® 546 donkey anti-
rabbit IgG (H+L), #A10040, Invitrogen) diluted (1:300) in 1 % BSA in PBS 
supplemented with Hoechst dye diluted (1:10,000) for 1 h at 37 °C. 
Afterwards, cells were washed twice with PBS for 10 min. Finally, cells 
were embedded by mounting coverslips on microscopy slides as 
described above (see 6.3.4). 
Samples were imaged using at Olympus FluoView™ FV1000 confocal 
microscope (see 6.3.3.1) starting with the identification of transfected cells 
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in the green channel, followed by optical section scans at different z-
positions in the blue, green, red and bright-field channels. 
6.5 Microscopy data analysis methods 
The analysis of raw microscopy data was performed using ImageJ 
software (Schneider et al., 2012). This software facilitates the analysis of 
defined ROIs, the generation of images stacks and the calculation of the 
fluorescence intensities. Moreover, the software was supplemented with 
different plugins for the calculation of the correlation coefficient between 
images or lateral shifting of one image in an images stack. ImageJ was 
also used to import raw microscopy data into other graphic programs and 
for figure editing. In some cases, events were counted manually on 
assembled images generated with CorelDRAW. 
6.5.1 Fluorescence intensity analysis 
For each experiment identical microscope settings were used for all days. 
The settings were identical regarding the microscope, optical equipment, 
magnification, illumination intensity and exposure times. The average 
fluorescence intensity in a ROI was corrected by subtracting the average 
intensity of an adequate ROI in the background. 
6.5.2 Pearson correlation coefficient 
PCC is used to quantify the degree of colocalization of signals in two 
images. PCC is unaffected by changes in the intensity offset (Adler & 
Parmryd, 2010). PCC values range from 1 (perfect correlation) to -1 
(perfect negatively correlation or mirror image) with 0 for a random 
distribution and absence of any relationship. The correlation coefficient 
was calculated by the following equation described by Adler: 
r = Σ (Ri – Rav) x (Gi – Gav) / √ (Σ (Ri – Rav)
2 x Σ (Gi – Gav)
2), 
where Ri is the fluorescence intensity of individual pixels in the first (here 
the red) image and Rav is its mean intensity, accordingly Gi and Gav are 
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the fluorescence intensity of individual pixels and the mean intensity of the 
second (here the green) image at the same pixels. 
The correlation coefficient calculation was done with the plugin 
Colocalization_Indicies (Kouichi Nakamura, Kyoto University) installed in 
ImageJ program. For the correction of the lateral shift that occasionally 
occurred during imaging, the ImageJ plugin Align Slice (Gabriel Landini, 
University of Birmingham) was used prior to PCC calculation. This plugin 
allows manual correction of image drift in the x- and y-axis: Corrections 
were done with reference to Tetraspeck beads or to 3 - 4 prominent 
structures in the image. 
6.5.3 Coclustering assay  
Using the PCC (see 6.5.2), the coclustering assay allows the 
determination of the degree of colocalization between two fluorescently 
labeled proteins. Due to the limitation of the optical system and 
experimental processes the value of 1 cannot be reached even for the 
correlation of a double-tagged protein (r = 0.63) (Sieber et al., 2006). With 
our system, I was able to reach a PCC close to this value (r = ~0.6). 
Membrane sheets (see 6.2.3) from co-transfected Jurkat cells expressing 
mRFP and mGFP labeled proteins were imaged in PBS supplemented 
with TMA-DPH for visualization of the membrane sheets and 100 nm 
Tetraspeck beads for the correction of lateral shifts that occasionally 
occurred during filter changes. An Olympus IX81 microscope (see 6.1.2.2) 
was used in the epifluorescence modus. Imaging with green and red filters 
allows specific recording of the green or the red tagged proteins. The 
green and red images were analyzed after lateral drift correction using the 
Align Slice plugin prior to PCC determination. The correlation coefficient 
was determined within a ROI of ~20 – 30 µm2 which was placed on the 
membrane sheet in the blue channel and subsequently used for 
duplicating this section in the green and red channel. The PCC between 
both duplicated sections was determined using the Colocalization_Indicies 
plugin for ImageJ (see 6.5.2). The PCC values calculated from individual 
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membrane sheets were averaged for each independent experiment. The 
exposure times were 1 s and 2 s in the green and red channel, 
respectively. 
6.5.4 Distribution of the expression levels 
The expression level of a fluorescently tagged protein is, in an ideal case, 
linearly proportional to the fluorescence intensity of the expressed protein. 
The high difference of the expression levels between analyzed proteins in 
the same experiment or the high deviation of the expression level 
between different individual experiments can influence the result of the 
analyzed data. To control the expression levels of individual events in 
different experiment, the frequency of the expression levels was plotted in 
histograms. The background corrected fluorescence intensities in the red 
and green channels for mRFP and mGFP tagged proteins, respectively, 
were determined (see 6.5.1). The fluorescence intensities were arranged 
in bins of 1000 (a.u) width starting from 0 and the absolute frequency 
counts were determined using Excel. Finally, the frequency counts were 
plotted against the intensity bins showing the expression level distribution 
of individual samples. The fluorescence intensity in the red channel was 
lower than that in the green channel even though the exposure time in the 
red channel was two-fold higher than in the green channel (for 6.5.3). 
6.5.5 Autocorrelation analysis 
Autocorrelation analysis is a convenient tool to calculate the radial 
average size of objects in an image or to analyze the trend in radial size 
between different images. This method was developed and validated in 
this work.  
This analysis was performed using the ImageJ software. First, a ROI was 
used to define and duplicate a region within the original image yielding a 
reference image for the analysis. Subsequently, the ROI was repeatedly 
shifted by 1 pixel into one direction in the original image using the Align 
Slice plugin followed by duplication of image in the ROI in the new 
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position. The duplicated images were used for PCC calculation between 
the reference image using the Colocalization_Indicies plugin. The PCC 
starts at 1 for the initial position (pixel shift = 0) and decreases upon 
shifting. The PCC values were plotted against the pixel shift yielding an 
exponential autocorrelation decay curve. The most important feature of 
the curve is the position at 50 % decay, at which half of a cluster or 
structure of the shifted image still correlates with its original image. The 
distance of displacement needed to reach the 50 % colocalization is an 
estimate of the average radial size of the present structures in the 
analyzed image. For better determination of this value, the autocorrelation 
decay curves were fitted using the following function: 
y = 1 – (a × x) / (b + x), 
where a and b are arithmetic parameters that can be determined through 
curve fitting and then used to calculate the x value indicating the half-
correlation position setting y = 0.5. The calculated x value corresponds to 
the number of shifted pixels to reach the 50 % autocorrelation point. For 
TIRF and epifluorescence images, the autocorrelation decay curves were 
averaged for each independent experiment and then fitted using this 
function to calculate the 50 % decay value (see above). STED 
micrographs were analysed by Dr. Jan-Gero Schlötel. In brief, the GDSC 
stack correlation plugin was used, after the intensity of each pixel was 
increased by one to avoid zero values that could not be processed. 
Autocorrelation analysis was done on three different ROIs for each 
membrane sheet. Then, the curves were averaged and fitted using a 
simple exponential decay function. The 50 % decay values determined for 
analyzed membranes were then averaged for each independent 
experiment.  
Results 
    
    69 
 
7 Results 
The introducing of FPs into life sciences has largely influenced the design 
of experiments. Also, in this study in most experiments FP-tagged 
constructs are used and analysed by microscopy. A construct similar to 
the C-terminally GFP-tagged CD81 construct cloned in this work was also 
generated and used in previously published works to study its functions 
during HCV entry (Coller et al., 2009) or cell-mediated immune response 
(Mittelbrunn et al., 2002). In this work, CD81-GFP was overexpressed in 
HepG2 and Jurkat cells. The membrane protein expression distribution 
was analysed in membrane sheets and it was confirmed that 
overexpressed and endogenous CD81 behave similarly as described 
below (see figure 20). Membrane sheets represent unroofed cells, and are 
prepared by applying a 100 ms ultrasound pulse on cells adhered onto 
glass coverslips. This sonication pulse generates pure mechanical 
shearing forces that rip off the upper part of the cell thus leaving behind 
only the basal plasma membrane attached to the coverslip. This two 
dimensional preparation enables studying membrane protein expression 
and distribution in the cell membrane with a high signal to noise ratio. 
7.1 Expression of CD81-GFP in HepG2 and Jurkat cells 
7.1.1 CD81-GFP is expressed at the cell membrane and 
is correctly oriented 
Membrane sheets generated from HepG2 or Jurkat T cells expressing 
CD81-GFP were fixed and immunostained for CD81 using an anti-CD81 
antibody raised against an extracellular epitope of CD81-LEL. First, I 
checked whether CD81-GFP is correctly expressed and oriented in the 
plasma membrane to exclude any possibility of flipping or missorting 
occurring during protein biosynthesis. The anti-CD81 antibody epitope 
should be located in the extracellular space between the glass coverslip 
and the tightly attached membrane sheets. Hence, the antibody has to 
diffuse between the coverslip and the membrane sheet from the edge to 
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the centre to reach the epitopes located in the middle of the membrane 
sheet. In the case of Jurkat T cells, which generate larger membrane 
sheets, the diffusion limitation prevented the antibody from reaching the 
centre of the sheet; accordingly, I saw a staining gradient starting bright at 
the periphery with a dark spot in the middle of the membrane sheet 
indicating the unstained area (figure 20C, middle upper panel). This 
observation confirms that the epitope of the antibody is located between 
the extracellular site and the coverslip indicating that the overexpressed 
CD81 is correctly oriented in the cell membrane. 
7.1.2 Endogenous and overexpressed CD81 molecules 
are localized in the same clusters  
Immunostained membrane sheets of transfected cells were imaged in the 
green and red channels. The GFP-tag of CD81-GFP was directly imaged 
in the green channel, while immunofluorescence signals were recorded in 
the red channel. In HepG2 cells, which do not express endogenous CD81, 
immunofluorescence originates only from the overexpressed CD81-GFP 
construct. However in Jurkat T cells, the antibody additionally binds to 
endogenously expressed CD81. Images recorded in the green and red 
channel show distribution of CD81 in spotty structures that overlap with 
each other (figure 20A and C). Moreover, the PCC between the red and 
the green images show a very good correlation between GFP and 
antibody signals in both cell types. In the case of HepG2 cells, for which 
all CD81-proteins are double labelled with both an antibody and GFP-tag, 
the PCC is close to a previously published value that indicates ideal 
correlation (Sieber et al., 2007). In Jurkat T cells, which also express 
endogenous CD81, the PCC is also close to this ideal value which 
indicates that the overexpressed and endogenous CD81 do not separate 
into distinct clusters.  
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Figure 20. Immunostaining of overexpressed and endogenous CD81 in HepG2 and 
Jurkat cells 
(A) HepG2 cells, which do not express endogenous CD81, were transfected with CD81-
GFP, sheeted, fixed and immunostained for CD81 using an anti-CD81 antibody 
recognizing an extracellular epitope (Flint et al., 1999). Upper left panel, overexpressed 
CD81-GFP is clustered in plasma membrane protein domains and not homogenously 
distributed. Upper middle panel, the immunostaining signal shows CD81 molecules 
assembled in spotty structures. Upper right panel, the membrane was visualized using 
the lipophilic dye TMA-DPH. The lower panels show magnified views of the white square 
ROIs indicated in the upper panels. Lower right panel, overlay of the magnified views 
showing a high overlap between the GFP and the immunostaining channels. The 
Pearson correlation coefficient between the two channels gives a value of 0.57 ± 0.09 
(mean ± SD; n = 70 membrane sheets from 3 independent experiments) which is 
comparable to a previous measurement of 0.63 (Sieber et al., 2006) from a double 
tagged protein and accepted as a reference for perfect colocalization. (B) Fluorescence 
intensities in the analysed membrane sheets in red (immunostaining) and green (GFP-
tag) channels show a linear relationship between both signals. The linear regression 
intercepts close to 0 confirms the zero level of endogenous CD81 in HepG2 cells. (C) 
Membrane sheet from a Jurkat T cell overexpressing CD81-GFP (panels in similar order 
as for A). Similar to HepG2 cells, overexpressed CD81-GFP in Jurkat T cells is non-
homogenously distributed but also clustered in membrane protein domains. The antibody 
staining was more sensitive for CD81 clustered in protein domains that were stronger in 
Jurkat cell (middle panels). Large Jurkat membrane sheets show after immunostaining a 
fluorescence intensity gradient from edge to the centre (upper middle panel) which 
indicates the correct orientation of the molecule in the membrane. In this case, the 
antibody diffusion is limited in the tight space between membranes and coverslips so that 
epitopes in the center of the membranes are not always reached. This effect was only 
observed for Jurkat membrane sheets since these are much larger than that those 
obtained from HepG2 cells. Note that membranes were directly fixed and not treated with 
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detergent. The calculated PCC between the two channels yielded similarly high values 
0.52 ± 0.08 (mean ± SD; n = 32 membranes from 4 independent experiments) and close 
to the value obtained from HepG2 cells, confirming that endogenous and overexpressed 
CD81 cluster together and do not form separate clusters (compare also the overlay in the 
lower right panel). (D) The scatter plot of the green and the red fluorescence signals 
shows a linear relationship between GFP- and immunostaining signals. The offset, where 
the linear regression intercepts with the y-axis in the absence of CD81-GFP 
overexpression, indicates the level of endogenous CD81. In most of the analysed 
membrane sheets, the ratio between overexpressed and endogenous CD81 is close to 1 
indicating that the overexpression generally doubled the cellular CD81 levels. Dotted 
circles in A and C indicate the high colocalization of randomly chosen spots in the green 
and the red channels. Red line projections in B and D indicate the membrane sheets 
presented in A and C, respectively. Note that the immunostaining and GFP intensities in 
B and D are not comparable due to different incubation times with antibodies and 
different recording times (for detailed information see 6.2.4) (derived from Homsi et al., 
2014).  
In the case of Jurkat T cells, an offset for immunostaining signals was 
observed (i.e. immunostaining signal, but not GFP signal), which 
corresponds to the endogenous CD81 level. For most sheets, CD81 
overexpression hardly doubled the total CD81 content (figure 20D). In 
addition, the scatter plot shows a high variance of measurements from the 
regression line for Jurkat T cells (figure 20D), whereas the values show a 
very low variance in HepG2 cells and the measurements are closely 
placed to the regression line (figure 20B). This large scattering observed 
in Jurkat cells results from the additional immunostaining of highly variable 
endogenous CD81. Moreover, the high correlation between endogenous 
CD81 and overexpressed CD81-GFP confirms that both CD81 proteins 
partition into the same clusters (figure 20C and figure legend). 
7.2 CD81-GFP overexpression levels compared to 
endogenous levels in HepG2 and Jurkat intact cells 
using FACS  
Immunostaining of CD81/CD81-GFP was also performed with intact 
HepG2 and Jurkat T cells overexpressing CD81-GFP. In this setup, the 
anti-CD81 antibody again can only access the extracellular domains of the 
CD81 protein. Therefore, stronger staining of CD81-GFP expressing 
whole cells would confirm cell surface expression and correct orientation 
of the overexpressed CD81-GFP. I performed this analysis using FACS 
(see 6.2.8). The immunostaining fluorescence intensities for CD81 
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detected in the red channel (APC-A filter) were plotted against the 
fluorescence intensities of the overexpression levels detected in the green 
channel (FITC-A filter) using a logarithmic scale (figure 21). As seen in 
(figure 20), HepG2 cells lack endogenous CD81 and the counted events 
show a line-like distribution starting from the gating origins (figure 21A). In 
contrast, a large scattering of the counted events was observed with 
Jurkat T cells. These showed an offset of the immunostaining seen by the 
shift of the entire cell population to the upper quadrant indicating the 
presence of endogenous CD81 (figure 21B). Moreover, the linear 
relationship between CD81-GFP signal and staining signal suggests that 
also under high expression level no CD81 is retained in cytosol. I 
conclude that cytograms in figure 21A and B correlate perfectly with the 
microscopy results already shown in (figure 20B and D), respectively. 
 
Figure 21. Overexpressed and endogenous CD81 levels in HepG2 and Jurkat cells 
analysed by flow cytometry. 
(A) Intact HepG2 cells overexpressing CD81-GFP were immunostained for CD81 (same 
antibody used as in figure 20) and analysed with a flow cytometer using FITC-A and 
APC-A filters for GFP and red immunostaining signals, respectively. Two-parameter 
cytograms at a logarithmic scale show the scattering of measured events in the green 
and red channels. Upper left cytogram, untreated and non-transfected cells used as a 
control cell population (for more details see 6.2.8). Upper right cytogram, non-transfected 
cells treated with only the secondary antibody used for staining control and gating. Lower 
left cytogram, untreated transfected cells allowed assessment of the expression level. 
Lower right cytogram, transfected and stained cells with first and secondary antibodies. 
The scattering of events in a line-like fashion indicates a linear relationship between the 
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red and the green signals. Furthermore, successful staining confirms the correct 
orientation of the overexpressed CD81-GFP protein. Moreover, linearity between CD81-
GFP signal and staining signal suggests that also under high expression no CD81 is 
retained in cytosol. An imaginary regression line would cross the origins of the gated 
quadrants which again confirms that HepG2 cells lack endogenous CD81. (B) Intact 
Jurkat cells overexpressing CD81-GFP and immunostained for CD81; upper cytograms, 
left, untreated and non-transfected cells; right, non-transfected cells treated with 
secondary antibody. Lower cytograms, left, transfected and untreated cells; right, 
transfected and stained cells for CD81. The counted events show a high degree of 
scattering and a linear trend between the two signals indicating the linear relation 
between red and green channel with an offset in the staining at the absence of CD81-
GFP signal corresponding to the endogenous CD81 level. The large scattering of the 
counted events is due to the endogenous CD81 offset signal. Furthermore, the slope of 
an imaginary regression line is lower than the one predicted in A. This is in line with 
figure 20 indicating a high endogenous CD81 level and an overall lower overexpression 
level of CD81-GFP in Jurkat cells. The histograms show representative results from one 
out of three independent experiments. For each experiment and condition 5,000 – 
30,000 events were counted. 
7.3 Increased CD81 concentration generates more 
clusters 
Overexpressed CD81 forms apparently more clusters in the membrane 
(compare the spotty structures in the green channel images of figure 20). 
However, the various clustering grade could not be completely resolved 
due to the diffraction limit of the epifluorescence microscopy. To study the 
clustering behaviour of CD81 at various concentrations of overexpressed 
CD81 STED superresolution microscopy experiments were performed 
using HepG2 cells, which lack endogenous CD81. At low CD81 
concentration a linear relationship between CD81 expression levels and 
cluster density was observed: At densities of up to 40 clusters/µm2 
doubling the CD81 concentration resulted in an almost twofold increase in 
cluster density (figure 22C; inset). At higher CD81 concentrations, cluster 
density slowly reached a plateau phase (figure 22C). The plateau phase is 
due to the limited ability to resolve properly individual clusters even at 
superresolution conditions which leads to underestimation of the actual 
cluster number (figure 22; see membrane sheets #3 and #4 at STED 
microscopy resolution in B). Hence, the data showed that CD81 
expression correlate linearly with the cluster density over a wide range of 
expression levels. In conclusion, these observations indicate that 
additional CD81 molecules assemble in new clusters rather than 
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increasing the size of clusters or being free, uniformly distributed 
molecules. 
 
Figure 22. Elevated CD81 concentrations lead to an increase in cluster number but 
apparently not in cluster size. 
HepG2 cells (which lack endogenous CD81) were transfected with CD81-GFP, sheeted 
and imaged with gated STED microscopy (for more details see 6.3.4). The GFP signal 
was enhanced by immunostaining with anti-GFP antibody (see 6.3.4). (A) Series of four 
confocal images (#1 to #4) showing membrane sheets with increasing CD81 
concentration prepared from cells with varying CD81 expression levels presented at the 
same scaling using a fire lookup table. The measured immunofluorescence intensity was 
Results 
 
76 
 
 
used to quantify the CD81 concentration. (B) The overviews in A were imaged by gated 
STED microscopy and shown are STED micrographs sections of the area indicated in 
the white squares ROIs in A. Three ROIs (one shown in the lower panel) were selected 
from the STED overview image and used for manual cluster counting; the average from 
the three ROIs was used to calculate the cluster density for the respective membrane 
sheet. (C) The calculated cluster densities were plotted against the CD81 concentration 
for each appropriate sheet. The membrane sheets shown in A are labelled #1 to #4 in 
the scatter plot. The cluster density and the CD81 concentration present a linear 
relationship at low CD81 concentrations (see also the inset in C). At high CD81 
concentration levels, it was hard to distinguish between individual clusters so that the 
curve reached a plateau. The data are collected from three independent experiments for 
each 8 – 13 membrane sheets were analysed (data provided by Dr. Jan-Gero Schlötel 
and Prof. Thorsten Lang; derived from Homsi et al., 2014). 
7.4 Generation of CD81 variants 
I aimed studying the clustering mechanism of CD81. Hence, I focused on 
the characterization of the protein domain(s) or feature(s) crucial for CD81 
assembly into cluster and CD81 enriched microdomains. The strategy to 
generate CD81 constructs was based on the crystal structure of the LEL 
published by Kitadokoro (Kitadokoro et al., 2001; Kitadokoro et al., 2002) 
and the 3D structure of CD81 described by Seigneuret (Seigneuret, 2006) 
which illustrates the different protein domains of CD81 (figure 23A). 
Kitadokoro and Seigneuret described the CD81-LEL (subdivided in - - 
- - and -domain) as the most important CD81 region, which is 
responsible for protein targeting, dimerization and interaction. In addition, 
CD81 palmitoylation has been described to play a prominent role in TEM 
formation (Hemler, 2005). Referring to this information, I generated a 
palmitoylation deficient mutant by substitution all six juxtamembrane 
cysteines for alanine (see 6.2.1). Moreover, I generated also a couple of 
deletion mutants, where domain(s) in the LEL were subsequently deleted 
(deleted domains are highlighted in red in the illustrations generated at 
atomic realistic scale in figure 23B). The following CD81 deletion 
constructs were generated:  lacking aa 115 – 155;  lacking aa 156 
– 190;  lacking aa 156 – 174 and  lacking aa 176 – 186 and effect of 
deletion/mutation on TEM formation was tested as described in the 
following sections. Size and expression of the generated constructs were 
tested using western blot analysis (see Appendix 1 A). 
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Figure 23. CD81 deletion mutants 
(A) Left, atomistic model of a human CD81 molecule based on previously published data 
from Seigneuret (Seigneuret, 2006). The CD81 molecule is embedded in a lipid bilayer 
comprising pre-equilibrated POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) 
molecules (Poger & Mark, 2010), and simulated using the LAMBADA and InflateGRO2 
routines (Schmidt & Kandt, 2012). Middle, ribbon representation; right, pictogram of 
CD81 structure which will be used for the next figures. The transmembrane domains (1 
– 4) are depicted in gold, the constant domain in blue and the variable domain in 
orange; SEL, small extracellular loop; LEL, large extracellular loop. (B) Magnified view of 
the extracellular domain with the deleted domains , ,  and  highlighted in red (this 
corresponds to the constructs , ,  and , respectively). Molecular illustrations 
were generated using VMD (Humphrey et al., 1996) and the integrated STRIDE routine 
(Frishman & Argos, 1995) (figure provided by Dr. Thomas Schmidt, based on figure 10 
and derived from Homsi et al., 2014). 
7.5 The CD81 -domain is essential for targeting of CD81 
into CD81 enriched microdomains 
I used the constructs described above (figure 23B) to identify the protein 
domain(s) and/or the role of palmitoylation necessary to drive CD81 
molecules into CD81 enriched microdomains. I overexpressed wild-type 
CD81-RFP together with either wild-type CD81-GFP or GFP-tagged CD81 
mutant in Jurkat T cells and then analysed whether the green and red 
overexpressed constructs were enriched in the same domains (figure 24). 
This quantification was done by calculating the PCC as a co-clustering 
grade between the red and the green channels. The PCC has the 
advantage of being independent from the offset and background in the 
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analysed channels (see 6.5.5). The wild-type constructs CD81-RFP and 
CD81-GFP yielded a high correlation coefficient and were enriched in the 
same domains (figure 24A), which confirms that cells did not discriminate 
between red- and green-labelled constructs and packed both together. 
Substitution mutations of the six juxtamembrane cysteines for alanines 
which suppress palmitoylation did not show major effects on co-clustering 
(figure 24C). This indicates that palmitoylation plays a secondary role in 
CD81 clustering. The deletion of the - and -helical domains, which 
make up almost half of the LEL, should strongly affect the structural 
conformation of the rest of the helices (see figure 23B). Even though the 
protein was so strongly modified, it was still able to enrich into CD81 
microdomains (figure 24C). This suggests that the described dimerization 
via the -region (Drummer et al., 2005; Kitadokoro et al., 2001; 
Kitadokoro et al., 2002) is not essential for domains integration. The 
variable domain of the LEL was described to play the major role in 
protein-protein interactions and functions. I thus expect that deletion of the 
variable domain thoroughly affects domain co-clustering. Indeed, upon 
deletion of the variable region and its two flanking cysteines ( 156 – 190; 
see figure 23B; Kitadokoro et al., 2001; Levy & Shoham, 2005a) the 
domain targeting was strongly decreased (figure 24C). The variable 
region is composed of two helical domains separated by a disulfide 
bridge, the -domain ( 156 – 174) and the -domain ( 176 – 186) see 
(figure 23B) (Kitadokoro et al., 2001). Deletion of the -domain did not 
affect domain co-clustering and the construct almost maintained wild-type 
behaviour, whereas deletion of the -domain alone decreased domain 
targeting to a level similar to that seen when deleting the entire variable 
region (figure 24B and C). This observation indicates that the -domain is 
essential for domain targeting. Therefore, the clustering and assembling 
of CD81 into CD81 enriched microdomains is driven by the -domain. 
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Figure 24. The -domain is required for targeting CD81 into CD81-enriched 
microdomains. 
Membrane sheets generated from Jurkat cells were co-transfected with wild-type CD81-
RFP and either wild-type CD81-GFP (A) or CD81--GFP (B). Images were recorded in 
the red (RFP), green (GFP) and blue (TMA-DPH for membrane visualisation) channel. 
The wild-type versions of CD81 tagged either with RFP (CD81-RFP) or GFP (CD81-
GFP) are assembled in the same domains. In contrast, deletion of the -domain strongly 
affects colocalization of CD81--GFP and full-length CD81-RFP. Dotted circles mark 
identical localizations and indicate protein clusters in the RFP, GFP and overlay 
micrographs which overlap in A and do not overlap in B. (C) The bar chart compares the 
PCC between the maximum colocalization observed with CD81-RFP/CD81-GFP (set to 
1) and modified colocalizations by CD81-RFP/GFP-labelled CD81 variants. The 
constructs are represented in the pictograms (derived from figure 10 and 7.4) from top to 
bottom: CD81, wild-type; C/A, all palmitoylation site of juxtamembrane cysteines were 
substituted with alanines; , ,  and deletion of the respective domains of the 
LEL. Red solid circles with acyl chains represent cysteine palmitoylation sites. The bar 
chart shows the mean PCC ± SE (n = 3 – 10 independent experiments); for each 
experiment 5 – 22 membrane sheets were averaged and normalized to control CD81-
GFP (derived from Homsi et al., 2014). 
7.6 All CD81 constructs show comparable cell surface 
expression levels  
The expression levels observed on membrane sheets analysed in figure 
24 was slightly variable, making it possible that differences in co-
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clustering are not due to domains deletion/mutation but intrinsically 
different expression levels. To exclude this possibility, the fluorescence 
intensities from the analysed membrane sheets were determined to 
compare overexpression levels of mutated constructs compared to the 
control (wild-type CD81). I calculated the relative fluorescence intensity 
after background correction in the green and red channel of each 
individual membrane sheet. The determined values were binned and 
plotted as intensity distribution histograms (figure 25). The frequency of 
the fluorescence intensities shows both a comparable width of distribution 
between each construct and its respective control and also comparable 
overexpression levels for all constructs. This result confirms that the effect 
seen in figure 24 is not caused by differing expression levels. In addition, 
western blot analysis experiments in Jurkat cells showed also comparable 
expression levels between CD81-GFP and CD81--GFP; moreover, no 
degradation products were observed for both constructs (see Appendix 1 
B and Appendix 2).  
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Figure 25. Expression level distributions of CD81-RFP/CD81-GFP and CD81-
RFP/GFP-labelled constructs in individual membrane sheets. 
Histograms show the frequency distribution of the fluorescence intensities in the red 
(RFP) or green (GFP) channel from individual membrane sheets. Plots illustrate absolute 
frequency counts of individual event intensities within 1000 a.u. bin width starting at 0. 
Note that the exposure time in the red channel was two-fold the green channel (see 
6.5.3). All analysed membrane sheets from different experiments of the respective 
construct and its appropriate control were pooled together. Each panel shows two 
red/green histogram pairs; first pairs show CD81-RFP/CD81-GFP control to which the 
averaged PCC of the tested construct shown in the second histogram pairs were 
normalized (derived from Homsi et al., 2014). 
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7.7 CD81-GFP and CD81- are similarly distributed and 
mainly found at the cell membrane in living Jurkat 
cells 
The CD81- is the most important construct analysed in figure 24 
because it showed the most profound effect on CD81 domain targeting 
(figure 24B and C). This effect was not due to different overexpression 
levels compared to wild-type CD81-GFP (figure 25). Next, I set out to 
analyse the subcellular distribution of CD81--GFP compared to wild-
type CD81-GFP, since mutations could involve the risk of disturbed 
protein trafficking from the intracellular compartments such as Golgi 
apparatus or the endoplasmatic reticulum to the plasma membrane. This 
could ultimately lead to retention of the protein in these subcellular 
structures. Using confocal laser scanning microscopy, I was able to check 
the distribution of the overexpressed protein in living Jurkat cells 
transfected either with CD81-GFP or CD81--GFP. The confocal scans 
verify that CD81--GFP and CD81-GFP show a similar subcellular 
distribution; none of the proteins is strongly retained in the subcellular 
compartments (figure 26). The results represented in (figures 25 and 26) 
confirm that CD81--GFP similar to CD81-GFP reaches the cell surface. 
This observation reinforces the specific effect of the -domain deletion 
seen in (figure 24). 
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Figure 26. CD81-GFP and CD81--GFP distribution in live Jurkat cells 
Suspension of live Jurkat cells expressing either CD81-GFP or CD81--GFP imaged 
with confocal microscopy after cell sedimentation onto uncoated glass coverslips in pre-
warmed Ringer solution at RT. Upper panel, cells expressing CD81-GFP; lower panel, 
cells expressing CD81--GFP; left, bright-field overviews; right, confocal micrographs in 
GFP channel. GFP expression was almost exclusively found at the plasma membrane 
showing a ring-like pattern for both constructs indicating that the overexpressed proteins 
were nearly all located at the plasma membrane. Some cells formed lamellipodia 
detected as green extensions seen also in the bright-field image (compare closed arrows 
in both pictures). Only in some cases, a weak intracellular accumulation of GFP signal 
(indicated by open arrows) was observed, which probably represents CD81 retention in 
the Golgi apparatus (Mittelbrunn et al., 2002). Images are shown at arbitrary scalings 
from one representative experiment out of four experiments in total (derived from Homsi 
et al., 2014). 
7.8 Immunoprecipitation of endogenous CD81 is less 
efficient with CD81- compared to wild-type CD81 
The lacking overlap between CD81-RFP and CD81--GFP suggests that 
both proteins interact less efficiently compared to CD81-RFP/CD81-GFP. 
To validate the crucial effect of the -domain deletion seen with a 
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microscopic assay, I performed immunoprecipitation experiments to study 
the interaction ability of the CD81- with endogenous CD81. Jurkat T 
cells overexpressing either CD81-GFP or CD81--GFP were solubilized 
with the mild detergent CHAPS to preserve tetraspanin-tetraspanin 
interactions (Charrin et al., 2009; Yáñez-Mó et al., 2009). Endogenous 
CD81 was successfully precipitated via CD81-GFP with GFP-Trap® A 
beads, whereas CD81--GFP was far less able to pull down endogenous 
CD81 (figure 27A), albeit it was efficiently pulled down by beads. 
Comparative quantification of pulled down endogenous CD81 via either 
CD81-GFP or CD81--GFP show a ~70 % decrease upon deletion of the 
-domain (figure 27B). However, the remaining weak band of the 
precipitated CD81 that is observed when using CD81--GFP suggests 
that both proteins are still able to interact, possibly via their /-domains. 
It thus appears that the interaction between CD81 proteins is mainly -
domain dependent. The immunoprecipitation results in combination with 
the microscopy observations seen in figure 24, where CD81--GFP is 
less enriched in CD81 domains, indicates that the deletion of the -
domain affects possibly CD81 dimerization (in this case independently 
from /-domains) or disturbs the interaction with other TEM components 
which causes the loss of the clustering pathway and leads to the 
missorting of the domain targeting. In addition, dimerization may be 
essential for domain targeting and it could be the first step of TEM 
formation. 
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Figure 27. Immunoprecipitation of endogenous CD81 with either overexpressed 
CD81-GFP or CD81--GFP 
10
7
 Jurkat cells expressing either CD81-GFP or CD81--GFP were lysed in 1 % 
CHAPS lysis buffer and used for immunoprecipitation. (A) Upper panel, 
immunoprecipitated CD81-GFP and CD81--GFP using GFP-Trap® A beads were 
detected via immunoblotting with anti-GFP. Lower panel, co-precipitated endogenous 
CD81 detected by immunoblot anti-CD81. (B) The ability of CD81-GFP or CD81--GFP 
to co-precipitate endogenous CD81 was quantified by calculating the ratios between the 
endogenous CD81 band and the band of the co-precipitated overexpressed GFP-
construct. In some experiments, the input levels of both constructs were not the same; to 
correct for this variation the CD81/CD81--GFP ratio was normalized to the ratio of 
CD81/CD81-GFP and plotted in a histogram, showing a huge decrease in the ability of 
CD81--GFP to precipitate endogenous CD81 compared to CD81-GFP. Values are 
given as mean ± SD (n = 3 independent experiments) (derived from Homsi et al., 2014). 
Western blot analysis and quantification were done in collaboration with Dr. Konstanze 
Scheffer and Dr. Luise Florin from the University of Mainz. 
7.9 The CD81 -domain is essential for protein partner 
interaction 
Immunoprecipitation experiments on cells solubilized under mild detergent 
treatment using CHAPS indicated that the -domain is a prerequisite for 
CD81-CD81 interaction/dimerization. Next, I performed additional 
immunoprecipitation experiments to study the effect of -domain deletion 
on protein partner interactions using similar conditions as in (figure 27). 
Cell lysates containing similar levels of endogenous CD81 and CD9 as 
well as comparable amounts of overexpressed CD81-GFP or CD81--
GFP (figure 28A), were used for an immunoprecipitation pull down assay 
for GFP-tagged proteins. The immunoprecipitation experiment showed 
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that upon deletion of the -domain, CD81--GFP was not able to 
precipitate neither endogenous CD9 nor endogenous CD81 (as seen 
before (figure 27A)). In contrast, wild-type CD81-GFP pulled down both 
endogenous CD81 and CD9 (figure 28B). This confirms that the -domain 
is crucial for partner protein interaction. 
 
Figure 28. Immunoprecipitation of endogenous CD9 and CD81 via either 
overexpressed CD81-GFP or CD81--GFP. 
10
7
 Jurkat cells expressing either CD81-GFP or CD81--GFP were lysed in 1 % 
CHAPS lysis buffer (EWI/2-RFP was also co-expressed). (A) Cell lysate used directly as 
input, showing similar expression levels of overexpressed CD81-GFP and CD81--GFP 
as well as of endogenous CD81 and CD9. (B) Material pulled-down from GFP-Trap® A 
beads showing a huge decrease of the precipitated endogenous CD81 via CD81--
GFP when compared with CD81-GFP. The interaction of CD81--GFP with 
endogenous CD9 was almost completely abolished when compared to CD81-GFP. 
Immunoblotting was done in collaboration with Dr. Konstanze Scheffer and Dr. Luise 
Florin from the University of Mainz. 
7.10 -domain dependent CD81 microdomain assembly is 
also observed in HepG2 cells 
The effect of the -domain deletion on CD81 domain targeting seen in 
Jurkat cells (figure 24) was observed both in a microscopic assay figure 
24 and by immunoprecipitation figures 27 and 28. To exclude that this 
mechanism exists only in one cell type, I repeated the assay of wild-type 
and mutant CD81 co-clustering with HepG2 cells. Similar to Jurkat cells, 
co-clustering was strongly reduced when the -domain was deleted figure 
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29. As for Jurkat T cells, CD81- in HepG2 cells was sorted into distinct 
clusters from wild-type CD81 (figure 29B). In addition, CD81- was not 
uniformly distributed, but clustered in separate structures in both cell lines 
though rather less clustered structures were observed in HepG2 cells. 
From the microscopic and biochemical observations, I conclude that the 
targeting of CD81 into CD81 domains is essentially driven by the -
domain independently from the cell type, while other LEL domains and 
palmitoylation are not a prerequisite, but may play a secondary role. 
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Figure 29. Clustering of CD81 into CD81 enriched domains in HepG2 cells  
Membrane sheets generated from HepG2 cells co-transfected with wild-type CD81-RFP 
and either wild-type CD81-GFP (A), CD81--GFP, CD81--GFP or CD81--GFP (B). 
Samples were recorded, presented and analyzed as described in figure 24. The high 
colocalization observed for wild-type CD81-RFP and wild-type CD81-GFP (A) was lost 
when using CD81--GFP (B). Dotted circles indicate identical regions in the images. (C) 
The PCC was analysed as described in figure 24 and is shown as mean ± SE (n = 3 – 5 
independent experiments, in each 5 – 19 membrane sheets were averaged and 
normalized to control). For pictogram description see the legend of figure 24 (derived 
from Homsi et al., 2014). 
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7.11 Lateral diffusion of CD81 is regulated by the -domain 
In the experiments described so far, I analysed CD81 domain targeting 
from a static viewpoint. In the following, I aimed to study CD81 domain 
behaviour over time using a dynamic approach. The specific features of 
TEMs or large tetraspanin webs are their circular shape and their stable 
position (Barreiro et al., 2008; Espenel et al., 2008). Therefore, TEM 
structures (formed by CD81) should be, in comparison to non-TEMs 
(formed by CD81-), less dynamic and more stable in shape and 
position. Consequently, I studied the apparent lateral diffusion of CD81 or 
CD81- by applying FRAP measurements in living cells (figure 30). 
Living Jurkat cells overexpressing either CD81-GFP or CD81--GFP 
were adhered on poly-L-Lysine coated coverslips and recorded in pre-
warmed Ringer solution at RT. CD81- diffused into the bleached area 
faster than wild-type CD81 (figure 30A and B). Consequently, I calculated 
the apparent lateral diffusion coefficients for CD81 and CD81- The 
determined diffusion coefficient value for CD81 was 0.03 µm2/s which is 
comparable to previously published values in polarized (0.07 µm2/s) and 
non-polarized (0.11 µm2/s) HepG2 cells (Harris et al., 2013). The lower 
value I determined here in Jurkat cells may be caused by differences in 
domain size between Jurkat and HepG2 cells (domain size should be 
higher in Jurkat cells). This point could be addressed in further 
experiments studying the size of clusters (see figures 36 and 39). In 
contrast, CD81- showed a strongly increased diffusion coefficient 
(figure 30C). These results indicate that restriction in lateral diffusion of 
CD81 is dependent on the -domain. 
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Fiugure 30. Determination of CD81-GFP and CD81--GFP apparent lateral 
diffusion coefficients via fluorescence recovery after photobleaching (FRAP) 
measurements in living Jurkat cells 
(A) Live Jurkat cells were adhered on poly-L-Lysine pre-coated glass coverslips 
expressing CD81-GFP (upper panel) or CD81--GFP (lower panel) and were recorded 
at 0.5 Hz in pre-warmed Ringer solution at RT. Image sequences of living Jurkat cells 
shown from left to right, before bleaching (pre-bleach) of a bleaching area indicated by 
the white square ROI (10 x 10 pixel; ~2.1 µm x 2.1 µm), after bleaching (post-bleach) 
and at 2, 6, 26, and 50 s after bleaching, indicating the fluorescence recovery of the 
bleached area by diffusion mediated substitution of bleached with unbleached molecules 
from the neighborhood. (B) FRAP recovery curves of CD81-GFP (green) and CD81--
GFP (red) showing a faster recovery of CD81--GFP comparing to CD81-GFP. For 
each independent experiment, the averages of the background corrected normalized 
recovery traces of 3 – 11 cells were calculated and plotted over time (average traces of 
one day shown in B; error bars illustrate the standard deviation between individually 
measured cells; (A) represents one measurement of CD81-GFP and one of CD81--
GFP derived from B). The plotted scatters were fitted to determine the half-times of the 
fluorescence recovery that was used to calculate the lateral diffusion coefficients (for 
more details see 6.3.3.2). (C) Calculated diffusion coefficients of CD81-GFP and CD81-
-GFP indicating an increase of the lateral diffusion for CD81--GFP. Values are given 
as mean ± SE (n = 4 independent experiments) (derived from Homsi et al., 2014). 
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7.12 CD81 domain stability and dynamics are controlled by 
the -domain 
As described in the previous paragraph 7.11, TEMs or large tetraspanins 
webs are stable in shape and position. Next, I studied CD81 and CD81- 
domain stability by exanimating cluster dynamics using TIRF microscopy. 
As in figure 30, I performed similar experiment on living Jurkat cells using 
TIRF microscopy which enables studying domain stability and behaviour 
over time. Almost all observed CD81 domains were stable over seconds 
(figure 31A). In contrast, CD81- clusters showed high instability even 
between two successive frames of a 0.5 s time interval (here I show 
images separated by 1.5 s time interval); therefore they may translocate 
and/or disassemble very quickly (figure 31B). Moreover, the analysis of 
the whole recorded frames in (figure 31A and B) for CD81 and CD81-
respectively, showed constant domain stability for CD81 and constant 
domain instability for CD81-over time (see figure 31C and D). The 
deletion of the entire variable region did not further change the dynamics 
of clusters. In contrast, upon deletion of the -domain alone the platforms 
retained their stability and behaved comparably to wild-type CD81 (figure 
31E). The observed effects of the -domain on cluster stability, dynamics, 
targeting and interaction confirm that CD81 is enriched in stable platforms 
or larger TEMs and that its interaction with other TEM components is 
driven by the -domain. 
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Figure 31. Cluster immobilization assay to study CD81 and CD81 deleted - and/or 
-domain dynamics 
Live intact Jurkat cells overexpressing CD81-GFP (A) or CD81--GFP (B) were 
adhered on pre-coated glass coverslips and imaged at 2 Hz in pre-warmed Ringer 
solution at RT using TIRF microscopy. (A and B) Starting from left, overview of the 
imaged cell followed by two magnified views of the white squared ROIs (indicated in the 
overview image) from two recorded images separated by 1.5 s and overlay. Wild-type 
CD81 domains remain unchanged over time while CD81--GFP are fluctuating. Dotted 
circles mark domains in the first image and were transferred to identical regions in the 
second image. Note that the yellow color indicating overlap is mainly observed for wild-
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type CD81. (C and D) For the entire movies the PCC between two successive frames 
was determined and the values were plotted against the recording time of the second 
image of the correlated pair. Plots in C and D are derived from the recordings in A and B, 
respectively, illustrating the high lateral dynamics over time seen by CD81--GFP (D) 
compared to CD81-GFP (C). (E) Cells expressing GFP-labeled CD81, CD81-, CD81-
 or CD81- were recorded as described above; at each time point the average PCC 
was calculated and for each construct the mean of the entire averaged traces was 
calculated. Values are given as mean ± SE (n = 4 independent experiments; for each 
experiment 5 – 8 cells were averaged and normalized to control) (derived from Homsi et 
al., 2014). 
7.13 Association of CD81 with CD9 requires the CD81 -
domain 
I elevated the concentration of CD9 in combination with either CD81 or 
CD81- and tested the association of CD81/CD81- with CD9 domains. 
Compared to the overlap with CD81 wild-type seen in figure 24, I found 
that CD81 overlapped less with CD9 and in general less colocalized 
domains were observed in both channels (figure 32A) indicating that the 
interaction of CD81 with CD9 is secondary. PCC quantification shows 
upon deletion of the -domain a strongly decreased overlap (figure 32B). 
These microscopy observations not only suggest that the interaction with 
CD9 is secondary, as shown before with the biochemical approach (Serru 
et al., 1999), but also indicate that the association is -domain dependent. 
Moreover, the association of CD81 and CD9 may occur mainly within 
TEMs, since the enrichment of CD81 and CD9 in the same domains 
indicates the presence of large tetraspanin complexes (Hemler, 2005; 
Rocha-Perugini et al., 2013; Rubinstein et al., 1996; Serru et al., 1999). 
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Figure 32. The interaction between CD81 and CD9 is -domain dependent 
(A) Membrane sheet generated from a Jurkat cell co-overexpressing CD81-GFP and 
CD9-RFP. Upper panel, recordings in the green and red channels visualized CD81-GFP 
and CD9-RFP, respectively; lower panel, membrane stained by the lipid dye TMA-DPH 
and overlay of the images in the upper panel. (B) The co-localization of CD81-GFP or 
CD81--GFP with CD9-RFP was analysed by PCC calculation as described in figure 
24. The deletion of the -domain strongly decreased the PCC. Dotted circles indicate 
identical pixel locations. Values are given as means ± SE (n = 3 independent 
experiments; for each experiment and condition values from 13 – 20 membranes sheets 
were averaged and the mean of CD81--GFP was normalized to control) (derived from 
Homsi et al., 2014). 
7.14 Autocorrelation analysis as a suitable tool for 
estimating average radial sizes 
For several questions an unbiased method for measuring the average 
size of membrane domains is required. To this end I turned to 
autocorrelation analysis for analysis of a variety of questions. This method 
was validated in this work using beads in different sizes and numbers 
(figure 33A). Bead size was determined via full width at half maximum 
(FWHM) approach (figure 33B) or autocorrelation approach ((figure 33C); 
2 x 50 % autocorrelation). Both approaches delivered comparable values 
indicating that the autocorrelation analysis is suitable for determining 
cluster sizes. In conclusion, autocorrelation analysis delivered an 
acceptable value to estimate average radial size or to at least detect size 
trends. 
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Figure 33. Autocorrelation analysis a convenient tool to measure average size 
(A) 100 nm, 200 nm or 500 nm beads were imaged in the green channel and analyzed 
within a region of interest with a variable number of beads, by linescans (B) and 
autocorrelation analysis (C). (B) The linescan measurements of individual beads were 
plotted and fitted using Gaussian formula. Fitted curves were used to determine the full 
width at half maximum (FWHM), which corresponds to the size of the bead. The 
determined FWHM values of all beads in one image were averaged. For each bead size 
five images were analyzed and the means of the averaged FWHM values were 
calculated. Values are given as means ± SD (n = 5 individual images). (C) The 
autocorrelation analysis was performed by calculation the PCC between the initial ROI 
and duplicated ROIs after one pixel shift in the same direction starting by the initial 
position, yielding 1 and performed to reach a value close to zero (see 6.5.5). The object 
size is proportional to the pixel shift needed to decrease the correlation coefficient to 50 
%, at which the shift is a rough estimate of the average radial size of all particles in the 
analyzed image. To facilitate the comparison of FWHM values, which refer to the 
diameter, with the autocorrelation values, I multiplied the autocorrelation values by 2. I 
noticed that the point spread function of the fluorescence microscope blurs the bead 
size; this effect was especially seen for bead sizes in the range of the microscope 
resolution limit (100 nm and 200 nm beads). The autocorrelation measurements were 
comparable to those resulted from the FWHM approach with an acceptable 
overestimation of 10 – 20 %. Consequently the measured values do not represent 
physical absolute values, but rather allow to estimate size and to detect trends of size 
differences (derived from Homsi et al., 2014). 
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7.14.1 Autocorrelation analysis suggest that CD81 
regulates cluster distribution within the cell 
membrane 
As mentioned above, tetraspanins play an important role in different 
cellular processes including mobility, morphology and adhesion (see 4.4). 
In addition, several reports described that CD81 regulates protein 
organization and cluster distribution within the cell membrane, so that 
tetraspanins are considered as master organizers of the plasma 
membrane (Cambi & Lidke; Hemler, 2005). The results shown in figure 31 
indicate that upon deletion of the -domain CD81- clusters showed high 
instability and highly disordered distribution (figure 31B and D). 
Interestingly, disordered integrin clusters were observed upon CD81 
depletion. In a collaboration with Dr. Thomas Quast from the Kolanus’ 
laboratory (University of Bonn), dendritic cells (DCs) derived from human 
monocytes (Mo-DCs) were treated with siRNA to knockdown CD81 (for 
more information see Quast et al., 2011). Intact Mo-DCs treated either 
with control siRNA or CD81 siRNA were stimulated with 
lipopolysaccharide (LPS), adhered onto fibronectin-coated coverslips, 
fixed, immunostained for the integrin CD29 and imaged using epi- and 
TIRF-microscopy (Quast et al., 2011). In contrast to the homogenous 
localization of CD29 clusters seen with control siRNA (figure 34A, upper 
panels), CD81 siRNA treated cells showed a disordered accumulation of 
CD29 clusters in the plasma membrane (figure 34A, lower panels). For 
studying CD29 integrin cluster size and shape, TIRF images were used 
which have better resolution and higher quality (high signal to noise ratio) 
(figure 34A, right panels and magnified views). CD29 cluster sizes at 
central and peripheral regions of the cell were analysed using the 
autocorrelation analysis (for more information see 6.5.5 and figure 33). 
The analysis showed no significant differences in size between CD29 
clusters after depletion of CD81 (CD81 siRNA) (figure 34B). Moreover, 
CD29 cluster size and distribution were similar between central (figure 
34B, left panel) and peripheral membrane regions (figure 34B, right 
panel). Though their size was in the rage of diffraction limit and it cannot 
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be entirely excluded a possibility of minimal size changes. These 
observations indicate that upon CD81 depletion, CD29 clusters retain their 
size, but lose their correct distribution. These observations are in line with 
previous reports confirming that CD81 organizes cluster distribution in the 
cell membrane and that tetraspanins play a role as master organizers of 
the cell membrane. 
 
Figure 34. CD81 organizes CD9 cluster distribution in the cell membrane 
(A) Intact Mo-DCs treated with either control siRNA (upper panels) or CD81 siRNA 
(lower panels), were stimulated with LPS, fixed, immunostained for CD9 and adhered 
onto fibronectin-coated (5 µg/cm
2
) glass coverslips. Cells were imaged via 
epifluorescence (left panels) or TIRF (right panels and magnified views) microscopy. 
White ROIs indicate regions analyzed by autocorrelation analysis in the central 50 x 50 
pixels ((c), further magnified at the right side) and peripheral 20 x 20 pixels (p) positions. 
Scale bars represent 10 and 1 µm for overviews and magnified views, respectively. (B) 
Autocorrelation decay curves of CD29 clusters in the central (right) and peripheral (left) 
regions of the basal plasma membrane (PM). For autocorrelation analysis, the image 
within a ROI was duplicated and correlated with the original position starting at 1 and 
then correlated with new positions after displacement pixel-wise up to 15 pixels (for more 
details see 6.5.5 and figure 33). This procedure was done in four different directions (up, 
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down, right and left). For each displaced pixel in all direction, four PCC values were 
averaged yielding an autocorrelation curve for the analyzed ROI. Finally, autocorrelation 
curves were averaged from five individual cells. Graphs show autocorrelation curves of 
control siRNA (dashed line) and CD81 siRNA (solid line); error bars represent standard 
deviation (n = 5). Pixel size was adjusted to 83.3 nm. Cells were prepared and 
immunostained by Dr. Thomas Quast (modified from Quast et al., 2011). 
7.14.2 Autocorrelation analysis is able to answer various 
questions about protein clustering 
In collaboration with Dr. Linda Diehl and Julita Kaczmarek (University 
Clinic of Bonn), a similar autocorrelation analysis (see figure 34) was 
performed to study the clustering behavior and distribution of the T cell 
receptor (TCR) and the lymphocyte function-associated antigen 1 alpha 
polypeptide (LFA-1 or CD11a). TCR and CD11a are recruited into 
cellular supra-molecular activation cluster (c-SMAC) and play an 
important role in cell-to-cell immune synapse (IS) formation (Kaczmarek et 
al., 2014). In brief, TCR and CD11a cluster size, distribution and density 
were studied on liver sinusoidal endothelial cells (LSEC), which are 
antigen-presenting cells (APC), derived either from wild-type mice (B6) or 
B7H1 immune response suppressor factor deficient mice (B7H1-/-). LSEC 
cells were stimulated with ovalbumin (OVA) and incubated with naïve CD8 
T cells for different incubation times (1, 4 and 24 h) and then fixed and 
immunostained for either TCR or CD11a (for more information see 
Kaczmarek et al., 2014). The same autocorrelation analysis like in figure 
34 was performed showing that the lack of B7H1 signaling did not alter 
clusters size and distribution neither of TCR nor of CD11a (figure 35A). 
In addition, no significant difference in cluster density was observed for 
both TCR and CD11a between B6 and B7H1-/- cells (figure 35B). The 
results shown in figures 34 and 35 and validated in figure 33 indicate that 
the autocorrelation analysis can be used in a wide range of applications. It 
is further used for studying TEMs size and growth under different 
conditions (see figures 36 and 39). In addition, this simple method can 
build a bridge between the biophysical background and its biologic or 
physiologic effects. In conclusion, various interesting questions could be 
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addressed via autocorrelation analysis method, which could represent a 
general tool to study cluster size, behavior and distribution. 
 
Figure 35. TCR and CD11a clusters distribution studied with autocorrelation 
analysis 
B6 and B7H1
-/-
 LSEC were stimulated with OVA co-cultured with naïve CD8 T cells for 1, 
4 and 24 h, fixed and stained for either TCR or CD11a. (A) Autocorrelation decay 
curves (see figure 34) showed no changes in cluster size of TCR or CD11a between B6 
LSEC (red line) and B7H1
-/-
 LSEC (black line). One pixel represents 83.3 nm. Values are 
means of five cells (n = 5) and error bars represent standard deviation. (B) Clusters were 
counted within square ROIs of (~3.7 µm x 3.7 µm). No significant differences of cluster 
density were observed. Density is given as means ± SE (n = 5). Cells were prepared, 
immunostained and imaged by Dr. Linda Diehl and Julita Kaczmarek. *p≤0.05 (modified 
from Kaczmarek et al., 2014). 
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7.15 The CD81 -domain is required for large TEMs or 
tetraspanin webs and it is essential for primary 
interaction 
Tetraspanins associate with Ig superfamily proteins to form TEMs 
(Boucheix & Rubinstein, 2001; Hemler, 2003; Stipp et al., 2003). EWI-2, 
related to the Ig superfamily, is a primary binding partner of CD81 which 
forms stable complexes with CD81 by direct protein-protein interaction 
with high stoichiometry (Charrin et al., 2003; Clark et al., 2001; Stipp, 
Kolesnikova et al., 2001; Stipp, Orlicky et al., 2001; Stipp et al., 2003). 
This direct interaction is mediated via the short cytoplasmic tail and the 
glycine-zipper motif in the TM from the EWI-2 side, and the TM3, TM4 and 
some additionally participation of the extracellular domains from CD81 
(Homsi et al., 2014; Montpellier et al., 2011). In the following it was tested 
how an increase of EWI-2 affects the domains formed by CD81. 
7.15.1 CD81 enrichment in large TEMs via the -domain 
and primary interactions 
The concentration of EWI-2 was elevated to promote the generation of 
TEMs. I aimed to check whether CD81 and CD81- are able to establish 
primary interactions with EWI-2 to form complexes that incorporate further 
into TEMs. Jurkat cells co-overexpressing EWI-2-RFP and either CD81-
GFP or CD81--GFP were analysed as described in figure 24. CD81 and 
EWI-2 co-enriched in the same domains (figure 36A and C), indicating 
that within CD81 clusters primary interaction with EWI-2 lead to co-
enrichment in TEMs. In contrast, CD81- clusters did not co-enrich/were 
not able to interact with EWI-2 indicating that CD81- clusters are not 
TEMs (figure 36B and C). 
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Figure 36. The CD81 -domain is necessary for building large TEMs 
(A and B) Membrane sheets generated from Jurkat cells co-overexpressing EWI-2 
(CD81 interaction partner) RFP-tagged together with CD81-GFP (A) or CD81--GFP 
(B). Upper panels from left to right, membrane sheet imaged in red, green and blue 
channels to visualize EWI-2-RFP, CD81-GFP (A) or CD81--GFP (B) and membrane 
integrity (using the lipid dye TMA-DPH), respectively. Lower panels from left to right, 
magnified views from the respective marked area of the white square ROIs in the upper 
panels and overlays. EWI-2-RFP showed a less clustered pattern when co-
overexpressed with CD81--GFP. Dotted circles indicate identical overlaps. (C) The co-
localization between the green and the red signals was determined by calculating the 
PCC. The co-localization between EWI-2 and the clusters in the green channel strongly 
decreased specifically upon deletion of the -domain. Values are given as mean ± SE (n 
= 3 independent experiments; for each experiment values from 5 – 20 membrane sheets 
were averaged and normalized to control). (D) Autocorrelation analysis of cells 
expressing CD81-GFP or CD81-C/A-GFP without (black bars) or in combination with 
EWI-2-RFP (gray bars). Autocorrelation analysis (for more explanation see figure 33) 
was performed on the images recorded in the green channel indicating that EWI-2 
induces domains size growth of both CD81 and the palmitoylation deficient mutant C/A. 
Values are given as means ± SE (n = 3 independent experiments; for each experiment 
values from 7 – 8 membrane sheets were averaged). (E) Autocorrelation analysis of cells 
co-expressing EWI-2-RFP and CD81-GFP or CD81--GFP. Analysis was performed on 
images recorded in the green channel showing almost three-fold larger domain size 
(referring to area and assuming circular shape) formed by CD81-GFP when compared to 
CD81--GFP and co-expression of EWI-2-RFP. Values are given as means ± SE (n = 3 
independent experiments; for each experiment values from 7 – 11 membrane sheets 
were averaged). The CD81-GFP/EWI-2-RFP conditions in D and E are identical. The 
smaller effect by D, can be explained by the presence of 38 % of very low EWI-2 
expressing cells to only 22 % in E (derived from Homsi et al., 2014). 
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7.15.2 Domain targeting effect is not caused by 
incomparable expression levels 
In addition to CD81 domain targeting (figure 24), domain dynamics (figure 
30) and domain stability (figure 31), the association of CD81 with EWI-2 is 
also -domain dependent (figure 36C). Fluorescence intensities analysis 
as described in (figure 25) revealed that this effect was not caused by 
incomparable expression levels between EWI2-RFP/CD81--GFP and 
EWI2-RFP/CD81-GFP (figure 37). In addition, I analysed the expression 
levels of CD81-GFP and CD81--GFP under identical conditions via 
western blot analysis which showed comparable CD81-GFP and CD81-
-GFP expression (see Appendix 2). As incomparable expression levels 
can be excluded as basis of the observed effect, I concluded that the -
domain regulates CD81 primary interactions and TEM integration. 
 
Figure 37. Expression level distribution of CD81-RFP/CD81-GFP and CD81-
RFP/CD81--GFP constructs in individual membrane sheets of the analyzed data 
in (figure 36C) 
Histograms show the distribution of the fluorescence intensities from individual analyzed 
membrane sheets in the red (RFP) or the green (GFP) channel prepared and plotted as 
described in figure 25. Note that the exposure time in the red channel was two-fold the 
exposure time in the green channel. Histograms show comparably distributed expression 
levels in the red and the green channel of the mutant and the control. 
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7.15.3 Development of large TEMs is palmitoylation 
independent  
Appearance of large bright platforms was observed upon elevation of the 
EWI-2 concentration and only in the presence of wild-type CD81 (figure 
36A). Using autocorrelation approach (figure 33) I analysed the structure 
size, which was strongly increased by overexpression of EWI-2 (figure 
36D and E) and only observed in the presence of the -domain (figure 
36E). This effect was not dependent on palmitoylation of CD81 (figure 
36D). The determined platform size of ~560 nm for CD81 domains (figure 
36E) is clearly above the resolution limit and even correcting for the 
blurring effect reduces the value by only ~10 %. In contrast, the size of 
CD81- clusters is limited by diffraction, and therefore only an upper 
estimate can be provided while the real size may be much smaller. These 
findings show that CD81 and EWI-2 interact with each other (figure 36A 
and C) and that, assuming a circular shape of CD81 platforms, EWI-2 
induces an increase in the area size of individual CD81 clusters by a 
factor of 3 (figure 36E), an effect which was not dependent on 
palmitoylation (figure 36D). In contrast, this interaction is -domain 
dependent (figure 36B and C). Therefore, upon EWI-2 elevation CD81- 
clusters did not grow and remained close to diffraction-limited size (figure 
36E). 
7.16 The microscopic observations correlate with the 
biochemical results 
The microscopic observations showed different degrees of overlap 
between CD81 and putatively interacting proteins (figure 38). The highest 
PCC value I calculated was determined between CD81 and CD81 (0.6; 
figure 24), followed by the value derived for the overlap between CD81 
and EWI-2 (0.53; figure 36). These high PCC values, which are close to 
the value for perfectly overlapping probes as determined in figure 20, 
indicate a strong interaction related to a primary interaction. In contrast, 
the determined PCC between CD81 and CD9 was much lower (0.35; 
figure 32), reflecting the presence of a secondary interaction. Therefore, 
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the level of interactions observed in immunoprecipitation and biochemical 
experiments as described above (primary and secondary interactions or 
interactions level 1 and level 2) is also reflected by the degree of overlap 
determined via microscopic approaches. 
 
Figure 38. The absolute values of the PCC between CD81 and CD81, EWI-2 or CD9 
document large agreement between microscopic and biochemical approaches for 
studying CD81 interactions 
The histogram illustrates the average absolute values of the correlation coefficients 
between CD81-GFP and CD81-RFP (figure 24; n = 15), CD81-GFP and EWI-2-RFP 
(figure 36; n = 6) and CD81-GFP and CD9-RFP (figure 32; n = 3); the correlation values 
indicate the degree of interactions that correlates well with the published biochemistry 
results (derived from Homsi et al., 2014).  
7.17 Elevation of primary interaction partners per se is not 
sufficient to form large TEMs 
The microscopic observations shown in figure 36 suggest that CD81 
interacts with EWI-2 which induces the formation of larger tetraspanin 
platforms, caused by increased primary complexes driven by the elevation 
of the primary interaction partner EWI-2. This proposition is well in line 
with previous work, where EWI-2wint (EWI-2 without its N-terminus, a 
natural cleavage product of EWI-2 Rocha-Perugini et al., 2008) influences 
the mobility of CD81 and reduces its global diffusion due to an increase in 
the proportion of confined molecules (Potel et al., 2013). The cluster-
missorting seen for CD81--GFP (figure 36B and C) could be caused by 
a lowered stabilizing effect of the CD81-LEL on the interaction with EWI-2. 
Such interactions should still be possible since CD81 and EWI-2 interact 
also via their TMs and intracellular domains (Montpellier et al., 2011). The 
same experiment as shown in figure 36 was performed in HepG2 cells by 
overexpressing CD81 with and without EWI-2 (figure 39A). Here no 
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increase in CD81 domain size upon elevation of EWI-2 was observed 
(figure 39B and C). This finding suggests that elevation of primary 
complexes induces the platform growth seen in Jurkat cells, but per se is 
not sufficient to drive the primary complexes into large TEMs or webs. In 
addition, the determination of CD81 cluster size in HepG2 cells at 
increased resolution using STED microscopy (figure 39C) suggests that 
CD81 clusters in HepG2 cells are smaller than those in Jurkat cells (figure 
36D). Albeit, this could not be definitely resolved, since the autocorrelation 
analysis in (figure 36D) was not yielded from STED images. However, 
multiplying the determined 50% autocorrelation value by two (in figure 
36D) yields an estimate of the CD81 cluster size in Jurkat cells which 
appears to be slightly greater than the resolution limit (compare with figure 
33C). Therefore, the observed differences in CD81 cluster size between 
HepG2 and Jurkat cells may explain the different lateral diffusion 
coefficient for CD81 calculated in this work for Jurkat cells (figure 30C) 
which was lower compared to slightly higher values previously published 
for HepG2 cells (Harris et al., 2013). 
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Figure 39. The expression of EWI-2 did not increase CD81 cluster size in HepG2  
Membrane sheets derived from figure 22 in addition with membrane sheets prepared at 
the same day from HepG2 cells co-transfected with CD81-GFP and EWI-2-RFP were 
used for autocorrelation analysis on STED-micrographs. CD81-GFP clusters were 
imaged using STED microscopy as described in figure 22. (A) Confocal images 
documenting the expression of EWI-2-RFP (red channel) and/or CD81-GFP (green 
channel). Upper panels, membrane sheet #2 from figure 22 A visualized in the red and 
green channels and shown at grey scale look up table, indicating the expression of 
CD81-GFP and the absence of EWI-2-RFP expression. Lower panels, membrane sheet 
prepared from a cell co-overexpressing EWI-2-RFP and CD81-GFP. Red images as well 
as green images were shown at same scaling, respectively. (B) Left, STED micrographs 
corresponding to the areas within the white squares in A derived from STED image 
overviews. Three ROIs (one shown in the right panel) on the STED overviews were 
selected for cluster size analysis by autocorrelation analysis (see 6.5.5). Same scaling 
using the grey look up table was used for all STED images. (C) Autocorrelation analysis 
results showing that the CD81-cluster size in HepG2 membrane sheets remains small 
even upon overexpression of EWI-2-RFP. Values are given as means ± SE (n = 3 
independent experiments; for each experiment 5 – 13 membrane sheets were 
averaged). Data analyzed by Dr. Jan-Gero Schlötel and Prof. Thorsten Lang (derived 
from Homsi et al., 2014). 
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7.18 The CD81 -domain is necessary to form functional 
CD81 microdomains 
As mentioned above, CD81 plays an important role during pathogen 
entry, which is driven by either direct interaction with CD81 independently 
from assembling into TEMs like by HCV (Rocha-Perugini et al., 2009) or 
by providing pathogen entry and/or exit platforms via building TEMs or 
tetraspanin webs like by HIV (Nydegger et al., 2006) or HPV (Scheffer et 
al., 2013; Spoden et al., 2008). Here, I aimed at studying the function at 
significance of the -domain during the formation of large TEMs to be 
used for pathogen induced endocytosis. As pathogen model, I used 
pseudovirions (PsVs) derived from HPV type 16 (see 6.1.8) to test 
whether CD81-GFP platforms are able to promote PsVs uptake and 
whether for this process the -domain is essential. 
7.18.1 Pathogen-induced endocytosis analysed on 
membrane sheets  
The treatment of Jurkat cells overexpressing CD81-GFP with PsVs 
strongly changed the pattern of CD81-GFP in the cell membrane and 
induced the formation of membrane sheet-associated endosomes 
overlapping with CD81 accumulated platforms (figure 40A). In contrast, in 
the absence of the -domain no changes of the CD81--GFP distribution 
were seen, and PsV induced endosomes were rarely detected (figure 
40B). Quantification of endosomes per cell base showed only for CD81-
GFP a huge PsV-induced endocytosis whereas in the absence of the -
domain endocytosis remained at control levels (figure 40C). These 
findings are completely new in the virology field and indicate that only in 
the presence of physiological large CD81 platforms or TEMs the PsV-
induced endocytosis takes place. Therefore, the pathogen endocytosis is 
-domain dependent and HPV PsVs require physiological CD81 platforms 
for their proper uptake. 
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Figure 40. CD81 -domain is necessary for virus endocytosis 
Jurkat cells expressing either CD81-GFP (A) or CD81--GFP (B) were incubated in the 
presence of a fluid phase marker (20 µM sulforhodamine) for 10 min at 37 °C with (A and 
B) or without (control) HPV pseudovirions (PsVs). Cells were then adhered onto PLL-
coated glass coverslips for 20 min at 37 °C; membrane sheets were generated and 
imaged in the green channel (CD81-GFP or CD81--GFP), red channel (visualizing 
integrated fluid phase marker in form of red spots indicating sealed organelles 
associated with the plasma membrane), and blue channel (visualizing membrane 
integrity via the lipid dye TMA-DPH). (A) Treatment of cells with PsVs dramatically 
changed the pattern of CD81 distribution and led to accumulation of CD81 domains that 
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often overlap with an endosome; similar pattern could be seen in the TMA-DPH image 
that also often overlap with the accumulated CD81 domains indicating a huge 
deformation of the plasma membrane and the presence of a multiple lipid bilayer stack 
due to the formation of a membrane-engulfed endosome. (B) The same treatment with 
PsVs did not affect the clustering pattern of CD81--GFP, and this construct was hardly 
detected in endocytic organelles. Upper panels from left to right, images recorded in the 
green, red and blue channels; lower panels, magnified views of the white square ROIs 
indicated in the upper panels and overlays. Dotted circles indicate identical pixel 
localizations. (C) Pixelwise overlapping endosomes with GFP-accumulations within cell 
bases were counted and the average of the quantified endosomes from different 
membrane sheets was calculated. Values are given as mean ± SE (n = 3 independent 
experiments; for each experiment and condition 5 membrane sheets were analysed and 
quantified) (derived from Homsi et al., 2014). 
7.18.2 Pathogen-induced endocytosis analysed on intact 
cells 
As in figure 40, the same experiment was repeated with whole cells 
omitting the sonication step. Only for the green channel TIRF microscopy 
was used selectively showing the GFP-signal distribution in the basal cell 
membrane. This experiment confirms the formation of PsV-triggered 
CD81-GFP platform accumulations overlapping with membrane-
associated endosomes on intact cells (figure 41A) whereas in the 
absence of the -domain no changes were detected (figure 41B). Please 
note that the red channel was recorded using epifluorescence microscopy 
showing a high fluorescence background from the cell body. Even at this 
low signal to noise ratio, I was able to distinguish endosomes within the 
focal plane overlapping with CD81 platforms in the green channel, though 
at lower sensitivity yielding an accordingly lower number of detected 
endosomes per cell base (figure 41C).  
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Figure 41. Deletion of CD81 -domain affects PsV endocytosis 
(A – C) Jurkat cells overexpressing either CD81-GFP (A) or CD81--GFP (B) were 
incubated with (A and B upper panels) or without (A and B lower panels; control) HPV 
pseudovirions (PsVs) for 10 min at 37 °C in the presence of a fluid phase marker (20 µM 
sulforhodamine) as described in figure 40. Cells were adhered onto PLL-coated 
coverslips for 20 min at 37 °C and directly fixed, washed and imaged in the green 
channel (left panels) using TIRF microscopy visualizing overexpressed CD81-GFP or 
CD81--GFP or in the red channel (right panels) using epifluorescence microscopy to 
detect internalized fluid phase marker in form of endosomes. Epifluorescence images 
show strong out of focus background signals coming from internal compartments of the 
cells decreasing the signal-to-noise ratio; in spite of the noisy signal in the red channel, it 
was possible to count endosomes in close proximity to the cell membrane. As seen in 
figure 40A, pseudovirions changed the pattern of CD81 domain distribution in form of 
huge and bright accumulations of domains that from ring-like structures engulfing sealed 
endosomes overlapping with red spots in the red channel and possibly not completely 
sealed endosomes which are not visible in the red channel (A; lower panel). This effect 
was not seen in the control images (A; upper panel). (B) The pattern of CD81--GFP 
remains unchanged upon treatment with PsVs and rarely endosomes were observed. (C) 
Quantification of endosomes overlapping with GFP-accumulations (CD81-GFP or CD81- 
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-GFP). Values are mean ± SE (n = 3 independent experiments; for each experiment 
and condition 5 cells were analysed). 
7.18.3 Pseudovirions uptake analysed on intact cells 
using confocal microscopy 
In figures 40 and 41, a short incubation time with PsVs was chosen to 
observe PsV-induced endosomes that are located at the focal plane of the 
basal membrane and are still associated with it. Next, I increased the 
incubation time with PsVs to let the endosomes propagate into the cell 
body. For a more specific detection of PsVs containing endosomes, I used 
anit-HPV-L1 antibody (see 6.1.4.1) to immunostain PsV particles after cell 
permeabilization. Using confocal microscopy, I was able to detect 
immunostained PsV particles widely distributed throughout the cytosol. 
Internalized PsV particles were only seen in cells overexpressing CD81-
GFP where they overlapped with CD81-GFP accumulations (figure 42A; 
upper panels). In contrast, in the absence of the -domain, hardly any 
stained PsV particles inside the cells were observed. Rather, some PsV 
particles were attached to the outer surface of the cells. In addition, no 
large CD81- accumulations were detected after PsVs infection (figure 
42A; lower panels). Quantification of cells containing one or more GFP-
accumulations inside the cell body overlapping with immunostained HPV-
L1 particles showed a strong decrease of internalized viral particles upon 
overexpressing of CD81- (figure 42B). 
This finding indicates that CD81- clusters are not able to generate 
platforms suitable for PsVs uptake; therefore the -domain is crucial for 
CD81 to build or to integrate into functional platforms which are capable to 
act as pathogen entry points. 
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Figure 42. Internalized PsV particles analysed by confocal microscopy 
(A) Jurkat cells expressing either CD81-GFP (upper panels) or CD81--GFP (lower 
panels) were incubated for 1 h at 37 °C with PsVs, adhered for 20 min at 37 °C onto 
PLL-coated glass coverslips, fixed, permeabilized and immunostained for the PsV 
protein L1. Jurkat cells have a large nucleus and a small cytosolic volume, and during 
cell adhesion the plasma membrane spreads out and attaches tightly to the coverslips in 
a manner that most cytosolic compartments are found at the bottom of the adhered cells 
in a thin planar section beyond the coverslip, where the recorded confocal scans were 
taken. Sometimes, due to the membrane spreading across the coverslip, the cell 
membrane was pulled down and closely associated to the nucleus even in the proximity 
of the coverslip (lower panel). From left to right, bright-field images, confocal scans in the 
green channel (CD81-GFP or CD81--GFP), confocal scans in the red channel 
(immunostained L1 PsV protein) and overlays. Internalized PsVs and/or PsVs that co-
localized with GFP-accumulations were observed by cells overexpressing CD81-GFP 
(upper panels) but hardly seen in cells overexpressing CD81--GFP. These 
accumulations of CD81-GFP overlapping with stained viral particles are likely largely 
identical to the previously observed accumulations of CD81-GFP overlapping with the 
fluid phase marker in membrane sheets (figure 40) and intact cells (figure 41). Arrows 
indicate identical locations in different channels. Images are shown at arbitrary scaling. 
(B) Cells that contain at least one overlapping GFP-accumulation (CD81-GFP or CD81-
-GFP) with stained viral particles were counted and the percentage of all analysed 
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cells was calculated. Values are given as mean ± SE (n = 3 independent experiments; 
for each experiment and condition 9 – 11 cells were analysed) (derived from Homsi et 
al., 2014). 
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8 Discussion 
8.1 Organization of proteins in the cell membrane  
The basic structure of the cell membrane has been a very important issue 
for researchers since the discovery of cell organelles. The topic has 
maintained its importance until today, since many questions have not 
been answered yet. Cell membrane components and their behavior have 
been studied over years. The principle structure has been discussed in 
several models starting from Danielli and Davson’s model (1935) to 
Singer and Nicolson’s model (1972) (see 4.3). Singer and Nicolson’s 
model revolutionized the concept of the membrane basic structure and 
introduced the cell membrane as a fluid of a lipid bilayer in which proteins 
are inserted and are able to diffuse freely. This dynamic description 
opened new windows to study the lateral organization of membrane 
components. The main biological question about lateral organization 
within the membrane is how proteins can build specific clusters and be 
sorted in different microdomains. This important phenomenon is still not 
completely understood. After elucidation of the membrane basic structure 
as mentioned before, the lateral organization within the cell membrane 
has been further investigated and explained with different models e.g. the 
picket fence model in which proteins are captured in diffusion 
compartments formed via protein interaction with cell cytoskeleton 
(Kusumi et al., 2005) or the lipid raft model in which the proteins are 
enriched in lipid rafts generated by clustering of sphingolipids and 
cholesterol in the outer membrane of the lipid bilayer (Chen et al., 2004; 
Lingwood & Simons, 2010). Nonetheless, the mechanisms suggested are 
neither able to explain the high degree of micropatterning, nor the high 
specificity of segregation observed for two isoforms of a protein that share 
a high degree of structural similarity (Kai et al., 2006; Low et al., 2006; 
Uhles et al., 2003). Therefore, specific interaction between proteins 
should be the main force which drives proteins to segregate preferentially 
into their appropriate domains. 
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Another suggested model to explain the high protein micropatterning is 
the cluster phase model (Destainville, 2008; Homsi et al., 2014; Meilhac & 
Destainville, 2011). This model is based on the competition between 
short-range attractions (few times the thermal energy KBT; Alberts et al., 
2008; Phillips, Kondev et al., 2009) at ~1 nm between proteins in a dense 
phase, and long-range repulsions (close to or lower than the thermal 
energy) at ~10 nm (Meilhac & Destainville, 2011). Consequently, at these 
specific and sensitive interaction ranges small variations of the attractive 
forces can result in huge changes in protein clustering including protein 
segregation or sorting into specialized, distinct clusters. This is due to the 
counterbalanced cost in entropy by the gain of stabilizing interactions 
(Homsi et al., 2014; Meilhac & Destainville, 2011). In contrast to the 
classical view mentioned above, the cluster phase model takes into 
account the dynamical interaction of the attractive forces. Therefore, 
binary interaction which may occur within a short protein-protein 
interaction motif cannot generate a stable state over long time scale. 
However, dynamic metastable interactions which have the ability to 
generate permanent cycles of flexible interactions that break up through 
thermal agitation and can explain why in cluster phases most molecules 
are free to diffuse inside clusters (Espenel et al., 2008). Moreover, this 
kind of interaction features allow molecules to enter and leave clusters 
and diffuse freely in the membrane to reach another cluster and integrate 
into it. This concept suggests that modulation of these weakened flexible 
forces could have a huge effect on molecule segregation. This point of 
view has been observed in other studies showing that small modifications 
of a single protein domain can induce protein missorting or abolish 
clustering (Schreiber et al., 2012). Such observations cannot be explained 
with the classical view which only focused on the loss of one direct 
primary interaction in which case only the number of binary complexes 
decreases, but would not influence the capability of the protein to 
segregate into clusters or to build completely distinct clusters. 
Theoretically, the cluster phase predicts that an increased concentration 
of interaction partners has an influence on the number rather than on the 
size of clusters (Destainville & Foret, 2008). This behavior has been 
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experimentally observed in (Sieber et al., 2006). In contrast, growth of 
clusters is predicted to occur if attractive forces are increased as a result 
between attractive and repulsive forces. 
In conclusion, the cluster phase model could be an alternative approach 
to describe and understand the lateral organization of the cell membrane 
based on the dynamic features of protein interactions. 
8.2 TEMs and approaches for studying static and 
dynamic features 
As outlined in the introduction, TEMs constitute a highly stoichiometric 
assembly of several proteins driven by an unknown mechanism. TEMs 
were mainly studied using biochemical approaches such as 
immunoprecipitation and density gradient centrifugation. Microscopy, in 
contrast has rarely been used. Biochemical methods yield a static view 
not able to deliver any information about the dynamics of TEM 
components during assembly or to differentiate between TEMs at different 
growth states. Focussing for many years on this single strategy for 
studying TEMs was a weakness in this research field and has delayed the 
understanding of the proper mechanism that drives these proteins 
assemblies. 
The first report that studied tetraspanin and TEM behavior in a dynamic 
view was (Espenel et al., 2008) who used microscopic approaches such 
as single-molecule analysis to compare trajectories of different tracked 
single tetraspanins and to calculate the lateral diffusion coefficient of a 
single tetraspanin while entering and leaving a TEM. This new dynamic 
information in the tetraspanin field has inspired other groups to suggest 
the first dynamic model of TEM building based on these microscopic 
results (see figure 9) (Charrin et al., 2009). The microscopic approaches 
have revolutionized the concept of TEMs being just static protein 
assemblies or macro-clusters of different protein components, but 
suggested that TEMs are rather dynamic assemblies of proteins which are 
in a continuous dynamical interaction network with their surroundings. 
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Here, I studied the dynamics of CD81 using FRAP microscopy and I 
showed, as will be discussed in detail in the following, that CD81 diffusion 
depends on the -domain (see figure 30). Using TIRF microscopy, my 
data indicate that the -domain is necessary for building TEMs because 
this specific domain is required for TEM stability over time (see figure 31). 
This kind of information was collected using dynamic imaging approaches. 
In addition, static microscopy approaches have been used in parallel to 
biochemical approaches. Astonishingly, the static microscopic methods I 
used in this work perfectly correlated with previously reported biochemical 
results (see figure 38). Moreover, the immunoprecipitation results in this 
work shown in figures 27 and 28 correlated also with the microscopic 
observations because upon deletion of the -domain not only loss in co-
clustering but also interaction with protein partners were weakened. I 
conclude that microscopic methods could introduce realistic approaches 
for studying microdomains in both static and dynamic ways, and open 
new avenues to extend our understanding about tetraspanins and TEM 
mechanism and protein clustering in general with respect to the classical 
biochemical approaches. 
8.3 Fluorescent protein labelling of CD81 does not alter 
its function 
FP-tagging of proteins always varies concerns regarding physiological 
behavior. However as mentioned before, similar C-terminally FP-tagged 
CD81 constructs have been successfully used in previous studies by 
other groups (Coller et al., 2009; Mittelbrunn et al., 2002). Additionally, the 
microscopic findings are perfectly in line with previous data based on 
immunoprecipitation experiments (see 8.2), indirectly indicating that FP-
tagging does not seriously alter the behavior of CD81. Moreover, the new 
immunoprecipitation data generated in this work confirms that CD81-GFP 
still binds to both endogenous CD81 and CD9 (figures 27 and 28). Finally, 
the immunostaining experiments for endogenous CD81 (see 7.1) confirm 
that CD81-GFP is co-enriched with endogenous CD81 with a high degree 
of correlation and both molecules form clusters together (figure 20). In 
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conclusion, all observations strongly indicate that FP-tagging does not 
alter the physiological function and behavior of proteins. 
8.4 Mechanisms of CD81 web formation and stabilization  
The lateral association of tetraspanins includes different categories of 
interactions (Berditchevski & Rubinstein, 2013). These different interaction 
stages are classified on the basis of their resistance to detergents. The 
first-level of interaction is direct and maintained after harsh detergent 
treatment (Yáñez-Mó et al., 2009). These tetraspanin-partner interactions 
are assumed to be the most stable interactions mediated by tetraspanin 
molecules. In contrast, the second-level of interactions is formed by 
tetraspanin-tetraspanin contacts and can only survive mild detergent 
treatment (Charrin et al., 2009; Yáñez-Mó et al., 2009). In some reviews, 
the interactions are classified in level 1 referring to direct interactions 
including direct tetraspanin-tetraspanin interactions or tetraspanin 
dimerization and level 2 referring to the secondary interactions mediated 
by palmitoylation (Hemler, 2005). Therefore, the first level or tetraspanin-
partner interactions constitute the initial step of TEM formation; and in our 
case, the interaction between CD81 and EWI-2 plays this crucial role in 
the organization of TEMs. The assembly of tetraspanins and their partners 
in TEMs or web is assumed to result from a network of interactions that 
grows to form TEMs, which represent large supra-molecular complexes. 
I studied the lateral association of CD81 in two cell types and I found that 
the -domain is essential for CD81 organization and assembly in CD81 
rich clusters or platforms. The -domain is required for physiological 
clusters able to grow and to form larger platforms in the presence of EWI-
2, however only in Jurkat cells. My data confirm that the primary 
interaction between CD81 and EWI-2 is crucial for TEM formation, but is 
not per se sufficient. Instead, additional interactions with other factors are 
required for TEM growth and assembly, probably also including a CD81 
dimerization step, as observed by the disturbed association of CD81 with 
CD81- in the immunoprecipitation experiments
Discussion 
    
    119 
 
During the characterization of the CD81 domain(s)/feature(s) important for 
CD81 assembly, I deleted the - and -helices responsible for weak 
hydrophobic interactions which are required for hydrophobic CD81 
dimerization or I removed the palmitoylation sites. These changes led only 
to minor differences in clustering behavior. The analysis of the molecular 
distribution in the plasma membrane from a static view cannot exclude 
that weak interactions, palmitoylation or other regions of the CD81 
molecule do play a role during protein biosynthesis and trafficking in the 
endoplasmatic reticulum or Golgi-apparatus or that their absence may 
affect the mean residence time of CD81 in TEMs at a long time range. 
However, the data are in line with previous work showing that 
palmitoylation deficient CD9 only has a slightly increased diffusion 
coefficient (by ~20 %) and almost retains its fraction of confined 
molecules (with a small ~10 % reduction) (Espenel et al., 2008). Taken 
together, this confirms that palmitoylation may play a secondary stabilizing 
role by tetraspanin interactions. 
Referring to these results, I conclude that CD81 clustering requires the -
domain which is also essential for CD81 to colocalize with CD9 (figure 32) 
or EWI-2 (figure 36). Therefore, the -domain is crucial for tetraspanin 
domain clustering and represents the starting point to form large TEMs. 
Additionally, it regulates TEM development and dynamics. 
The above observation is interesting because the variable domain of the 
LEL specifies tetraspanins (it has a different aa sequence for each 
tetraspanin member), and it is varied in length and secondary structure 
(Seigneuret et al., 2001). If it is possible that -domains in all tetraspanin 
had the same function, they would be essential for the formation of large 
TEMs each specifically with distinct binding partners. This suggestion is in 
accordance with previously published studies showing that a chimera CD9 
molecule carrying only the LEL of CD81 behaves like CD81 in viral entry 
(Zhang et al., 2004). 
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8.5 Are there other co-factors necessary for TEM growth? 
In this work I was able to detect TEM growth upon increasing the 
concentration of EWI-2 protein which represents a primary interaction 
partner of most important tetraspanin molecules including CD81 and CD9 
(Charrin et al., 2003; Kolesnikova et al., 2003; Sala-Valdés et al., 2006). 
Moreover, EWI-2 plays a central role in TEM building and ensures the 
connection to the actin cytoskeleton through its direct association with 
ERM-proteins (Sala-Valdés et al., 2006). As discussed above (see 8.1), 
cluster growth is theoretically predicted when attractive forces are 
increased (see 4.3.4 and figure 7). This effect was observed in Jurkat 
cells when increasing the EWI-2 concentration (figure 36). However, 
increasing the EWI-2 concentration had no effect in HepG2 cells (figure 
39). These observations indicate that TEM growth may be regulated by 
other factors, which may have to be present to initiate the growth process. 
Previous reports showed that some tetraspanins interact directly with 
integrins and form complexes e.g. CD81/41, CD151/31 and 
CD151/61 which are very stable and resistant to digitonin detergent 
treatment. Moreover, these tetraspanin/integrin complexes are affected by 
altered integrin expression (Serru et al., 1999). Another report 
documented a similar effect of integrin expression on tetraspanin 
clustering, where 31 and 64 integrins promoted CD9 clustering 
(Yang et al., 2006). Additionally, EWI-2 is identified as a prominent cell-
surface partner for 41 integrin and at the same time a CD81 primary 
protein partner (as mentioned above). Hence, these three proteins form 
the EWI-2-CD81-41 complex which is promoted by EWI-2 
overexpression (Kolesnikova et al., 2003). Thus, 41 integrin together 
with EWI-2 and CD81 influence clustering and protein complex building. 
CD81 and EWI-2 were overexpressed together in HepG2 and Jurkat cells; 
therefore, an important issue is to check whether Jurkat or HepG2 cells 
express the third complex member41. Interestingly, both integrin 
components 4 and 1 of 41 are expressed in Jurkat cells 
(Kolesnikova et al., 2003), whereas only 1 integrin is expressed in 
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HepG2, while 4 is missing (Londrigan et al., 2000) or at least in a 
monolayer-culture (Ohno et al., 2009). Hence, these observations taken 
together with the literature indicate that 4 may be also a prerequisite for 
complex building. In addition, 41 integrin plays an important role in cell 
motility and fibronectin matrix assembly (Wu et al., 1995). More precisely, 
in Jurkat cells the 4 integrin associates physically with praxillin (a 
signaling adapter). Praxillin binds to 4 at high stoichiometry and 
connects the 4 tail to other integrins to form a complex (Liu et al., 1999). 
Finally, CD81 is described as a central linker between EWI-2 and 41 
(Kolesnikova et al., 2003). I may suggest that the simultaneously 
presence of EWI-2, CD81 and41 conceivably together with other 
molecules or co-factors such as praxillin is necessary to form big cluster 
or TEM, an effect seen here only in Jurkat cells. 
8.6 Does CD81 really constitute a master organizer of the 
plasma membrane? 
CD81 is ubiquitously expressed in nearly all cell types (Oren et al., 1990). 
Moreover, the participation of CD81 in different cellular processes (see 
4.5.2) indicates that this protein plays a central role in cell membrane 
organization. The depletion of CD81 leads to acute physiological 
disorders seen in CD81-/- knockout mice which developed humeral 
immune response disorder (Tsitsikov et al., 1997), spontaneous formation 
of multinuclear giant cells (Takeda et al., 2003), protein biosynthesis 
disorders (Shoham et al., 2003), low fertility (Rubinstein et al., 2006) as 
well as altered, lymphocyte proliferative responses (Miyazaki et al., 1997), 
neurobehavioral sensitivity (Michna et al., 2001), brain (Geisert et al., 
2002) and retinal pigment epithelium (Pan et al., 2011) development. In 
addition, CD81 is involved in pathogen entry (see table 1 and 4.5.2). Most 
of these effects occur at the plasma membrane and are dependent on the 
correct distribution and function of different cell surface components. As 
shown in (figure 31B and D), the non-functional, -domain-deleted version 
of CD81 (CD81-) showed a highly disordered clustering behaviour and 
a high degree of domain instability. In addition, overexpression of CD81-
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 even in the presence of endogenous CD81 in Jurkat cells, affected 
pathogen induced endocytosis (compare figures 40, 41 and 42). These 
results indicate that protein domain formation and distribution may play a 
key role in cellular processes mediated by cell surface, and that CD81 
may be a central protein indispensable for domain organization, building 
and distribution. Furthermore, the affected pathogen entry in the presence 
of both CD81- and endogenous CD81 seen in this work indicates that 
CD81- plays a dominant negative role by acting antagonistically to 
wild-type CD81. Moreover, CD81 knockdown induced serious disorder of 
integrin clusters figure 34, and also affected cell adhesion and motility 
(Quast et al., 2011). This important phenotype observed upon depletion of 
CD81 via siRNA is in line with the previous findings and all data confirm 
that CD81 constitutes a master organizer of the plasma membrane that 
plays an important role in membrane protein clustering and distribution. 
8.7 Cluster phase as an alternative, more realistic 
explanation for tetraspanins web formation 
According to previous concepts of TEM or web building, the classical view 
of TEM formation suggests that a large TEM is generated by a defined 
sequence of interactions which connects proteins with each other to form 
a network and allows them to grow laterally to form supra-molecular 
clusters.  
In contrast, the static and dynamic results found in this work, which cannot 
be explained by this classical view of TEM building, indicate that the issue 
of TEM organization and protein micropatterning mechanisms is rather 
controlled by a more physical, dynamical, simple explanation related to 
the cluster phase model discussed above (see 8.1). 
My data have shown that the deletion of the -domain (only 11 aa) leads 
to protein segregation in different clusters; such moderate attraction 
forces, which involve only few residue-residue interactions represent the 
specific interactions which control the preferential interaction of proteins to 
be integrated into specific clusters. This indicates that a very specific 
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interaction between proteins plays the main role in protein organization 
and controls the micropatterning mechanisms. These moderate 
interactions represent the metastable interactions described by the cluster 
phase model (see 8.1) which may explain the ability of a single 
tetraspanin molecule to diffuse freely inside clusters and even change 
between clusters after a free diffusion step in the membrane as seen by 
(Espenel et al., 2008). 
Therefore, the -domain interactions (metastable interactions) play an 
essential role to ensure higher energetic affinity and thermodynamically 
more stable attractions between CD81 and its partners, in addition to 
other less specific attraction forces. As shown above, the deletion of the -
domain heavily disturbs the colocalization between CD81- and CD9 
(figure 32) or EWI-2 (figure 36). 
Astonishingly, the theoretical concept of the cluster phase model has 
been reinforced by many experimental results found in this work. First, for 
a wide range of CD81 concentrations more, but similarly sized clusters 
were observed (figure 22). This validates the suggestion described by 
(Destainville & Foret, 2008), that the increased concentration of a cluster 
component has minor effects on cluster size but dramatically increases 
the number of clusters, similar to previous observations seen by (Sieber et 
al., 2006). Second, the deletion of a small single protein domain (the -
domain) has induced protein missorting and abolished TEM clustering 
(see figures 24, 32 and 36). These findings cannot be explained with the 
classical view which only focusses on the loss of one direct primary 
interaction, but rather reinforce the presence of metastable interactions 
controlling protein organization as described in 8.1. Finally, the cluster 
phase model suggests that growth of clusters is predicted to occur upon 
increasing of attractive forces. This suggestion was also validated with my 
findings and observed upon increasing the EWI-2 concentration (see 
figure 36) or the presence of soluble interaction partners on the surface 
represented by the PsVs (see figures 40 and 41). Therefore, the new 
findings in this work represent an alternative explanation, in which the 
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mechanism controlling TEM building may be based on the cluster phase 
model. 
In conclusion, the arguments of previous reports on the cluster phase 
theory are reinforced in this work and support the hypothesis described in 
(Homsi et al., 2014) namely that CD81 and its partners form cluster 
phases driven by free-energy gain, which results from weak interactions 
e.g. via hydrophobic interfaces or palmitoylation or by more specific 
interactions involving the -domain (see Appendix 3). This work opens 
new avenues for a better understanding of the TEM building and 
represents a new dynamical concept of protein lateral organization that 
may inspire future suggestions on TEM building mechanisms or protein 
organization models. 
8.8 Are all observed CD81-enriched platforms TEMs? 
The microscopy data in this work document that over a wide concentration 
range CD81 is assembled in domains. These domains are enriched with 
CD81, but the possibility of presence of other TEM and non-TEM 
components cannot be excluded. In addition, the data deliver several 
arguments indicating that the CD81 platforms observed represent TEMs. 
In particular the large CD81 microdomains represent bona fide TEMs. The 
primary interaction partner EWI-2, which is known as an essential TEM 
component, is recruited into the CD81 domains increasing their size. In 
addition, the tetraspanin CD9, whose association with CD81 occurs only 
into TEMs also co-enriches with CD81 domains. Moreover, the CD81 
domains show lower lateral mobility, more robust morphology and higher 
stability compared to non-TEM CD81- clusters that do not overlap 
neither with EWI-2 nor with CD9. Finally, the CD81 domains represent 
physiological platforms able to promote PsV-triggered endocytosis. These 
arguments confirm that the studied CD81 platforms in this work actually 
represent TEMs. Such detail seen by microscopic approaches would not 
be revealed in biochemical experiments. This paints out the importance of 
studying TEMs with microscopic approaches that in the future may give 
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more detailed answers about the significance of heterogeneity of 
observed TEMs. 
8.9 The role of CD81 TEMs in pathogen entry 
8.9.1 CD81 organized in TEMs is required for HPV 
endocytosis 
The CD81 molecule has been described in many studies as an important 
player in pathogen entry (see table 1) (Monk & Partridge, 2012; van 
Spriel, Annemiek B & Figdor, 2010). As mentioned before, the mechanism 
that drives pathogen entry is dependent on the type of pathogen (see 
4.5.2). For example, direct association with CD81 is required for the early 
steps of HCV entry (Potel et al., 2013; Rocha-Perugini et al., 2009). In 
contrast, the organization of CD81 into TEMs is a prerequisite for 
pathogen entry in the case of Plasmodium (Silvie et al., 2006) and HIV 
(Krementsov et al., 2010; Nydegger et al., 2006). In addition, HPV 
endocytosis is also gated via TEM association, where virus particles 
together with CD81-containing TEMs co-internalize into endosomes in an 
actin mediated, but clathrin-, caveolin-, and dynamin-idependent pathway 
(Scheffer et al., 2013; Scheffer et al., 2014). My data confirm that the 
organization of CD81 into functional platforms is required for HPV 
pseudovirions triggered endocytosis, which is strongly affected by 
perturbation of TEM assembly. Hence, these observations confirm also 
that HPV endocytosis is mediated by TEMs which generate linkage to the 
actin cytoskeleton, since CD81 directly binds to EWI-2 and both interact 
further with ERM-proteins (Coffey et al., 2009; Gordón-Alonso et al., 2012; 
Sala-Valdés et al., 2006; Stipp et al., 2003) which generate association 
with cell cytoskeleton (Arpin et al., 2011). Therefore, CD81 plays a key 
role by TEM building and the formation of functional CD81 platforms 
requires the -domain. 
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8.9.2 Possibilities to treat pathogen entry by inhibition of 
CD81 organization 
The most popular strategy for interfering with pathogen entry is the 
application of antibodies raised against CD81 or especially the LEL of 
CD81 (Meuleman & Leroux-Roels, 2008; Silvie et al., 2003; Spoden et al., 
2008). In this work I identified a much smaller domain (the -domain 
including only 11 aa) to play the key role in CD81 organization and 
pathogen entry. Therefore, it would be sufficient to interfere with this small 
domain by using an aptamer which is much cheaper and easier to 
produce, and can inhibit CD81 platform formation and consequently affect 
viral entry. Moreover, this therapeutical strategy could be clinically very 
convenient and much easier to realize. 
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9 Conclusion and outlook 
In this work I identified the function of the -domain of CD81, a small 
protein domain of only 11 aa that according to the data controls 
tetraspanin clustering and TEM building, and plays a key role in the 
formation of functional tetraspanin webs. 
In collaboration with Prof. Dr. Nicolas Destainville, based on these 
findings, an improved, general TEM building model is suggested, which is 
stimulating new ideas and concepts in the field of the tetraspanin 
research. However, the complete TEM building mechanism including all 
its necessary components is still not completely known. Based on these 
findings, future works should identity more potential key players for TEM 
organization, such as integrins, immunoglobulin superfamily members, 
and other critical tetraspanins (e.g. CD82, CD151, etc…). More protein 
candidates could be determined by immunoprecipitation analysis with 
endogenous CD81 after TEM building (e.g. during EWI-2 overexpression). 
Using gated STED super resolution microscopy, clustering behavior and 
cluster size could be studied at different stages of TEM formation. In this 
way, the size and shape of TEMs could be analyzed over a large 
concentration range of CD81 and/or EWI-2 in the cell membrane. 
Moreover, referring to super resolution images, TEMs could be 
quantitatively analyzed to estimate the real proportions of different TEM 
components, revealing the relationship between the concentration of 
different TEM components and TEM number, size and shape. 
Additional experiments using dynamic approaches are also required to 
understand the mechanism of TEM building over time. 
The understanding of the physiological function of TEMs also has high 
importance in the therapeutical field. Deletion of the -domain of the CD81 
protein affected the formation of physiologically active TEMs and 
consequently HPV entry. Therefore, additional infection experiments on 
different cell lines and different pathogens could reinforce my findings and 
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generalize the role of the -domain in pathogen entry. Additionally, the 
small size of the -domain (only 11 aa) making it an interesting target for 
future therapeutic strategies. 
Finally, TEMs constitute a membrane microdomain with key roles in 
diverse cellular processes, but the mechanism of their formation is still not 
completely clear to date. My data supplemented with the suggested TEM 
building model open new windows to study the mechanisms and 
principles of TEM formation using modern microscopic analysis. 
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Appendix 1. Western blot analysis of GFP-tagged CD81 variants in HepG2 and 
Jurkat cells  
(A) HepG2 cells were transfected with GFP-tagged CD81 variants lysed in RIPA buffer 
and used directly for western blot analysis. GFP-tagged constructs were detected via 
immunoblotting with anti-GFP (B-2) antibody (#sc-9996, Santa Cruz, USA). Bands were 
visualized after treatment with the secondary antibody goat anti-Mouse (#926-32210, LI-
COR, Germany) and scanning using Odyssey® CLx Imaging System (LI-COR Inc., 
Lincoln, USA) (for more information see 6.2.7). The detected bands showed the 
expected sizes for all overexpressed constructs. Note that the varying band intensities 
may cause by different cell viability after electroporation pulse. Such variability was not 
relevant for the performed experiments in HepG2 cells because during imaging cohorts 
of membrane sheets from cells with similar expression levels were obtained. Top section 
shows non contrasted bands, lower section showed same bands after contrast 
adjustment. (B) 10
7
 Jurkat cells expressing either CD81-GFP or CD81--GFP were 
lysed in RIPA buffer and used directly for western blot analysis following the same 
protocol as in A. CD81-GFP or CD81--GFP detected bands ran at the expected sizes. 
No degradation products were observed and both constructs showed comparable 
expression levels. (C) A table shows the names of constructs followed by the number of 
amino acids in the respective construct sequence (aa) and the number of deleted amino 
acids compared to wild-type sequence (-aa). 
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Appendix 2. Western blot analysis of CD81-GFP and CD81--GFP in Jurkat cells  
10
7
 Jurkat cells expressing cytosolic GFP (empty plasmid pEGFP_C1), CD81-GFP or 
CD81--GFP were lysed in 1 % CHAPS lysis buffer (EWI/2-RFP was also co-
expressed). Cell lysates were used directly for western blot analysis. GFP-signals were 
detected via immunoblotting with first antibody anti-GFP rabbit polyclonal (#A11122, 
Invitrogen, Carlsbad, CA, USA) and second antibody goat anti-rabbit IgG-HRP (#sc-
2030, Santa Cruz, USA). Endogenous CD81 was visualized via immunoblotting with first 
anti-body anti-CD81 (1.3.3.22) mouse monoclonal (#sc-7637, Santa Cruz, USA) and the 
second antibody goat anti-mouse (#sc-2031, Santa Cruz, USA). Membranes were 
developed on autoradiography films after treatment with western Blotting Luminol 
Reagent (#sc-2048, Santa Cruz, USA) (for more information see 6.2.7). The first lane of 
pEGFP_C1 was used for expression control. CD81-GFP and CD81--GFP bands 
showed similar overexpression levels of both construct. In addition, no degradation 
products were observed. For loading control, the endogenous CD81 was visualized 
showing same loaded materials in all lanes. 
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Appendix 3. Cluster phase dynamics model described in (Homsi et al., 2014) 
The cartoons represent the cluster phase model at molecular level. (A) Tetraspanin 
domains formed by tetraspanins and tetraspanin partner proteins are regulated by the 
competition between moderate short-range attractions, which favor protein assembly in a 
condensed phase, and long-rage repulsions, which disfavor assembly into a macro-
phase. The effect of steric hindrance within clusters causing physical repulsion has been 
described by (Sieber et al., 2007), and recently, Weitz (2013) proposed that the 
crystallographic shape of proteins can spontaneously alter membrane curvature which 
similarly leads to repulsion of proteins within a cluster (Weitz & Destainville, 2013). 
Proteins segregate in distinct clusters depending on their common energetic affinity 
(depicted here in different colors grey, red and blue). Therefore, each given color 
represents a different protein species. While some degree of missorting does occur, this 
is a rather rare event (Meilhac & Destainville, 2011). Yellow dots indicate the specific 
interaction sites between brick-red proteins and pink proteins, which represent the 
protein couple CD81/EWI-2 with yellow dots illustrating the specific interaction sites of -
domains. (B) Magnified view of the right cluster in A at two different time points t2 > t1. 
Within a crowded cluster phase, proteins diffuse laterally when interacting with partner 
proteins (indicated by purple arrows). Moreover, proteins can also, even within dense 
clusters, perform rotational diffusion and change interaction partners (illustrated by the 
red-brick protein interacting with two different proteins simultaneously between t1 and t2 
and indicated by orange arrows). Sometimes proteins engage in interaction after gaining 
free energy between t1 and t2, because interaction energies are moderate with respect to 
KBT (indicated by red arrows). In contrast to the classical view, this model represents 
clustering at a more dynamic view, where the primary, binary interactions are replaced 
by a network of fluctuating interactions with temporary partners. This concept fits well to 
recently published work using single molecule tracking experiments which show that 
individual proteins can enter and leave domains (Espenel et al., 2008) (indicated here by 
black arrows) (modified from Homsi et al., 2014). 
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